TWI649362B - Composition, liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element - Google Patents
Composition, liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element Download PDFInfo
- Publication number
- TWI649362B TWI649362B TW103135373A TW103135373A TWI649362B TW I649362 B TWI649362 B TW I649362B TW 103135373 A TW103135373 A TW 103135373A TW 103135373 A TW103135373 A TW 103135373A TW I649362 B TWI649362 B TW I649362B
- Authority
- TW
- Taiwan
- Prior art keywords
- liquid crystal
- group
- crystal alignment
- composition
- formula
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 279
- 239000004973 liquid crystal related substance Substances 0.000 title claims description 489
- 239000003795 chemical substances by application Substances 0.000 title claims description 216
- 229920001721 polyimide Polymers 0.000 claims abstract description 206
- 239000004642 Polyimide Substances 0.000 claims abstract description 142
- -1 amide imide Chemical class 0.000 claims abstract description 130
- 239000002904 solvent Substances 0.000 claims abstract description 110
- 229920000642 polymer Polymers 0.000 claims abstract description 87
- 239000002243 precursor Substances 0.000 claims abstract description 40
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims abstract description 8
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 100
- 239000000758 substrate Substances 0.000 claims description 81
- 125000004432 carbon atom Chemical group C* 0.000 claims description 77
- 125000000217 alkyl group Chemical group 0.000 claims description 72
- 150000001875 compounds Chemical class 0.000 claims description 67
- 238000000034 method Methods 0.000 claims description 56
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 41
- 150000000000 tetracarboxylic acids Chemical class 0.000 claims description 41
- 125000003545 alkoxy group Chemical group 0.000 claims description 32
- 229910052731 fluorine Inorganic materials 0.000 claims description 32
- 239000011737 fluorine Substances 0.000 claims description 25
- 229910052799 carbon Inorganic materials 0.000 claims description 24
- 125000005647 linker group Chemical group 0.000 claims description 24
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 23
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 23
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 22
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical group C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 22
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 20
- 125000000623 heterocyclic group Chemical group 0.000 claims description 19
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 18
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 18
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 claims description 17
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 17
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 17
- 125000004122 cyclic group Chemical group 0.000 claims description 16
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 15
- 125000000962 organic group Chemical group 0.000 claims description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 11
- 235000012000 cholesterol Nutrition 0.000 claims description 11
- 125000001153 fluoro group Chemical group F* 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 11
- 125000001424 substituent group Chemical group 0.000 claims description 11
- 238000006116 polymerization reaction Methods 0.000 claims description 9
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 claims description 8
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 8
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 claims description 7
- 125000002947 alkylene group Chemical group 0.000 claims description 6
- 125000002883 imidazolyl group Chemical group 0.000 claims description 6
- ZFPGARUNNKGOBB-UHFFFAOYSA-N 1-Ethyl-2-pyrrolidinone Chemical compound CCN1CCCC1=O ZFPGARUNNKGOBB-UHFFFAOYSA-N 0.000 claims description 5
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 claims description 5
- VATRWWPJWVCZTA-UHFFFAOYSA-N 3-oxo-n-[2-(trifluoromethyl)phenyl]butanamide Chemical compound CC(=O)CC(=O)NC1=CC=CC=C1C(F)(F)F VATRWWPJWVCZTA-UHFFFAOYSA-N 0.000 claims description 5
- 125000003342 alkenyl group Chemical group 0.000 claims description 5
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 claims description 4
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims description 4
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 claims description 4
- 125000003700 epoxy group Chemical group 0.000 claims description 4
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 claims description 4
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 claims description 4
- 235000013772 propylene glycol Nutrition 0.000 claims description 4
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 3
- 150000005676 cyclic carbonates Chemical group 0.000 claims description 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims 1
- 239000004615 ingredient Substances 0.000 abstract description 3
- 238000011156 evaluation Methods 0.000 description 184
- 239000010408 film Substances 0.000 description 167
- 239000000243 solution Substances 0.000 description 98
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 95
- 238000000576 coating method Methods 0.000 description 94
- 239000011248 coating agent Substances 0.000 description 85
- 230000015572 biosynthetic process Effects 0.000 description 61
- 238000003786 synthesis reaction Methods 0.000 description 57
- 239000002244 precipitate Substances 0.000 description 55
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 51
- 210000004027 cell Anatomy 0.000 description 49
- 229920005575 poly(amic acid) Polymers 0.000 description 49
- 210000002858 crystal cell Anatomy 0.000 description 48
- 239000004576 sand Substances 0.000 description 45
- 230000014759 maintenance of location Effects 0.000 description 42
- 229920005989 resin Polymers 0.000 description 39
- 239000011347 resin Substances 0.000 description 39
- 238000006243 chemical reaction Methods 0.000 description 35
- 238000004519 manufacturing process Methods 0.000 description 35
- 239000000843 powder Substances 0.000 description 35
- 230000000052 comparative effect Effects 0.000 description 32
- 238000001308 synthesis method Methods 0.000 description 26
- 230000005856 abnormality Effects 0.000 description 24
- 239000003054 catalyst Substances 0.000 description 23
- 239000007787 solid Substances 0.000 description 23
- 239000012456 homogeneous solution Substances 0.000 description 22
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 20
- 150000004985 diamines Chemical class 0.000 description 19
- 238000010438 heat treatment Methods 0.000 description 18
- 238000005245 sintering Methods 0.000 description 18
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 16
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 16
- 239000002253 acid Substances 0.000 description 13
- 150000001408 amides Chemical class 0.000 description 13
- 238000007639 printing Methods 0.000 description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- 125000006158 tetracarboxylic acid group Chemical group 0.000 description 12
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 229920003270 Cymel® Polymers 0.000 description 10
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 10
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 10
- 239000012528 membrane Substances 0.000 description 10
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 150000003335 secondary amines Chemical group 0.000 description 9
- 125000006850 spacer group Chemical group 0.000 description 9
- 239000004952 Polyamide Substances 0.000 description 8
- 150000001412 amines Chemical class 0.000 description 8
- 125000003277 amino group Chemical group 0.000 description 8
- 150000002148 esters Chemical class 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 229920002647 polyamide Polymers 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 6
- 150000007974 melamines Chemical class 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- 229960004063 propylene glycol Drugs 0.000 description 5
- 238000007789 sealing Methods 0.000 description 5
- LDQMZKBIBRAZEA-UHFFFAOYSA-N 2,4-diaminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C(N)=C1 LDQMZKBIBRAZEA-UHFFFAOYSA-N 0.000 description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- 239000004988 Nematic liquid crystal Substances 0.000 description 4
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 125000005577 anthracene group Chemical group 0.000 description 4
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 4
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 4
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Chemical compound CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 125000003709 fluoroalkyl group Chemical group 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 230000001678 irradiating effect Effects 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 4
- 125000001624 naphthyl group Chemical group 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 description 4
- 239000005020 polyethylene terephthalate Substances 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical group C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 238000002834 transmittance Methods 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- HOLGXWDGCVTMTB-UHFFFAOYSA-N 2-(2-aminophenyl)aniline Chemical group NC1=CC=CC=C1C1=CC=CC=C1N HOLGXWDGCVTMTB-UHFFFAOYSA-N 0.000 description 3
- QPRQEDXDYOZYLA-UHFFFAOYSA-N 2-methylbutan-1-ol Chemical compound CCC(C)CO QPRQEDXDYOZYLA-UHFFFAOYSA-N 0.000 description 3
- UENRXLSRMCSUSN-UHFFFAOYSA-N 3,5-diaminobenzoic acid Chemical compound NC1=CC(N)=CC(C(O)=O)=C1 UENRXLSRMCSUSN-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 229920001807 Urea-formaldehyde Polymers 0.000 description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
- BUCJGDQWMGOWHV-UHFFFAOYSA-N acetylene;urea Chemical class C#C.NC(N)=O BUCJGDQWMGOWHV-UHFFFAOYSA-N 0.000 description 3
- ORILYTVJVMAKLC-UHFFFAOYSA-N adamantane Chemical group C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 3
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 3
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 3
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 3
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 3
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 description 3
- 239000011229 interlayer Substances 0.000 description 3
- 238000009766 low-temperature sintering Methods 0.000 description 3
- 229940018564 m-phenylenediamine Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229910001507 metal halide Inorganic materials 0.000 description 3
- 150000005309 metal halides Chemical class 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 125000003518 norbornenyl group Chemical group C12(C=CC(CC1)C2)* 0.000 description 3
- 229920002401 polyacrylamide Polymers 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 238000011085 pressure filtration Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 125000003226 pyrazolyl group Chemical group 0.000 description 3
- 125000000714 pyrimidinyl group Chemical group 0.000 description 3
- 125000000168 pyrrolyl group Chemical group 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical group C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 3
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 2
- 125000001989 1,3-phenylene group Chemical group [H]C1=C([H])C([*:1])=C([H])C([*:2])=C1[H] 0.000 description 2
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 2
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- BBMCTIGTTCKYKF-UHFFFAOYSA-N 1-heptanol Chemical compound CCCCCCCO BBMCTIGTTCKYKF-UHFFFAOYSA-N 0.000 description 2
- UONVFNLDGRWLKF-UHFFFAOYSA-N 2,5-diaminobenzoic acid Chemical compound NC1=CC=C(N)C(C(O)=O)=C1 UONVFNLDGRWLKF-UHFFFAOYSA-N 0.000 description 2
- FPZWZCWUIYYYBU-UHFFFAOYSA-N 2-(2-ethoxyethoxy)ethyl acetate Chemical compound CCOCCOCCOC(C)=O FPZWZCWUIYYYBU-UHFFFAOYSA-N 0.000 description 2
- XKZQKPRCPNGNFR-UHFFFAOYSA-N 2-(3-hydroxyphenyl)phenol Chemical compound OC1=CC=CC(C=2C(=CC=CC=2)O)=C1 XKZQKPRCPNGNFR-UHFFFAOYSA-N 0.000 description 2
- QQZOPKMRPOGIEB-UHFFFAOYSA-N 2-Oxohexane Chemical compound CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 2
- JTXMVXSTHSMVQF-UHFFFAOYSA-N 2-acetyloxyethyl acetate Chemical compound CC(=O)OCCOC(C)=O JTXMVXSTHSMVQF-UHFFFAOYSA-N 0.000 description 2
- CETWDUZRCINIHU-UHFFFAOYSA-N 2-heptanol Chemical compound CCCCCC(C)O CETWDUZRCINIHU-UHFFFAOYSA-N 0.000 description 2
- HXDLWJWIAHWIKI-UHFFFAOYSA-N 2-hydroxyethyl acetate Chemical compound CC(=O)OCCO HXDLWJWIAHWIKI-UHFFFAOYSA-N 0.000 description 2
- PFNHSEQQEPMLNI-UHFFFAOYSA-N 2-methyl-1-pentanol Chemical compound CCCC(C)CO PFNHSEQQEPMLNI-UHFFFAOYSA-N 0.000 description 2
- WFRBDWRZVBPBDO-UHFFFAOYSA-N 2-methyl-2-pentanol Chemical compound CCCC(C)(C)O WFRBDWRZVBPBDO-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- LJGHYPLBDBRCRZ-UHFFFAOYSA-N 3-(3-aminophenyl)sulfonylaniline Chemical group NC1=CC=CC(S(=O)(=O)C=2C=C(N)C=CC=2)=C1 LJGHYPLBDBRCRZ-UHFFFAOYSA-N 0.000 description 2
- MXLMTQWGSQIYOW-UHFFFAOYSA-N 3-methyl-2-butanol Chemical compound CC(C)C(C)O MXLMTQWGSQIYOW-UHFFFAOYSA-N 0.000 description 2
- HTSABYAWKQAHBT-UHFFFAOYSA-N 3-methylcyclohexanol Chemical compound CC1CCCC(O)C1 HTSABYAWKQAHBT-UHFFFAOYSA-N 0.000 description 2
- HCFAJYNVAYBARA-UHFFFAOYSA-N 4-heptanone Chemical compound CCCC(=O)CCC HCFAJYNVAYBARA-UHFFFAOYSA-N 0.000 description 2
- RZKSECIXORKHQS-UHFFFAOYSA-N Heptan-3-ol Chemical compound CCCCC(O)CC RZKSECIXORKHQS-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- AMNPXXIGUOKIPP-UHFFFAOYSA-N [4-(carbamothioylamino)phenyl]thiourea Chemical compound NC(=S)NC1=CC=C(NC(N)=S)C=C1 AMNPXXIGUOKIPP-UHFFFAOYSA-N 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 125000004849 alkoxymethyl group Chemical group 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical group C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 2
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000001273 butane Substances 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical group C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- KZTYYGOKRVBIMI-UHFFFAOYSA-N diphenyl sulfone Chemical compound C=1C=CC=CC=1S(=O)(=O)C1=CC=CC=C1 KZTYYGOKRVBIMI-UHFFFAOYSA-N 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- XLLIQLLCWZCATF-UHFFFAOYSA-N ethylene glycol monomethyl ether acetate Natural products COCCOC(C)=O XLLIQLLCWZCATF-UHFFFAOYSA-N 0.000 description 2
- HJUFTIJOISQSKQ-UHFFFAOYSA-N fenoxycarb Chemical compound C1=CC(OCCNC(=O)OCC)=CC=C1OC1=CC=CC=C1 HJUFTIJOISQSKQ-UHFFFAOYSA-N 0.000 description 2
- 125000004428 fluoroalkoxy group Chemical group 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- VPVSTMAPERLKKM-UHFFFAOYSA-N glycoluril Chemical compound N1C(=O)NC2NC(=O)NC21 VPVSTMAPERLKKM-UHFFFAOYSA-N 0.000 description 2
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 2
- VAMFXQBUQXONLZ-UHFFFAOYSA-N icos-1-ene Chemical compound CCCCCCCCCCCCCCCCCCC=C VAMFXQBUQXONLZ-UHFFFAOYSA-N 0.000 description 2
- 150000002466 imines Chemical class 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- WSKHYOXDVZCOJP-UHFFFAOYSA-N naphthalene-1,6-diamine Chemical compound NC1=CC=CC2=CC(N)=CC=C21 WSKHYOXDVZCOJP-UHFFFAOYSA-N 0.000 description 2
- ZDWYJINCYGEEJB-UHFFFAOYSA-N naphthalene-1,7-diamine Chemical compound C1=CC=C(N)C2=CC(N)=CC=C21 ZDWYJINCYGEEJB-UHFFFAOYSA-N 0.000 description 2
- KPSSIOMAKSHJJG-UHFFFAOYSA-N neopentyl alcohol Chemical compound CC(C)(C)CO KPSSIOMAKSHJJG-UHFFFAOYSA-N 0.000 description 2
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 2
- 239000004843 novolac epoxy resin Substances 0.000 description 2
- SJWFXCIHNDVPSH-UHFFFAOYSA-N octan-2-ol Chemical compound CCCCCCC(C)O SJWFXCIHNDVPSH-UHFFFAOYSA-N 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 2
- JYVLIDXNZAXMDK-UHFFFAOYSA-N pentan-2-ol Chemical compound CCCC(C)O JYVLIDXNZAXMDK-UHFFFAOYSA-N 0.000 description 2
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 2
- AQIXEPGDORPWBJ-UHFFFAOYSA-N pentan-3-ol Chemical compound CCC(O)CC AQIXEPGDORPWBJ-UHFFFAOYSA-N 0.000 description 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical group C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 238000006068 polycondensation reaction Methods 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 150000003141 primary amines Chemical class 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- 125000002755 pyrazolinyl group Chemical group 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 238000007650 screen-printing Methods 0.000 description 2
- 239000000565 sealant Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 2
- 125000001425 triazolyl group Chemical group 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- FADNCTVVKDWKIX-UHFFFAOYSA-N (2,4-diaminophenyl)methanol Chemical compound NC1=CC=C(CO)C(N)=C1 FADNCTVVKDWKIX-UHFFFAOYSA-N 0.000 description 1
- LYSJSRSBKUIFDF-UHFFFAOYSA-N (2-aminophenyl)-(3-aminophenyl)methanone Chemical compound NC1=CC=CC(C(=O)C=2C(=CC=CC=2)N)=C1 LYSJSRSBKUIFDF-UHFFFAOYSA-N 0.000 description 1
- DIROCAXZQHFLCZ-UHFFFAOYSA-N (2-hydroxy-3-prop-2-enoyloxypropyl) benzoate Chemical compound C=CC(=O)OCC(O)COC(=O)C1=CC=CC=C1 DIROCAXZQHFLCZ-UHFFFAOYSA-N 0.000 description 1
- OHLQBRYVKXJYHZ-UHFFFAOYSA-N (3,5-diaminophenyl)methanol Chemical compound NC1=CC(N)=CC(CO)=C1 OHLQBRYVKXJYHZ-UHFFFAOYSA-N 0.000 description 1
- YKNMIGJJXKBHJE-UHFFFAOYSA-N (3-aminophenyl)-(4-aminophenyl)methanone Chemical compound C1=CC(N)=CC=C1C(=O)C1=CC=CC(N)=C1 YKNMIGJJXKBHJE-UHFFFAOYSA-N 0.000 description 1
- NMRPBPVERJPACX-UHFFFAOYSA-N (3S)-octan-3-ol Natural products CCCCCC(O)CC NMRPBPVERJPACX-UHFFFAOYSA-N 0.000 description 1
- JDGFELYPUWNNGR-UHFFFAOYSA-N 1,2,3,3a,4,5,6,6a-octahydropentalene-1,3,4,6-tetracarboxylic acid Chemical compound OC(=O)C1CC(C(O)=O)C2C(C(=O)O)CC(C(O)=O)C21 JDGFELYPUWNNGR-UHFFFAOYSA-N 0.000 description 1
- UGUHFDPGDQDVGX-UHFFFAOYSA-N 1,2,3-thiadiazole Chemical group C1=CSN=N1 UGUHFDPGDQDVGX-UHFFFAOYSA-N 0.000 description 1
- JWTGRKUQJXIWCV-UHFFFAOYSA-N 1,2,3-trihydroxypropyl 2-methylprop-2-enoate Chemical group CC(=C)C(=O)OC(O)C(O)CO JWTGRKUQJXIWCV-UHFFFAOYSA-N 0.000 description 1
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 description 1
- OUPZKGBUJRBPGC-UHFFFAOYSA-N 1,3,5-tris(oxiran-2-ylmethyl)-1,3,5-triazinane-2,4,6-trione Chemical compound O=C1N(CC2OC2)C(=O)N(CC2OC2)C(=O)N1CC1CO1 OUPZKGBUJRBPGC-UHFFFAOYSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- UADFTMJGFBALAH-UHFFFAOYSA-N 1,3-bis[4-[1-[4-(oxiran-2-ylmethoxy)phenyl]-1-[4-[2-[4-(oxiran-2-ylmethoxy)phenyl]propan-2-yl]phenyl]ethyl]phenoxy]propan-2-ol Chemical compound C=1C=C(C(C)(C=2C=CC(OCC(O)COC=3C=CC(=CC=3)C(C)(C=3C=CC(OCC4OC4)=CC=3)C=3C=CC(=CC=3)C(C)(C)C=3C=CC(OCC4OC4)=CC=3)=CC=2)C=2C=CC(OCC3OC3)=CC=2)C=CC=1C(C)(C)C(C=C1)=CC=C1OCC1CO1 UADFTMJGFBALAH-UHFFFAOYSA-N 0.000 description 1
- ULAFJDYDLJSYLI-UHFFFAOYSA-N 1,3-diphenylcyclobutane-1,2,3,4-tetracarboxylic acid Chemical compound C1(=CC=CC=C1)C1(C(C(C1C(=O)O)(C(=O)O)C1=CC=CC=C1)C(=O)O)C(=O)O ULAFJDYDLJSYLI-UHFFFAOYSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- QOFXGXMENLLBPT-UHFFFAOYSA-N 1,4-bis(butan-2-yloxymethyl)benzene Chemical compound CCC(C)OCC1=CC=C(COC(C)CC)C=C1 QOFXGXMENLLBPT-UHFFFAOYSA-N 0.000 description 1
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 description 1
- YFOOEYJGMMJJLS-UHFFFAOYSA-N 1,8-diaminonaphthalene Chemical compound C1=CC(N)=C2C(N)=CC=CC2=C1 YFOOEYJGMMJJLS-UHFFFAOYSA-N 0.000 description 1
- PWGJDPKCLMLPJW-UHFFFAOYSA-N 1,8-diaminooctane Chemical compound NCCCCCCCCN PWGJDPKCLMLPJW-UHFFFAOYSA-N 0.000 description 1
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 description 1
- GDXHBFHOEYVPED-UHFFFAOYSA-N 1-(2-butoxyethoxy)butane Chemical compound CCCCOCCOCCCC GDXHBFHOEYVPED-UHFFFAOYSA-N 0.000 description 1
- QWOZZTWBWQMEPD-UHFFFAOYSA-N 1-(2-ethoxypropoxy)propan-2-ol Chemical compound CCOC(C)COCC(C)O QWOZZTWBWQMEPD-UHFFFAOYSA-N 0.000 description 1
- VTBOTOBFGSVRMA-UHFFFAOYSA-N 1-Methylcyclohexanol Chemical compound CC1(O)CCCCC1 VTBOTOBFGSVRMA-UHFFFAOYSA-N 0.000 description 1
- DRPGMPGXMZRHRN-UHFFFAOYSA-N 1-N,4-N-bis[(3-aminophenyl)methyl]benzene-1,4-diamine Chemical compound C1(=CC=C(C=C1)NCC1=CC(=CC=C1)N)NCC1=CC(=CC=C1)N DRPGMPGXMZRHRN-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- VLDPXPPHXDGHEW-UHFFFAOYSA-N 1-chloro-2-dichlorophosphoryloxybenzene Chemical compound ClC1=CC=CC=C1OP(Cl)(Cl)=O VLDPXPPHXDGHEW-UHFFFAOYSA-N 0.000 description 1
- RRQYJINTUHWNHW-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxy)ethane Chemical compound CCOCCOCCOCC RRQYJINTUHWNHW-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- BPIUIOXAFBGMNB-UHFFFAOYSA-N 1-hexoxyhexane Chemical compound CCCCCCOCCCCCC BPIUIOXAFBGMNB-UHFFFAOYSA-N 0.000 description 1
- HIETXQBDOKUUDB-UHFFFAOYSA-N 1-n,4-n-bis[(4-aminophenyl)methyl]benzene-1,4-diamine Chemical compound C1=CC(N)=CC=C1CNC(C=C1)=CC=C1NCC1=CC=C(N)C=C1 HIETXQBDOKUUDB-UHFFFAOYSA-N 0.000 description 1
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- WCZNKVPCIFMXEQ-UHFFFAOYSA-N 2,3,5,6-tetramethylbenzene-1,4-diamine Chemical compound CC1=C(C)C(N)=C(C)C(C)=C1N WCZNKVPCIFMXEQ-UHFFFAOYSA-N 0.000 description 1
- 229940075142 2,5-diaminotoluene Drugs 0.000 description 1
- RLYCRLGLCUXUPO-UHFFFAOYSA-N 2,6-diaminotoluene Chemical compound CC1=C(N)C=CC=C1N RLYCRLGLCUXUPO-UHFFFAOYSA-N 0.000 description 1
- VXQBJTKSVGFQOL-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethyl acetate Chemical compound CCCCOCCOCCOC(C)=O VXQBJTKSVGFQOL-UHFFFAOYSA-N 0.000 description 1
- XXXFZKQPYACQLD-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl acetate Chemical compound CC(=O)OCCOCCO XXXFZKQPYACQLD-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- CRQBUNFZJOLMKC-UHFFFAOYSA-N 2-(3-aminophenyl)aniline Chemical group NC1=CC=CC(C=2C(=CC=CC=2)N)=C1 CRQBUNFZJOLMKC-UHFFFAOYSA-N 0.000 description 1
- NCHBYORVPVDWBJ-UHFFFAOYSA-N 2-(3-methylbutoxy)ethanol Chemical compound CC(C)CCOCCO NCHBYORVPVDWBJ-UHFFFAOYSA-N 0.000 description 1
- INFFATMFXZFLAO-UHFFFAOYSA-N 2-(methoxymethoxy)ethanol Chemical compound COCOCCO INFFATMFXZFLAO-UHFFFAOYSA-N 0.000 description 1
- RWLALWYNXFYRGW-UHFFFAOYSA-N 2-Ethyl-1,3-hexanediol Chemical compound CCCC(O)C(CC)CO RWLALWYNXFYRGW-UHFFFAOYSA-N 0.000 description 1
- WOFPPJOZXUTRAU-UHFFFAOYSA-N 2-Ethyl-1-hexanol Natural products CCCCC(O)CCC WOFPPJOZXUTRAU-UHFFFAOYSA-N 0.000 description 1
- HQLKZWRSOHTERR-UHFFFAOYSA-N 2-Ethylbutyl acetate Chemical compound CCC(CC)COC(C)=O HQLKZWRSOHTERR-UHFFFAOYSA-N 0.000 description 1
- OHKOAJUTRVTYSW-UHFFFAOYSA-N 2-[(2-aminophenyl)methyl]aniline Chemical compound NC1=CC=CC=C1CC1=CC=CC=C1N OHKOAJUTRVTYSW-UHFFFAOYSA-N 0.000 description 1
- WFSMVVDJSNMRAR-UHFFFAOYSA-N 2-[2-(2-ethoxyethoxy)ethoxy]ethanol Chemical compound CCOCCOCCOCCO WFSMVVDJSNMRAR-UHFFFAOYSA-N 0.000 description 1
- WAEVWDZKMBQDEJ-UHFFFAOYSA-N 2-[2-(2-methoxypropoxy)propoxy]propan-1-ol Chemical compound COC(C)COC(C)COC(C)CO WAEVWDZKMBQDEJ-UHFFFAOYSA-N 0.000 description 1
- SEFYJVFBMNOLBK-UHFFFAOYSA-N 2-[2-[2-(oxiran-2-ylmethoxy)ethoxy]ethoxymethyl]oxirane Chemical compound C1OC1COCCOCCOCC1CO1 SEFYJVFBMNOLBK-UHFFFAOYSA-N 0.000 description 1
- PTXMNGZGHGYOIJ-UHFFFAOYSA-N 2-[4-hydroxy-3,3-bis(hydroxymethyl)butan-2-yl]oxyethyl prop-2-enoate Chemical compound OCC(CO)(CO)C(C)OCCOC(=O)C=C PTXMNGZGHGYOIJ-UHFFFAOYSA-N 0.000 description 1
- JUHBZVGMCWBTAX-UHFFFAOYSA-N 2-[[(2,3-diphenyloxiran-2-yl)-diphenylmethoxy]-diphenylmethyl]-2,3-diphenyloxirane;ethane Chemical compound CC.C=1C=CC=CC=1C(C1(C(O1)C=1C=CC=CC=1)C=1C=CC=CC=1)(C=1C=CC=CC=1)OC(C1(C(O1)C=1C=CC=CC=1)C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 JUHBZVGMCWBTAX-UHFFFAOYSA-N 0.000 description 1
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 description 1
- IIQLVLWFQUUZII-UHFFFAOYSA-N 2-amino-5-(4-amino-3-carboxyphenyl)benzoic acid Chemical group C1=C(C(O)=O)C(N)=CC=C1C1=CC=C(N)C(C(O)=O)=C1 IIQLVLWFQUUZII-UHFFFAOYSA-N 0.000 description 1
- ZGDMDBHLKNQPSD-UHFFFAOYSA-N 2-amino-5-(4-amino-3-hydroxyphenyl)phenol Chemical group C1=C(O)C(N)=CC=C1C1=CC=C(N)C(O)=C1 ZGDMDBHLKNQPSD-UHFFFAOYSA-N 0.000 description 1
- NQBXSWAWVZHKBZ-UHFFFAOYSA-N 2-butoxyethyl acetate Chemical compound CCCCOCCOC(C)=O NQBXSWAWVZHKBZ-UHFFFAOYSA-N 0.000 description 1
- HFACYWDPMNWMIW-UHFFFAOYSA-N 2-cyclohexylethanamine Chemical compound NCCC1CCCCC1 HFACYWDPMNWMIW-UHFFFAOYSA-N 0.000 description 1
- SVONRAPFKPVNKG-UHFFFAOYSA-N 2-ethoxyethyl acetate Chemical compound CCOCCOC(C)=O SVONRAPFKPVNKG-UHFFFAOYSA-N 0.000 description 1
- TZYRSLHNPKPEFV-UHFFFAOYSA-N 2-ethyl-1-butanol Chemical compound CCC(CC)CO TZYRSLHNPKPEFV-UHFFFAOYSA-N 0.000 description 1
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 1
- WOYWLLHHWAMFCB-UHFFFAOYSA-N 2-ethylhexyl acetate Chemical compound CCCCC(CC)COC(C)=O WOYWLLHHWAMFCB-UHFFFAOYSA-N 0.000 description 1
- UPGSWASWQBLSKZ-UHFFFAOYSA-N 2-hexoxyethanol Chemical compound CCCCCCOCCO UPGSWASWQBLSKZ-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- OBCSAIDCZQSFQH-UHFFFAOYSA-N 2-methyl-1,4-phenylenediamine Chemical compound CC1=CC(N)=CC=C1N OBCSAIDCZQSFQH-UHFFFAOYSA-N 0.000 description 1
- CRWNQZTZTZWPOF-UHFFFAOYSA-N 2-methyl-4-phenylpyridine Chemical compound C1=NC(C)=CC(C=2C=CC=CC=2)=C1 CRWNQZTZTZWPOF-UHFFFAOYSA-N 0.000 description 1
- XEZFBMMCYVYRTI-UHFFFAOYSA-N 2-methyl-5-propylaniline Chemical compound CCCC1=CC=C(C)C(N)=C1 XEZFBMMCYVYRTI-UHFFFAOYSA-N 0.000 description 1
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 1
- NDVWOBYBJYUSMF-UHFFFAOYSA-N 2-methylcyclohexan-1-ol Chemical compound CC1CCCCC1O NDVWOBYBJYUSMF-UHFFFAOYSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- UDXXYUDJOHIIDZ-UHFFFAOYSA-N 2-phosphonooxyethyl prop-2-enoate Chemical compound OP(O)(=O)OCCOC(=O)C=C UDXXYUDJOHIIDZ-UHFFFAOYSA-N 0.000 description 1
- JRBJSXQPQWSCCF-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine Chemical group C1=C(N)C(OC)=CC(C=2C=C(OC)C(N)=CC=2)=C1 JRBJSXQPQWSCCF-UHFFFAOYSA-N 0.000 description 1
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical group C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 1
- WFNVGXBEWXBZPL-UHFFFAOYSA-N 3,5-diaminophenol Chemical compound NC1=CC(N)=CC(O)=C1 WFNVGXBEWXBZPL-UHFFFAOYSA-N 0.000 description 1
- DUTLDPJDAOIISX-UHFFFAOYSA-N 3-(1,1,1,3,3,3-hexafluoropropan-2-yl)aniline Chemical compound NC1=CC=CC(C(C(F)(F)F)C(F)(F)F)=C1 DUTLDPJDAOIISX-UHFFFAOYSA-N 0.000 description 1
- LXJLFVRAWOOQDR-UHFFFAOYSA-N 3-(3-aminophenoxy)aniline Chemical compound NC1=CC=CC(OC=2C=C(N)C=CC=2)=C1 LXJLFVRAWOOQDR-UHFFFAOYSA-N 0.000 description 1
- NDXGRHCEHPFUSU-UHFFFAOYSA-N 3-(3-aminophenyl)aniline Chemical group NC1=CC=CC(C=2C=C(N)C=CC=2)=C1 NDXGRHCEHPFUSU-UHFFFAOYSA-N 0.000 description 1
- QCAHUFWKIQLBNB-UHFFFAOYSA-N 3-(3-methoxypropoxy)propan-1-ol Chemical compound COCCCOCCCO QCAHUFWKIQLBNB-UHFFFAOYSA-N 0.000 description 1
- ZBMISJGHVWNWTE-UHFFFAOYSA-N 3-(4-aminophenoxy)aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=CC(N)=C1 ZBMISJGHVWNWTE-UHFFFAOYSA-N 0.000 description 1
- QSPMTSAELLSLOQ-UHFFFAOYSA-N 3-(4-aminophenyl)aniline Chemical group C1=CC(N)=CC=C1C1=CC=CC(N)=C1 QSPMTSAELLSLOQ-UHFFFAOYSA-N 0.000 description 1
- CROFKKWKPANQKX-UHFFFAOYSA-N 3-[(3-aminophenyl)-dimethylsilyl]aniline Chemical compound C=1C=CC(N)=CC=1[Si](C)(C)C1=CC=CC(N)=C1 CROFKKWKPANQKX-UHFFFAOYSA-N 0.000 description 1
- CKOFBUUFHALZGK-UHFFFAOYSA-N 3-[(3-aminophenyl)methyl]aniline Chemical compound NC1=CC=CC(CC=2C=C(N)C=CC=2)=C1 CKOFBUUFHALZGK-UHFFFAOYSA-N 0.000 description 1
- OQOCRVBUYRQQPS-UHFFFAOYSA-N 3-[2-(3-aminophenyl)ethyl]aniline Chemical compound NC1=CC=CC(CCC=2C=C(N)C=CC=2)=C1 OQOCRVBUYRQQPS-UHFFFAOYSA-N 0.000 description 1
- LMQOEUTZXKKSBC-UHFFFAOYSA-N 3-[3-(3-aminophenoxy)propoxy]aniline Chemical compound NC1=CC=CC(OCCCOC=2C=C(N)C=CC=2)=C1 LMQOEUTZXKKSBC-UHFFFAOYSA-N 0.000 description 1
- CKTOHFTWIAKLPM-UHFFFAOYSA-N 3-[3-(3-aminophenyl)propyl]aniline Chemical compound NC1=CC=CC(CCCC=2C=C(N)C=CC=2)=C1 CKTOHFTWIAKLPM-UHFFFAOYSA-N 0.000 description 1
- RKVYQWSCHYCGPT-UHFFFAOYSA-N 3-[4-(3-aminophenoxy)butoxy]aniline Chemical compound NC1=CC=CC(OCCCCOC=2C=C(N)C=CC=2)=C1 RKVYQWSCHYCGPT-UHFFFAOYSA-N 0.000 description 1
- ITXOUPUVWUUSAN-UHFFFAOYSA-N 3-[4-(3-aminophenyl)butyl]aniline Chemical compound NC=1C=C(C=CC1)CCCCC1=CC(=CC=C1)N ITXOUPUVWUUSAN-UHFFFAOYSA-N 0.000 description 1
- XKBRJCSVQIUYGX-UHFFFAOYSA-N 3-[5-(3-aminophenoxy)pentoxy]aniline Chemical compound NC1=CC=CC(OCCCCCOC=2C=C(N)C=CC=2)=C1 XKBRJCSVQIUYGX-UHFFFAOYSA-N 0.000 description 1
- GSCPDZHWVNUUFI-UHFFFAOYSA-N 3-aminobenzamide Chemical compound NC(=O)C1=CC=CC(N)=C1 GSCPDZHWVNUUFI-UHFFFAOYSA-N 0.000 description 1
- GALUFHRFAYTRDG-UHFFFAOYSA-N 3-ethoxybutyl acetate Chemical compound CCOC(C)CCOC(C)=O GALUFHRFAYTRDG-UHFFFAOYSA-N 0.000 description 1
- JRXXEXVXTFEBIY-UHFFFAOYSA-N 3-ethoxypropanoic acid Chemical compound CCOCCC(O)=O JRXXEXVXTFEBIY-UHFFFAOYSA-N 0.000 description 1
- HTNUUDFQRYBJPH-UHFFFAOYSA-N 3-methoxypropanehydrazide Chemical compound COCCC(=O)NN HTNUUDFQRYBJPH-UHFFFAOYSA-N 0.000 description 1
- IPWGAPCYYMTTLT-UHFFFAOYSA-N 3-propylaniline Chemical compound CCCC1=CC=CC(N)=C1 IPWGAPCYYMTTLT-UHFFFAOYSA-N 0.000 description 1
- YBRVSVVVWCFQMG-UHFFFAOYSA-N 4,4'-diaminodiphenylmethane Chemical compound C1=CC(N)=CC=C1CC1=CC=C(N)C=C1 YBRVSVVVWCFQMG-UHFFFAOYSA-N 0.000 description 1
- XTEBLARUAVEBRF-UHFFFAOYSA-N 4-(1,1,1,3,3,3-hexafluoropropan-2-yl)aniline Chemical compound NC1=CC=C(C(C(F)(F)F)C(F)(F)F)C=C1 XTEBLARUAVEBRF-UHFFFAOYSA-N 0.000 description 1
- UITKHKNFVCYWNG-UHFFFAOYSA-N 4-(3,4-dicarboxybenzoyl)phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1C(=O)C1=CC=C(C(O)=O)C(C(O)=O)=C1 UITKHKNFVCYWNG-UHFFFAOYSA-N 0.000 description 1
- AIVVXPSKEVWKMY-UHFFFAOYSA-N 4-(3,4-dicarboxyphenoxy)phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1OC1=CC=C(C(O)=O)C(C(O)=O)=C1 AIVVXPSKEVWKMY-UHFFFAOYSA-N 0.000 description 1
- LFBALUPVVFCEPA-UHFFFAOYSA-N 4-(3,4-dicarboxyphenyl)phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)C(C(O)=O)=C1 LFBALUPVVFCEPA-UHFFFAOYSA-N 0.000 description 1
- XDYLWBWPEDSSLU-UHFFFAOYSA-N 4-(3-carboxyphenyl)benzene-1,2,3-tricarboxylic acid Chemical compound OC(=O)C1=CC=CC(C=2C(=C(C(O)=O)C(C(O)=O)=CC=2)C(O)=O)=C1 XDYLWBWPEDSSLU-UHFFFAOYSA-N 0.000 description 1
- LVNPGQZSPDFZNC-UHFFFAOYSA-N 4-(4-amino-3-fluorophenyl)-2-fluoroaniline Chemical group C1=C(F)C(N)=CC=C1C1=CC=C(N)C(F)=C1 LVNPGQZSPDFZNC-UHFFFAOYSA-N 0.000 description 1
- SOFXBRQDJPTYIK-UHFFFAOYSA-N 4-(4-aminophenyl)silylaniline Chemical compound C1=CC(N)=CC=C1[SiH2]C1=CC=C(N)C=C1 SOFXBRQDJPTYIK-UHFFFAOYSA-N 0.000 description 1
- HLBLWEWZXPIGSM-UHFFFAOYSA-N 4-Aminophenyl ether Chemical compound C1=CC(N)=CC=C1OC1=CC=C(N)C=C1 HLBLWEWZXPIGSM-UHFFFAOYSA-N 0.000 description 1
- HNHQPIBXQALMMN-UHFFFAOYSA-N 4-[(3,4-dicarboxyphenyl)-dimethylsilyl]phthalic acid Chemical compound C=1C=C(C(O)=O)C(C(O)=O)=CC=1[Si](C)(C)C1=CC=C(C(O)=O)C(C(O)=O)=C1 HNHQPIBXQALMMN-UHFFFAOYSA-N 0.000 description 1
- MOCQGMXEHQTAEN-UHFFFAOYSA-N 4-[(3,4-dicarboxyphenyl)-diphenylsilyl]phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1[Si](C=1C=C(C(C(O)=O)=CC=1)C(O)=O)(C=1C=CC=CC=1)C1=CC=CC=C1 MOCQGMXEHQTAEN-UHFFFAOYSA-N 0.000 description 1
- IWXCYYWDGDDPAC-UHFFFAOYSA-N 4-[(3,4-dicarboxyphenyl)methyl]phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1CC1=CC=C(C(O)=O)C(C(O)=O)=C1 IWXCYYWDGDDPAC-UHFFFAOYSA-N 0.000 description 1
- IGSBHTZEJMPDSZ-UHFFFAOYSA-N 4-[(4-amino-3-methylcyclohexyl)methyl]-2-methylcyclohexan-1-amine Chemical compound C1CC(N)C(C)CC1CC1CC(C)C(N)CC1 IGSBHTZEJMPDSZ-UHFFFAOYSA-N 0.000 description 1
- ASNOFHCTUSIHOM-UHFFFAOYSA-N 4-[10-(4-aminophenyl)anthracen-9-yl]aniline Chemical compound C1=CC(N)=CC=C1C(C1=CC=CC=C11)=C(C=CC=C2)C2=C1C1=CC=C(N)C=C1 ASNOFHCTUSIHOM-UHFFFAOYSA-N 0.000 description 1
- APXJLYIVOFARRM-UHFFFAOYSA-N 4-[2-(3,4-dicarboxyphenyl)-1,1,1,3,3,3-hexafluoropropan-2-yl]phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1C(C(F)(F)F)(C(F)(F)F)C1=CC=C(C(O)=O)C(C(O)=O)=C1 APXJLYIVOFARRM-UHFFFAOYSA-N 0.000 description 1
- GEYAGBVEAJGCFB-UHFFFAOYSA-N 4-[2-(3,4-dicarboxyphenyl)propan-2-yl]phthalic acid Chemical compound C=1C=C(C(O)=O)C(C(O)=O)=CC=1C(C)(C)C1=CC=C(C(O)=O)C(C(O)=O)=C1 GEYAGBVEAJGCFB-UHFFFAOYSA-N 0.000 description 1
- UHNUHZHQLCGZDA-UHFFFAOYSA-N 4-[2-(4-aminophenyl)ethyl]aniline Chemical compound C1=CC(N)=CC=C1CCC1=CC=C(N)C=C1 UHNUHZHQLCGZDA-UHFFFAOYSA-N 0.000 description 1
- ZYEDGEXYGKWJPB-UHFFFAOYSA-N 4-[2-(4-aminophenyl)propan-2-yl]aniline Chemical compound C=1C=C(N)C=CC=1C(C)(C)C1=CC=C(N)C=C1 ZYEDGEXYGKWJPB-UHFFFAOYSA-N 0.000 description 1
- WUPRYUDHUFLKFL-UHFFFAOYSA-N 4-[3-(4-aminophenoxy)phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=CC(OC=2C=CC(N)=CC=2)=C1 WUPRYUDHUFLKFL-UHFFFAOYSA-N 0.000 description 1
- KWFFEQXPFFDJER-UHFFFAOYSA-N 4-[3-(4-aminophenoxy)propoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCOC1=CC=C(N)C=C1 KWFFEQXPFFDJER-UHFFFAOYSA-N 0.000 description 1
- BOVVHULZWVFIOX-UHFFFAOYSA-N 4-[3-(4-aminophenyl)phenyl]aniline Chemical compound C1=CC(N)=CC=C1C1=CC=CC(C=2C=CC(N)=CC=2)=C1 BOVVHULZWVFIOX-UHFFFAOYSA-N 0.000 description 1
- BMIUMBLWVWZIHD-UHFFFAOYSA-N 4-[3-(4-aminophenyl)propyl]aniline Chemical compound C1=CC(N)=CC=C1CCCC1=CC=C(N)C=C1 BMIUMBLWVWZIHD-UHFFFAOYSA-N 0.000 description 1
- SSDBTLHMCVFQMS-UHFFFAOYSA-N 4-[4-(1,1,1,3,3,3-hexafluoropropan-2-yl)phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=C(C(C(F)(F)F)C(F)(F)F)C=C1 SSDBTLHMCVFQMS-UHFFFAOYSA-N 0.000 description 1
- LAFZPVANKKJENB-UHFFFAOYSA-N 4-[4-(4-aminophenoxy)butoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCCOC1=CC=C(N)C=C1 LAFZPVANKKJENB-UHFFFAOYSA-N 0.000 description 1
- JCRRFJIVUPSNTA-UHFFFAOYSA-N 4-[4-(4-aminophenoxy)phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC(C=C1)=CC=C1OC1=CC=C(N)C=C1 JCRRFJIVUPSNTA-UHFFFAOYSA-N 0.000 description 1
- PZBWQICCJHUJGP-UHFFFAOYSA-N 4-[4-(4-aminophenyl)butyl]aniline Chemical compound C1=CC(N)=CC=C1CCCCC1=CC=C(N)C=C1 PZBWQICCJHUJGP-UHFFFAOYSA-N 0.000 description 1
- QBSMHWVGUPQNJJ-UHFFFAOYSA-N 4-[4-(4-aminophenyl)phenyl]aniline Chemical compound C1=CC(N)=CC=C1C1=CC=C(C=2C=CC(N)=CC=2)C=C1 QBSMHWVGUPQNJJ-UHFFFAOYSA-N 0.000 description 1
- SLHXQWDUYXSTPA-UHFFFAOYSA-N 4-[5-(4-aminophenoxy)pentoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCCCOC1=CC=C(N)C=C1 SLHXQWDUYXSTPA-UHFFFAOYSA-N 0.000 description 1
- UURATDYSEHCBAO-UHFFFAOYSA-N 4-[6-(3,4-dicarboxyphenyl)pyridin-2-yl]phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1C1=CC=CC(C=2C=C(C(C(O)=O)=CC=2)C(O)=O)=N1 UURATDYSEHCBAO-UHFFFAOYSA-N 0.000 description 1
- JBXBSFFXAMVASC-UHFFFAOYSA-N 4-[7-(4-aminophenoxy)heptoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCCCCCOC1=CC=C(N)C=C1 JBXBSFFXAMVASC-UHFFFAOYSA-N 0.000 description 1
- SURHEQARWKWZMT-UHFFFAOYSA-N 4-[8-(4-aminophenoxy)octoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCCCCCCOC1=CC=C(N)C=C1 SURHEQARWKWZMT-UHFFFAOYSA-N 0.000 description 1
- PBPYNPXJEIOCEL-UHFFFAOYSA-N 4-[[4-[(4-aminophenyl)methyl]phenyl]methyl]aniline Chemical compound C1=CC(N)=CC=C1CC(C=C1)=CC=C1CC1=CC=C(N)C=C1 PBPYNPXJEIOCEL-UHFFFAOYSA-N 0.000 description 1
- CXXSQMDHHYTRKY-UHFFFAOYSA-N 4-amino-2,3,5-tris(oxiran-2-ylmethyl)phenol Chemical compound C1=C(O)C(CC2OC2)=C(CC2OC2)C(N)=C1CC1CO1 CXXSQMDHHYTRKY-UHFFFAOYSA-N 0.000 description 1
- QZHXKQKKEBXYRG-UHFFFAOYSA-N 4-n-(4-aminophenyl)benzene-1,4-diamine Chemical compound C1=CC(N)=CC=C1NC1=CC=C(N)C=C1 QZHXKQKKEBXYRG-UHFFFAOYSA-N 0.000 description 1
- BFGKGEGCVZLKGB-UHFFFAOYSA-N 4-n-[[4-[(4-aminoanilino)methyl]phenyl]methyl]benzene-1,4-diamine Chemical compound C1=CC(N)=CC=C1NCC(C=C1)=CC=C1CNC1=CC=C(N)C=C1 BFGKGEGCVZLKGB-UHFFFAOYSA-N 0.000 description 1
- RHJVCIJERZCGKT-UHFFFAOYSA-N 4-octadecoxybenzene-1,3-diamine Chemical compound CCCCCCCCCCCCCCCCCCOC1=CC=C(N)C=C1N RHJVCIJERZCGKT-UHFFFAOYSA-N 0.000 description 1
- SIBBGGADHQDMHI-UHFFFAOYSA-N 4-tert-butyl-2,6-bis(hydroxymethyl)phenol Chemical compound CC(C)(C)C1=CC(CO)=C(O)C(CO)=C1 SIBBGGADHQDMHI-UHFFFAOYSA-N 0.000 description 1
- YGYCECQIOXZODZ-UHFFFAOYSA-N 4415-87-6 Chemical compound O=C1OC(=O)C2C1C1C(=O)OC(=O)C12 YGYCECQIOXZODZ-UHFFFAOYSA-N 0.000 description 1
- DYXJYKFGJLLBHY-UHFFFAOYSA-N 5-(1,1,1,3,3,3-hexafluoropropan-2-yl)-2-methylaniline Chemical compound NC=1C=C(C=CC1C)C(C(F)(F)F)C(F)(F)F DYXJYKFGJLLBHY-UHFFFAOYSA-N 0.000 description 1
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical group N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
- LPEKGGXMPWTOCB-UHFFFAOYSA-N 8beta-(2,3-epoxy-2-methylbutyryloxy)-14-acetoxytithifolin Natural products COC(=O)C(C)O LPEKGGXMPWTOCB-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- MRABAEUHTLLEML-UHFFFAOYSA-N Butyl lactate Chemical compound CCCCOC(=O)C(C)O MRABAEUHTLLEML-UHFFFAOYSA-N 0.000 description 1
- BOWIUXJGIWTFFU-UHFFFAOYSA-N C1(=CC(=CC=C1)NCC1=CC=C(C=C1)N)NCC1=CC=C(C=C1)N Chemical compound C1(=CC(=CC=C1)NCC1=CC=C(C=C1)N)NCC1=CC=C(C=C1)N BOWIUXJGIWTFFU-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 229940126062 Compound A Drugs 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- XXRCUYVCPSWGCC-UHFFFAOYSA-N Ethyl pyruvate Chemical compound CCOC(=O)C(C)=O XXRCUYVCPSWGCC-UHFFFAOYSA-N 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 239000004640 Melamine resin Substances 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- RQCFSJSUNRVCTN-MEMLXQNLSA-N NC1=CC(=C(C=C1)COC1=CC=C(C=C1)[C@@H]1CC[C@H](CC1)CCCCCCC)N Chemical compound NC1=CC(=C(C=C1)COC1=CC=C(C=C1)[C@@H]1CC[C@H](CC1)CCCCCCC)N RQCFSJSUNRVCTN-MEMLXQNLSA-N 0.000 description 1
- ZQMWQUQQDBBEBB-MXVIHJGJSA-N NC1=CC(=C(C=C1)OC1=CC=C(C=C1)[C@@H]1CC[C@H](CC1)CCCCCCC)N Chemical compound NC1=CC(=C(C=C1)OC1=CC=C(C=C1)[C@@H]1CC[C@H](CC1)CCCCCCC)N ZQMWQUQQDBBEBB-MXVIHJGJSA-N 0.000 description 1
- ZVFRMELZVKCNLO-ZWGSZDQZSA-N NC1=CC(=C(C=C1)OC1=CC=C(C=C1)[C@@H]1CC[C@H](CC1)[C@@H]1CC[C@H](CC1)CCCCC)N Chemical compound NC1=CC(=C(C=C1)OC1=CC=C(C=C1)[C@@H]1CC[C@H](CC1)[C@@H]1CC[C@H](CC1)CCCCC)N ZVFRMELZVKCNLO-ZWGSZDQZSA-N 0.000 description 1
- DFBAKUIRMFXYFL-UHFFFAOYSA-N NC=1C=C(OCCCCCCCCCOC2=CC(=CC=C2)N)C=CC1 Chemical compound NC=1C=C(OCCCCCCCCCOC2=CC(=CC=C2)N)C=CC1 DFBAKUIRMFXYFL-UHFFFAOYSA-N 0.000 description 1
- VVQRHMZIPYZPDL-UHFFFAOYSA-N NC=1C=C(OCCCCCCCCOC2=CC(=CC=C2)N)C=CC1 Chemical compound NC=1C=C(OCCCCCCCCOC2=CC(=CC=C2)N)C=CC1 VVQRHMZIPYZPDL-UHFFFAOYSA-N 0.000 description 1
- REVLAIHBLDVITK-UHFFFAOYSA-N NC=1C=C(OCCCCCCOC2=CC(=CC=C2)N)C=CC1 Chemical compound NC=1C=C(OCCCCCCOC2=CC(=CC=C2)N)C=CC1 REVLAIHBLDVITK-UHFFFAOYSA-N 0.000 description 1
- WTWVABORTJNTEF-UHFFFAOYSA-N O1C(COC2(C(C(=C(C(=C2F)F)C2=C(C(=C(C(=C2)F)F)F)F)F)F)OCC2CO2)C1 Chemical group O1C(COC2(C(C(=C(C(=C2F)F)C2=C(C(=C(C(=C2)F)F)F)F)F)F)OCC2CO2)C1 WTWVABORTJNTEF-UHFFFAOYSA-N 0.000 description 1
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical compound OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical group C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- GWNRJFTZPSCRAY-UHFFFAOYSA-N [3-(3-aminobenzoyl)oxyphenyl] 3-aminobenzoate Chemical compound NC1=CC=CC(C(=O)OC=2C=C(OC(=O)C=3C=C(N)C=CC=3)C=CC=2)=C1 GWNRJFTZPSCRAY-UHFFFAOYSA-N 0.000 description 1
- IVGBGCPUDUTSHT-UHFFFAOYSA-N [3-(3-aminobenzoyl)phenyl]-(3-aminophenyl)methanone Chemical compound NC1=CC=CC(C(=O)C=2C=C(C=CC=2)C(=O)C=2C=C(N)C=CC=2)=C1 IVGBGCPUDUTSHT-UHFFFAOYSA-N 0.000 description 1
- VRJPMYDKXNTGFV-UHFFFAOYSA-N [3-(4-aminobenzoyl)oxyphenyl] 4-aminobenzoate Chemical compound C1=CC(N)=CC=C1C(=O)OC1=CC=CC(OC(=O)C=2C=CC(N)=CC=2)=C1 VRJPMYDKXNTGFV-UHFFFAOYSA-N 0.000 description 1
- FDLQZKYLHJJBHD-UHFFFAOYSA-N [3-(aminomethyl)phenyl]methanamine Chemical compound NCC1=CC=CC(CN)=C1 FDLQZKYLHJJBHD-UHFFFAOYSA-N 0.000 description 1
- SLROFZGOINZDQM-UHFFFAOYSA-N [4-(3-aminobenzoyl)oxyphenyl] 3-aminobenzoate Chemical compound NC1=CC=CC(C(=O)OC=2C=CC(OC(=O)C=3C=C(N)C=CC=3)=CC=2)=C1 SLROFZGOINZDQM-UHFFFAOYSA-N 0.000 description 1
- FPXWISWMBLVKOD-UHFFFAOYSA-N [4-(4-aminobenzoyl)oxyphenyl] 4-aminobenzoate Chemical compound C1=CC(N)=CC=C1C(=O)OC(C=C1)=CC=C1OC(=O)C1=CC=C(N)C=C1 FPXWISWMBLVKOD-UHFFFAOYSA-N 0.000 description 1
- ISKQADXMHQSTHK-UHFFFAOYSA-N [4-(aminomethyl)phenyl]methanamine Chemical compound NCC1=CC=C(CN)C=C1 ISKQADXMHQSTHK-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- RDYPTJMUFKFOMS-UHFFFAOYSA-N acetylene;formaldehyde;urea Chemical compound O=C.C#C.NC(N)=O RDYPTJMUFKFOMS-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- XIWMTQIUUWJNRP-UHFFFAOYSA-N amidol Chemical compound NC1=CC=C(O)C(N)=C1 XIWMTQIUUWJNRP-UHFFFAOYSA-N 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- BALIDSJNGIOVDT-UHFFFAOYSA-N anthracene-1,2,5,6-tetracarboxylic acid Chemical compound OC(=O)C1=C(C(O)=O)C=CC2=CC3=C(C(O)=O)C(C(=O)O)=CC=C3C=C21 BALIDSJNGIOVDT-UHFFFAOYSA-N 0.000 description 1
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 125000000751 azo group Chemical group [*]N=N[*] 0.000 description 1
- 125000003828 azulenyl group Chemical group 0.000 description 1
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical group C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 1
- 150000005130 benzoxazines Chemical class 0.000 description 1
- 239000004305 biphenyl Chemical group 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- GSEZYWGNEACOIW-UHFFFAOYSA-N bis(2-aminophenyl)methanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=CC=C1N GSEZYWGNEACOIW-UHFFFAOYSA-N 0.000 description 1
- MKFFVFISLKXOSB-UHFFFAOYSA-N bis(3-aminophenyl) benzene-1,3-dicarboxylate Chemical compound NC1=CC=CC(OC(=O)C=2C=C(C=CC=2)C(=O)OC=2C=C(N)C=CC=2)=C1 MKFFVFISLKXOSB-UHFFFAOYSA-N 0.000 description 1
- GUNJOTGKRMYBEL-UHFFFAOYSA-N bis(3-aminophenyl) benzene-1,4-dicarboxylate Chemical compound NC1=CC=CC(OC(=O)C=2C=CC(=CC=2)C(=O)OC=2C=C(N)C=CC=2)=C1 GUNJOTGKRMYBEL-UHFFFAOYSA-N 0.000 description 1
- TUQQUUXMCKXGDI-UHFFFAOYSA-N bis(3-aminophenyl)methanone Chemical compound NC1=CC=CC(C(=O)C=2C=C(N)C=CC=2)=C1 TUQQUUXMCKXGDI-UHFFFAOYSA-N 0.000 description 1
- FRCGXWDENTYRDC-UHFFFAOYSA-N bis(4-aminophenyl) benzene-1,3-dicarboxylate Chemical compound C1=CC(N)=CC=C1OC(=O)C1=CC=CC(C(=O)OC=2C=CC(N)=CC=2)=C1 FRCGXWDENTYRDC-UHFFFAOYSA-N 0.000 description 1
- CFTXGNJIXHFHTH-UHFFFAOYSA-N bis(4-aminophenyl) benzene-1,4-dicarboxylate Chemical compound C1=CC(N)=CC=C1OC(=O)C1=CC=C(C(=O)OC=2C=CC(N)=CC=2)C=C1 CFTXGNJIXHFHTH-UHFFFAOYSA-N 0.000 description 1
- ZLSMCQSGRWNEGX-UHFFFAOYSA-N bis(4-aminophenyl)methanone Chemical compound C1=CC(N)=CC=C1C(=O)C1=CC=C(N)C=C1 ZLSMCQSGRWNEGX-UHFFFAOYSA-N 0.000 description 1
- JRPRCOLKIYRSNH-UHFFFAOYSA-N bis(oxiran-2-ylmethyl) benzene-1,2-dicarboxylate Chemical compound C=1C=CC=C(C(=O)OCC2OC2)C=1C(=O)OCC1CO1 JRPRCOLKIYRSNH-UHFFFAOYSA-N 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 1
- RRIRSNXZGJWTQM-UHFFFAOYSA-N butyl 3-methoxypropanoate Chemical compound CCCCOC(=O)CCOC RRIRSNXZGJWTQM-UHFFFAOYSA-N 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 229920003174 cellulose-based polymer Polymers 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- LMGZGXSXHCMSAA-UHFFFAOYSA-N cyclodecane Chemical group C1CCCCCCCCC1 LMGZGXSXHCMSAA-UHFFFAOYSA-N 0.000 description 1
- ARUKYTASOALXFG-UHFFFAOYSA-N cycloheptylcycloheptane Chemical group C1CCCCCC1C1CCCCCC1 ARUKYTASOALXFG-UHFFFAOYSA-N 0.000 description 1
- WVIIMZNLDWSIRH-UHFFFAOYSA-N cyclohexylcyclohexane Chemical group C1CCCCC1C1CCCCC1 WVIIMZNLDWSIRH-UHFFFAOYSA-N 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000004855 decalinyl group Chemical group C1(CCCC2CCCCC12)* 0.000 description 1
- OWEZJUPKTBEISC-UHFFFAOYSA-N decane-1,1-diamine Chemical compound CCCCCCCCCC(N)N OWEZJUPKTBEISC-UHFFFAOYSA-N 0.000 description 1
- NHADDZMCASKINP-HTRCEHHLSA-N decarboxydihydrocitrinin Natural products C1=C(O)C(C)=C2[C@H](C)[C@@H](C)OCC2=C1O NHADDZMCASKINP-HTRCEHHLSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 229940019778 diethylene glycol diethyl ether Drugs 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- IPZJQDSFZGZEOY-UHFFFAOYSA-N dimethylmethylene Chemical group C[C]C IPZJQDSFZGZEOY-UHFFFAOYSA-N 0.000 description 1
- MGHPNCMVUAKAIE-UHFFFAOYSA-N diphenylmethanamine Chemical compound C=1C=CC=CC=1C(N)C1=CC=CC=C1 MGHPNCMVUAKAIE-UHFFFAOYSA-N 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- HOWGUJZVBDQJKV-UHFFFAOYSA-N docosane Chemical group CCCCCCCCCCCCCCCCCCCCCC HOWGUJZVBDQJKV-UHFFFAOYSA-N 0.000 description 1
- QFTYSVGGYOXFRQ-UHFFFAOYSA-N dodecane-1,12-diamine Chemical compound NCCCCCCCCCCCCN QFTYSVGGYOXFRQ-UHFFFAOYSA-N 0.000 description 1
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- PPBYBJMAAYETEG-UHFFFAOYSA-N ethene;formaldehyde;urea Chemical compound C=C.O=C.NC(N)=O PPBYBJMAAYETEG-UHFFFAOYSA-N 0.000 description 1
- CEIPQQODRKXDSB-UHFFFAOYSA-N ethyl 3-(6-hydroxynaphthalen-2-yl)-1H-indazole-5-carboximidate dihydrochloride Chemical compound Cl.Cl.C1=C(O)C=CC2=CC(C3=NNC4=CC=C(C=C43)C(=N)OCC)=CC=C21 CEIPQQODRKXDSB-UHFFFAOYSA-N 0.000 description 1
- IJUHLFUALMUWOM-UHFFFAOYSA-N ethyl 3-methoxypropanoate Chemical compound CCOC(=O)CCOC IJUHLFUALMUWOM-UHFFFAOYSA-N 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- 229940117360 ethyl pyruvate Drugs 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- PWSKHLMYTZNYKO-UHFFFAOYSA-N heptane-1,7-diamine Chemical compound NCCCCCCCN PWSKHLMYTZNYKO-UHFFFAOYSA-N 0.000 description 1
- VBZWSGALLODQNC-UHFFFAOYSA-N hexafluoroacetone Chemical compound FC(F)(F)C(=O)C(F)(F)F VBZWSGALLODQNC-UHFFFAOYSA-N 0.000 description 1
- RXTNIJMLAQNTEG-UHFFFAOYSA-N hexan-2-yl acetate Chemical compound CCCCC(C)OC(C)=O RXTNIJMLAQNTEG-UHFFFAOYSA-N 0.000 description 1
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- IPLONMMJNGTUAI-UHFFFAOYSA-M lithium;bromide;hydrate Chemical group [Li+].O.[Br-] IPLONMMJNGTUAI-UHFFFAOYSA-M 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M methacrylate group Chemical group C(C(=C)C)(=O)[O-] CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- GQKZBCPTCWJTAS-UHFFFAOYSA-N methoxymethylbenzene Chemical compound COCC1=CC=CC=C1 GQKZBCPTCWJTAS-UHFFFAOYSA-N 0.000 description 1
- BDJSOPWXYLFTNW-UHFFFAOYSA-N methyl 3-methoxypropanoate Chemical compound COCCC(=O)OC BDJSOPWXYLFTNW-UHFFFAOYSA-N 0.000 description 1
- 229940057867 methyl lactate Drugs 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- XTAZYLNFDRKIHJ-UHFFFAOYSA-N n,n-dioctyloctan-1-amine Chemical compound CCCCCCCCN(CCCCCCCC)CCCCCCCC XTAZYLNFDRKIHJ-UHFFFAOYSA-N 0.000 description 1
- 229940017144 n-butyl lactate Drugs 0.000 description 1
- OBKARQMATMRWQZ-UHFFFAOYSA-N naphthalene-1,2,5,6-tetracarboxylic acid Chemical compound OC(=O)C1=C(C(O)=O)C=CC2=C(C(O)=O)C(C(=O)O)=CC=C21 OBKARQMATMRWQZ-UHFFFAOYSA-N 0.000 description 1
- OLAPPGSPBNVTRF-UHFFFAOYSA-N naphthalene-1,4,5,8-tetracarboxylic acid Chemical compound C1=CC(C(O)=O)=C2C(C(=O)O)=CC=C(C(O)=O)C2=C1C(O)=O OLAPPGSPBNVTRF-UHFFFAOYSA-N 0.000 description 1
- OKBVMLGZPNDWJK-UHFFFAOYSA-N naphthalene-1,4-diamine Chemical compound C1=CC=C2C(N)=CC=C(N)C2=C1 OKBVMLGZPNDWJK-UHFFFAOYSA-N 0.000 description 1
- KQSABULTKYLFEV-UHFFFAOYSA-N naphthalene-1,5-diamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1N KQSABULTKYLFEV-UHFFFAOYSA-N 0.000 description 1
- GOGZBMRXLADNEV-UHFFFAOYSA-N naphthalene-2,6-diamine Chemical compound C1=C(N)C=CC2=CC(N)=CC=C21 GOGZBMRXLADNEV-UHFFFAOYSA-N 0.000 description 1
- HBJPJUGOYJOSLR-UHFFFAOYSA-N naphthalene-2,7-diamine Chemical compound C1=CC(N)=CC2=CC(N)=CC=C21 HBJPJUGOYJOSLR-UHFFFAOYSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- ZCYXXKJEDCHMGH-UHFFFAOYSA-N nonane Chemical compound CCCC[CH]CCCC ZCYXXKJEDCHMGH-UHFFFAOYSA-N 0.000 description 1
- SXJVFQLYZSNZBT-UHFFFAOYSA-N nonane-1,9-diamine Chemical compound NCCCCCCCCCN SXJVFQLYZSNZBT-UHFFFAOYSA-N 0.000 description 1
- BKIMMITUMNQMOS-UHFFFAOYSA-N normal nonane Natural products CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical group C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- OURNLUUIQWKTRH-UHFFFAOYSA-N oxirane;phenol Chemical compound C1CO1.OC1=CC=CC=C1.OC1=CC=CC=C1 OURNLUUIQWKTRH-UHFFFAOYSA-N 0.000 description 1
- GXOHBWLPQHTYPF-UHFFFAOYSA-N pentyl 2-hydroxypropanoate Chemical compound CCCCCOC(=O)C(C)O GXOHBWLPQHTYPF-UHFFFAOYSA-N 0.000 description 1
- FVDOBFPYBSDRKH-UHFFFAOYSA-N perylene-3,4,9,10-tetracarboxylic acid Chemical compound C=12C3=CC=C(C(O)=O)C2=C(C(O)=O)C=CC=1C1=CC=C(C(O)=O)C2=C1C3=CC=C2C(=O)O FVDOBFPYBSDRKH-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229950000688 phenothiazine Drugs 0.000 description 1
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- 229920000962 poly(amidoamine) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- NTUCQKRAQSWLOP-UHFFFAOYSA-N propan-2-yloxymethylbenzene Chemical compound CC(C)OCC1=CC=CC=C1 NTUCQKRAQSWLOP-UHFFFAOYSA-N 0.000 description 1
- ILVGAIQLOCKNQA-UHFFFAOYSA-N propyl 2-hydroxypropanoate Chemical compound CCCOC(=O)C(C)O ILVGAIQLOCKNQA-UHFFFAOYSA-N 0.000 description 1
- JCMFJIHDWDKYIL-UHFFFAOYSA-N propyl 3-methoxypropanoate Chemical compound CCCOC(=O)CCOC JCMFJIHDWDKYIL-UHFFFAOYSA-N 0.000 description 1
- FOWDZVNRQHPXDO-UHFFFAOYSA-N propyl hydrogen carbonate Chemical compound CCCOC(O)=O FOWDZVNRQHPXDO-UHFFFAOYSA-N 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- JREWFSHZWRKNBM-UHFFFAOYSA-N pyridine-2,3,4,5-tetracarboxylic acid Chemical compound OC(=O)C1=CN=C(C(O)=O)C(C(O)=O)=C1C(O)=O JREWFSHZWRKNBM-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 125000006413 ring segment Chemical group 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Substances C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- JLGLQAWTXXGVEM-UHFFFAOYSA-N triethylene glycol monomethyl ether Chemical compound COCCOCCOCCO JLGLQAWTXXGVEM-UHFFFAOYSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- SRPWOOOHEPICQU-UHFFFAOYSA-N trimellitic anhydride Chemical compound OC(=O)C1=CC=C2C(=O)OC(=O)C2=C1 SRPWOOOHEPICQU-UHFFFAOYSA-N 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- KLNPWTHGTVSSEU-UHFFFAOYSA-N undecane-1,11-diamine Chemical compound NCCCCCCCCCCCN KLNPWTHGTVSSEU-UHFFFAOYSA-N 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1003—Preparatory processes
- C08G73/1007—Preparatory processes from tetracarboxylic acids or derivatives and diamines
- C08G73/1028—Preparatory processes from tetracarboxylic acids or derivatives and diamines characterised by the process itself, e.g. steps, continuous
- C08G73/1032—Preparatory processes from tetracarboxylic acids or derivatives and diamines characterised by the process itself, e.g. steps, continuous characterised by the solvent(s) used
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1042—Copolyimides derived from at least two different tetracarboxylic compounds or two different diamino compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1075—Partially aromatic polyimides
- C08G73/1078—Partially aromatic polyimides wholly aromatic in the diamino moiety
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L79/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
- C08L79/04—Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
- C08L79/08—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D179/00—Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen, with or without oxygen, or carbon only, not provided for in groups C09D161/00 - C09D177/00
- C09D179/04—Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
- C09D179/08—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/52—Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
- C09K19/54—Additives having no specific mesophase characterised by their chemical composition
- C09K19/56—Aligning agents
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
- G02F1/133711—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
- G02F1/133723—Polyimide, polyamide-imide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nonlinear Science (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Mathematical Physics (AREA)
- Wood Science & Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Liquid Crystal (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
本發明為提供一種組成物,其為含有(A)成份:下述式[A]:
Description
本發明為有關,形成聚醯亞胺膜所使用的組成物、液晶顯示元件之製造中所使用的液晶配向處理劑、該液晶配向處理劑所得之液晶配向膜及使用該液晶配向膜所得之液晶顯示元件之發明。 The present invention relates to a composition for forming a polyimide film, a liquid crystal alignment treatment agent used in the manufacture of a liquid crystal display element, a liquid crystal alignment film obtained by the liquid crystal alignment treatment agent, and a liquid crystal obtained by using the liquid crystal alignment film Invention of display element.
高分子材料等有機材料所形成之膜,著重於就形成之容易度或絕緣性能等,於電子裝置中,已廣泛地被使用作為層間絕緣膜或保護膜等。其中,又以作為顯示裝置而被廣知的液晶顯示元件中,有機材料所形成之有機膜被作為液晶配向膜使用。 Films formed from organic materials, such as polymer materials, focus on ease of formation or insulating properties, etc., and have been widely used as interlayer insulating films or protective films in electronic devices. Among them, in a liquid crystal display element widely known as a display device, an organic film formed of an organic material is used as a liquid crystal alignment film.
近年來,液晶顯示元件於大畫面之液晶電視或高精細度之移動裝置之用途(數位相機或可攜式電話之顯示部份)已廣泛地被實用化。伴隨此點,其與以往相比較時,其所使用之基板將更大型化,此外,基板段差的凹凸將變得更大。但即使於該些狀況中,就顯示特性之觀點而言,對於大型基板或段差,液晶配向膜也要求應具有均勻的塗膜。該液晶配向膜之製作步驟中,使用聚醯胺酸或 溶劑可溶性聚醯亞胺(亦稱為聚醯亞胺)等之聚醯亞胺系聚合物(亦稱為樹脂)的液晶配向處理劑塗佈於基板之情形,工業上一般為使用凸版(Flexo)印刷法或噴墨塗佈法等進行。此時,液晶配向處理劑之溶劑中,除具有對樹脂之具有優良溶解性的溶劑(亦稱為良溶劑)之N-甲基-2-吡咯啶酮(亦稱為NMP)或γ-丁內酯(亦稱為γ-BL)等以外,就提高液晶配向膜之塗膜性等觀點,也可混合樹脂溶解性較低之溶劑(亦稱為貧溶劑)的乙二醇單丁醚等(例如專利文獻1)。 In recent years, the use of liquid crystal display elements in large-screen LCD TVs or high-definition mobile devices (display parts of digital cameras or portable phones) has been widely used. Along with this, when compared with the past, the substrate used in it will be larger, and the unevenness of the substrate will become larger. However, even in these situations, from the viewpoint of display characteristics, the liquid crystal alignment film is required to have a uniform coating film for a large substrate or step. In the manufacturing process of the liquid crystal alignment film, polyamic acid or Solvent soluble polyimide (also known as polyimide) and other polyimide-based polymers (also known as resins) liquid crystal alignment treatment agent is applied to the substrate, the industry generally uses Flexo (Flexo) ) Printing method or inkjet coating method. At this time, in the solvent of the liquid crystal alignment treatment agent, in addition to N-methyl-2-pyrrolidone (also known as NMP) or γ-butane which has a solvent (also known as a good solvent) having excellent solubility in the resin In addition to lactone (also known as γ-BL), etc., from the viewpoint of improving the coating properties of the liquid crystal alignment film, it is also possible to mix ethylene glycol monobutyl ether, etc. with a solvent having a low resin solubility (also known as a poor solvent) (For example, Patent Document 1).
[專利文獻1]日本特開平2-37324號公報 [Patent Document 1] Japanese Patent Laid-Open No. 2-37324
聚醯亞胺系之有機膜(亦稱為聚醯亞胺膜),除液晶配向膜以外,亦廣泛地被使用於電子裝置中之層間絕緣膜或保護膜等。液晶配向膜之情形亦相同般,可由含有聚醯亞胺前驅體之聚醯胺酸或聚醯亞胺的溶液之組成物(亦稱為塗佈溶液)所形成。因而,於其他電子裝置中,亦有提高聚醯亞胺膜之塗膜性的需求。即,提高聚醯亞胺膜之塗膜性時,可有效地抑制伴隨塗佈所發生的缺陷。 In addition to liquid crystal alignment films, polyimide-based organic films (also known as polyimide films) are also widely used as interlayer insulating films or protective films in electronic devices. The same is true for liquid crystal alignment films, which can be formed by a composition (also called a coating solution) containing a solution of polyimide or a solution of a polyimide precursor. Therefore, in other electronic devices, there is also a need to improve the coating properties of the polyimide film. That is, when the coating properties of the polyimide film are improved, defects accompanying coating can be effectively suppressed.
又,使用「使用具有側鏈的二胺化合物所得 的聚醯胺酸或聚醯亞胺」所得之液晶配向處理劑,因側鏈部位具有高疏水性,故液晶配向膜之塗膜性會有降低之傾向。特別是,會有無法得到均勻塗膜性之情形,即,伴隨潑彈而發生沙孔之情形,其於作為液晶顯示元件之際,該部份將形成顯示缺陷。因此,欲製得均勻的塗膜性時,對於塗佈於基板塗佈溶液必須具有大量混合量的擴大潤濕性之貧溶劑。但是,貧溶劑對於溶解聚醯胺酸或聚醯亞胺之能力較為劣化,故大量混合時,會有引起樹脂析出之問題。 Also, using "obtained from a diamine compound having a side chain The liquid crystal alignment treatment agent obtained from "polyamic acid or polyimide" has a high hydrophobicity of the side chain part, so the coating property of the liquid crystal alignment film tends to be reduced. In particular, there may be a case where uniform coating properties cannot be obtained, that is, a case where sand holes occur along with splashing, and when used as a liquid crystal display element, this part will form a display defect. Therefore, when a uniform coating film property is to be obtained, it is necessary to have a large amount of a poor solvent to expand the wettability for the coating solution applied to the substrate. However, the poor solvent has a relatively poor ability to dissolve polyamic acid or polyimide, so when mixed in a large amount, there will be a problem of resin precipitation.
此外,近年來,配合智慧手機或可攜式電話等之移動裝置等用途,而多使用液晶顯示元件,但該些用途中,為盡可能確保更大之顯示面等觀點,黏著液晶顯示元件之基板間所使用的封閉劑,多存在於接近液晶配向膜端部之位置。因此,若液晶配向膜端部之塗膜性劣化之情形,即,液晶配向膜之端部未能形成直線之情形,或其端部形成拱起狀態之情形,將會降低液晶配向膜與封閉劑間之黏著(亦稱為密著)效果,而會使液晶顯示元件之顯示特性或信賴性降低。 In addition, in recent years, liquid crystal display elements have been used more often in conjunction with mobile devices such as smartphones or portable phones. However, in these applications, in order to ensure the largest possible display surface, etc. The sealing agent used between the substrates mostly exists near the end of the liquid crystal alignment film. Therefore, if the coating property of the end of the liquid crystal alignment film is deteriorated, that is, the end of the liquid crystal alignment film fails to form a straight line, or the end of the liquid crystal is arched, the liquid crystal alignment film and the sealing will be reduced The adhesion (also known as adhesion) effect between the agents will reduce the display characteristics or reliability of the liquid crystal display element.
此外,使用聚醯亞胺之組成物或液晶配向處理劑中,因該些所使用的溶劑之NMP或γ-BL之沸點較高,故於製作層間絕緣膜或保護膜等聚醯亞胺膜及液晶配向膜之際,必須進行高溫下之燒結。因此,就降低能量費用之觀點,於製作該些聚醯亞胺膜及液晶配向膜之際,多尋求可以進行低溫下之燒結。 In addition, in the composition using polyimide or liquid crystal alignment treatment agent, the NMP or γ-BL of these solvents used has a high boiling point, so it is used to fabricate polyimide films such as interlayer insulating films or protective films In the case of liquid crystal alignment films, sintering at high temperature must be performed. Therefore, from the viewpoint of reducing the energy cost, in the production of these polyimide films and liquid crystal alignment films, it is often sought to enable sintering at low temperatures.
,因而本發明為,以提供兼具有上述特性的組成物為目的。即,本發明之目的為提供一種,於形成聚醯亞胺膜之際,可抑制伴隨潑彈所造成之沙孔的產生,而提供一種於其端部也具有優良塗膜性的組成物。而即使進行低溫之燒結,也可以製作聚醯亞胺膜的組成物為目的。 Therefore, the present invention aims to provide a composition having the above-mentioned characteristics. That is, an object of the present invention is to provide a composition capable of suppressing the generation of sand holes caused by splashing when forming a polyimide film, and to provide a composition having excellent coating properties at the ends. Even if low-temperature sintering is performed, the composition of the polyimide film can be produced for the purpose.
又,同時提供一種使用本發明之組成物的液晶配向處理劑時,於形成液晶配向膜之際,可抑制伴隨潑彈所造成之沙孔的產生,此外,其端部之塗膜性也為優良的液晶配向處理劑。特別是,即使為使用「使用具有側鏈的二胺化合物所得的聚醯胺酸或聚醯亞胺」所得的液晶配向處理劑時,也可提供具有該些具有優良特性的液晶配向處理劑。此外,又提供一種即使製作液晶配向膜之際的燒結為低溫狀態時,液晶顯示元件中的電氣特性,特別是電壓保持率(亦稱為VHR)也為優良的液晶配向處理劑。 Also, when providing a liquid crystal alignment treatment agent using the composition of the present invention, when forming a liquid crystal alignment film, the generation of sand holes caused by splashing can be suppressed, and the coating properties of the ends are also Excellent liquid crystal alignment treatment agent. In particular, even when a liquid crystal alignment treatment agent obtained using "polyamide acid or polyimide obtained by using a diamine compound having a side chain" is used, a liquid crystal alignment treatment agent having these excellent characteristics can be provided. In addition, there is provided a liquid crystal alignment treatment agent having excellent electrical characteristics, particularly voltage retention (also referred to as VHR) in a liquid crystal display element even when sintering at the time of producing a liquid crystal alignment film is at a low temperature.
此外,又提供一種前述組成物所得之聚醯亞胺膜、前述液晶配向處理劑所得之液晶配向膜及具有前述液晶配向膜的顯示元件。 In addition, there is provided a polyimide film obtained from the foregoing composition, a liquid crystal alignment film obtained from the liquid crystal alignment treatment agent, and a display device having the liquid crystal alignment film.
本發明者們,經過進行深入研究結果,得知含有具特定結構的溶劑與由聚醯亞胺前驅體或聚醯亞胺所選出之至少1種的聚合物的組成物,對於達成上述目的極為有效,因而完成本發明。 The present inventors have conducted intensive studies and found that a composition containing a solvent having a specific structure and at least one polymer selected from a polyimide precursor or polyimide is extremely important for achieving the above object Effective, thus completing the present invention.
即,本發明為具有以下主要內容者。 That is, the present invention has the following main contents.
(1)一種組成物,其特徵為含有(A)成份:下述式[A]所示溶劑:
(2)如上述(1)之組成物,其中,前述(A)成份之溶劑為下述式[A-1]所示之溶劑:
(3)如上述(1)或上述(2)之組成物,其中,前述(B)成份為,由具有下述式[1-1]及式[1-2]所示結構所選出之至少1種之結構的二胺化合物作為原料的一部份使用的由聚醯亞胺前驅體及聚醯亞胺所選出之至少1種的聚合物:
(4)如上述(3)之組成物,其中,具有前述式[1-1]及式[1-2]所示結構的二胺化合物為下述式[1a]所示二胺
化合物:
(5)如上述(1)~上述(4)中任一者之組成物,其中,前述(B)成份之聚合物為,具有由羧基(COOH基)及羥基(OH基)所選出之至少1種的取代基之二胺化合物作為原料的一部使用所得的由聚醯亞胺前驅體及聚醯亞胺所選出之至少1種的聚合物。 (5) The composition according to any one of (1) to (4) above, wherein the polymer of the component (B) is at least one selected from a carboxyl group (COOH group) and a hydroxyl group (OH group) A diamine compound of one kind of substituent is used as a part of the raw material, and at least one kind of polymer selected from a polyimide precursor and a polyimide is obtained.
(6)如上述(5)之組成物,其中,前述具有羧基及羥基的二胺化合物為,下述式[2a]所示二胺化合物:
(7)如上述(1)~上述(6)中任一者之組成物,其中,前述(B)成份之聚合物為,使用下述式[3a]所示二胺化
合物作為原料之一部份使用的由聚醯亞胺前驅體及聚醯亞胺所選出之至少1種的聚合物:
(8)如上述(7)之組成物,其中,前述式[3a]中之B1表示-CONH-,B2表示碳數1~5之伸烷基,B3表示單鍵,B4表示咪唑基或吡啶基,n表示1之二胺化合物。 (8) The composition as described in (7) above, wherein B 1 in the above formula [3a] represents -CONH-, B 2 represents an alkylene group having 1 to 5 carbon atoms, B 3 represents a single bond, and B 4 represents Imidazolyl or pyridyl, n represents a diamine compound of 1.
(9)如上述(1)~上述(8)中任一者之組成物,其中,前述(B)成份之聚合物為,下述式[4]:
(10)如上述(1)~上述(9)中任一者之組成物,其中,前述(B)成份之聚合物為由聚醯胺酸烷酯及聚醯亞胺所選出之至少1種的聚合物。 (10) The composition according to any one of (1) to (9) above, wherein the polymer of the component (B) is at least one selected from polyalkylamide and polyimide Of polymers.
(11)如上述(1)~上述(10)中任一者之組成物,其中,(C)成份含有由N-甲基-2-吡咯啶酮、N-乙基-2-吡咯啶酮及γ-丁內酯所選出之至少1種的溶劑。 (11) The composition according to any one of (1) to (10) above, wherein the component (C) contains N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone And at least one solvent selected from γ-butyrolactone.
(12)如上述(1)~上述(11)中任一者之組成物,其中,(D)成份含有由1-己醇、環己醇、1,2-乙二醇、1,2-丙二醇、丙二醇單丁醚、乙二醇單丁醚、二丙二醇二甲醚及下述式[D-1]~式[D-3]所示溶劑所選出之至少1種的溶劑:
(13)如上述(1)~上述(12)中任一者之組成物,該組成物中,含有由,具有環氧基、異氰酸酯基、環氧丙烷基或環碳酸酯基的交聯性化合物、具有由羥基、羥基烷基及低級烷氧基烷基所成群所選出之至少1種取代基的交聯性化合物,及具有聚合性不飽和鍵結的交聯性化合物,所選出之至少1種的交聯性化合物。 (13) The composition according to any one of (1) to (12) above, which contains a crosslinking property having an epoxy group, an isocyanate group, a glycidyl group or a cyclic carbonate group Compounds, cross-linkable compounds with at least one substituent selected from the group consisting of hydroxy, hydroxyalkyl, and lower alkoxyalkyl, and cross-linkable compounds with polymerizable unsaturated bonds, selected At least one crosslinkable compound.
(14)如上述(1)~上述(13)中任一者之組成物,其中,前述(A)成份,為組成物所含的溶劑全體之5~70質量%。 (14) The composition according to any one of (1) to (13) above, wherein the component (A) is 5 to 70% by mass of the total solvent contained in the composition.
(15)如上述(11)~上述(14)中任一者之組成物,其中,前述(C)成份為組成物所含的溶劑全體之40~80質量%。 (15) The composition according to any one of (11) to (14) above, wherein the (C) component is 40 to 80% by mass of the total solvent contained in the composition.
(16)如上述(12)~上述(15)中任一者之組成物,其中,前述(D)成份為組成物所含的溶劑全體之1~50質量%。 (16) The composition according to any one of (12) to (15) above, wherein the (D) component is 1 to 50% by mass of the total solvent contained in the composition.
(17)如上述(1)~上述(16)中任一者之組成物,其中,前述(B)成份為組成物中的0.1質量%~30質量%。 (17) The composition according to any one of (1) to (16) above, wherein the component (B) is 0.1% by mass to 30% by mass in the composition.
(18)一種聚醯亞胺膜,其特徵為,由上述(1)~ 上述(17)中任一者之組成物所得者。 (18) A polyimide film, characterized by the above (1) ~ Those obtained by the composition of any one of (17) above.
(19)一種液晶配向處理劑,其特徵為,由上述(1)~上述(17)中任一者之組成物所得者。 (19) A liquid crystal alignment treatment agent characterized by being obtained from the composition of any one of (1) to (17) above.
(20)一種液晶配向膜,其特徵為,使用上述(19)之液晶配向處理劑所得者。 (20) A liquid crystal alignment film characterized by using the liquid crystal alignment treatment agent of (19) above.
(21)一種液晶配向膜,其特徵為,使用上述(19)之液晶配向處理劑,經噴墨法而得者。 (21) A liquid crystal alignment film characterized by using the liquid crystal alignment treatment agent of (19) above by an inkjet method.
(22)一種液晶顯示元件,其特徵為,具有上述(20)或上述(21)之液晶配向膜。 (22) A liquid crystal display device characterized by having the liquid crystal alignment film of (20) or (21) above.
(23)如上述(20)或上述(21)之液晶配向膜,其係使用於具備電極的一對基板之間具有液晶層,於前述一對基板之間,配置可經由活性能量線及熱中至少一者而聚合的含有聚合性化合物之液晶組成物,經由於前述電極間持續施加電壓,使前述聚合性化合物聚合之步驟所製得的液晶顯示元件者。 (23) The liquid crystal alignment film according to the above (20) or (21), which is used between a pair of substrates provided with electrodes, has a liquid crystal layer, and is arranged between the pair of substrates via active energy rays and heat At least one of the polymerized compound-containing liquid crystal compositions polymerized is a liquid crystal display element produced by the step of continuously applying a voltage between the electrodes to polymerize the polymerizable compound.
(24)一種液晶顯示元件,其特徵為,具有上述(23)之液晶配向膜。 (24) A liquid crystal display device characterized by having the liquid crystal alignment film of (23) above.
(25)如上述(20)或上述(21)之液晶配向膜,其係使用於具備電極的一對基板之間具有液晶層,於前述一對基板之間,配置可經由活性能量線及熱中至少一者而聚合的含有聚合性基之液晶配向膜,經由於前述電極間持續施加電壓,使前述聚合性基聚合之步驟所製得液晶顯示元件者。 (25) The liquid crystal alignment film according to the above (20) or (21), which is used between a pair of substrates provided with electrodes and has a liquid crystal layer, and between the pair of substrates, is arranged to pass active energy rays and heat At least one of the polymerized group-containing liquid crystal alignment films polymerized is a liquid crystal display element produced by continuously applying a voltage between the electrodes to polymerize the polymerizable group.
(26)一種液晶顯示元件,其特徵為,具有上述 (25)之液晶配向膜。 (26) A liquid crystal display element characterized by having the above (25) The liquid crystal alignment film.
本發明之含有具有特定結構的溶劑,與由聚醯亞胺前驅體或聚醯亞胺所選出之至少1種的聚合物的組成物,於形成聚醯亞胺膜之際,可抑制伴隨潑彈所造成之沙孔的產生,而可製得端部亦具有該些優良塗膜性的聚醯亞胺膜。同時,即使進行低溫之燒結下,也可製作聚醯亞胺膜。 The composition of the present invention containing a solvent having a specific structure and at least one polymer selected from a polyimide precursor or polyimide can suppress the accompanying splash when forming a polyimide film The formation of sand holes caused by bullets, and the polyimide film with excellent coating properties at the end can also be produced. At the same time, even under low temperature sintering, polyimide film can be produced.
又,使用本發明之組成物的液晶配向處理劑時,可提供一種於形成液晶配向膜之際,可抑制伴隨潑彈所造成之沙孔的產生,此外,其端部之塗膜性也為優良的液晶配向處理劑。特別是,使用「使用具有側鏈的二胺化合物所得的聚醯胺酸或聚醯亞胺」的液晶配向處理劑時,也可提供具有該些優良特性的液晶配向處理劑。此外,即使於製作液晶配向膜之際的燒結為低溫處理下,也可提供液晶顯示元件中具有優良電氣特性、特別是具有優良電壓保持率(VHR)的液晶配向處理劑。 In addition, when the liquid crystal alignment treatment agent of the composition of the present invention is used, it is possible to provide the formation of a liquid crystal alignment film, which can suppress the occurrence of sand holes caused by splashing. In addition, the coating properties of the ends are also Excellent liquid crystal alignment treatment agent. In particular, when a liquid crystal alignment treatment agent using "polyamic acid or polyimide obtained by using a diamine compound having a side chain" is used, a liquid crystal alignment treatment agent having these excellent characteristics can also be provided. In addition, even if the sintering at the time of producing the liquid crystal alignment film is a low-temperature treatment, it is possible to provide a liquid crystal alignment treatment agent having excellent electrical characteristics, particularly excellent voltage retention (VHR) in the liquid crystal display element.
又,本發明之組成物作為液晶配向處理劑使用時,可抑制伴隨潑彈所造成之沙孔的產生,此外,復可提供一種端部具有優良塗膜性的液晶配向膜。特別是,使用「使用具有側鏈的二胺化合物所得的聚醯胺酸或聚醯亞胺」的液晶配向處理劑時,也可提供具有該些優良特性的液晶配向膜。此外,即使製作液晶配向膜之際的燒結為低 溫狀態時,也可提供液晶顯示元件中,具有優良電氣特性、特別是具有優良電壓保持率(VHR)的液晶配向膜。因此,具有本發明之液晶配向處理劑所得之液晶配向膜的液晶顯示元件,為具有極優良信賴性者,而適用於大畫面且高精細度之液晶電視或中小型的汽車導航系統或智慧手機等。 In addition, when the composition of the present invention is used as a liquid crystal alignment treatment agent, the formation of sand holes caused by splashing can be suppressed, and in addition, a liquid crystal alignment film having excellent coating properties at the ends can be provided. In particular, when a liquid crystal alignment treatment agent using "polyamic acid or polyimide obtained using a diamine compound having a side chain" is used, a liquid crystal alignment film having these excellent characteristics can also be provided. In addition, even when the sintering at the time of manufacturing the liquid crystal alignment film is low In a warm state, it is also possible to provide a liquid crystal alignment film having excellent electrical characteristics, particularly excellent voltage retention (VHR) in a liquid crystal display element. Therefore, the liquid crystal display device having the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present invention is one with excellent reliability, and is suitable for large-screen and high-definition LCD TVs or small and medium-sized car navigation systems or smartphone Wait.
(a)‧‧‧聚醯亞胺膜(液晶配向膜) (a) ‧‧‧Polyimide film (liquid crystal alignment film)
(b)‧‧‧鉻蒸鍍基板 (b) ‧‧‧ chromium vapor-deposited substrate
[圖1]表示塗佈玻璃基板的聚醯亞胺膜之端部為直線性之圖。 [Fig. 1] A diagram showing that the end of a polyimide film coated with a glass substrate is linear.
[圖2]表示塗佈玻璃基板的聚醯亞胺膜之端部為膨大狀態之圖。 [Fig. 2] A diagram showing that the end of the polyimide film coated with a glass substrate is in an expanded state.
以下,將對本發明作詳細之說明。 Hereinafter, the present invention will be described in detail.
本發明為,一種含有下述(A)成份及(B)成份之組成物、液晶配向處理劑、使用該液晶配向處理劑所得之液晶配向膜,及具有該液晶配向膜之液晶顯示元件。 The present invention is a composition containing the following components (A) and (B), a liquid crystal alignment treatment agent, a liquid crystal alignment film obtained using the liquid crystal alignment treatment agent, and a liquid crystal display element having the liquid crystal alignment film.
(A)成份:下述式[A]所示溶劑(亦稱為特定溶劑)。 (A) Ingredient: A solvent (also called a specific solvent) represented by the following formula [A].
(B)成份:由聚醯亞胺前驅體及聚醯亞胺所選出之至少1種的聚合物(亦稱為特定聚合物)。 (B) Ingredients: at least one kind of polymer (also called specific polymer) selected from polyimide precursor and polyimide.
本發明之特定溶劑,只要可溶解聚醯亞胺前驅體及聚醯亞胺等聚醯亞胺系聚合物之溶劑(亦稱為良溶劑)者即可使用,另外,亦具有提高聚醯亞胺膜及液晶配向膜之塗膜性的效果。即,本發明之特定溶劑,通常,與作為良溶劑所使用的NMP相比較時,其具有較低之作為溶劑的表面張力,而作為特定溶劑的塗佈溶液時,與未使用其之塗佈溶液相比較時,其對於基板具有更高的塗佈溶液之擴大潤濕性。如此,於作為聚醯亞胺膜及液晶配向膜之際,可提高該些膜之端部的直線性。此外,因對於基板具有更高的塗佈溶液之擴大潤濕性,故亦可抑制伴隨潑彈所造成的沙孔之發生。 The specific solvent of the present invention can be used as long as it can dissolve polyimide precursors and polyimide-based polymers such as polyimide-based polymers (also known as good solvents). In addition, it also has an improved polyimide The coating effect of amine film and liquid crystal alignment film. That is, the specific solvent of the present invention generally has a lower surface tension as the solvent when compared with the NMP used as a good solvent, and the coating solution as the specific solvent is not as good as the coating without using it Compared with the solution, it has a higher wettability of the coating solution for the substrate. In this way, when used as a polyimide film and a liquid crystal alignment film, the linearity of the ends of these films can be improved. In addition, because of the higher wettability of the coating solution for the substrate, the occurrence of sand holes caused by splashing can also be suppressed.
此外,本發明之特定溶劑,通常與作為良溶劑使用的NMP或γ-BL相比較時,其沸點較低。因此,於製作聚醯亞胺膜及液晶配向膜之際的燒結也可在低溫下進行。因此,特別是,即使製作液晶配向膜之際的燒結為低溫狀態時,也可製得於液晶顯示元件中為優良VHR的液晶配向膜。 In addition, the specific solvent of the present invention generally has a lower boiling point when compared with NMP or γ-BL used as a good solvent. Therefore, the sintering at the time of producing the polyimide film and the liquid crystal alignment film can also be performed at a low temperature. Therefore, in particular, even when the sintering at the time of manufacturing the liquid crystal alignment film is in a low temperature state, a liquid crystal alignment film with excellent VHR in the liquid crystal display element can be produced.
此外,本發明之(B)成份為由聚醯亞胺前驅體或聚醯亞胺所選出之至少1種的聚合物。其中,使用本發明之組成物作為液晶配向處理劑,以製作液晶配向膜之情 形中,又以使用具有由下述式[1-1]及式[1-2]所示結構所選出之至少1種的側鏈(亦統稱為特定側鏈結構)的聚醯亞胺前驅體或聚醯亞胺所選出之至少1種的聚合物(亦稱為特定聚合物)者為佳。 In addition, the component (B) of the present invention is a polymer selected from at least one type of polyimide precursor or polyimide. Among them, the composition of the present invention is used as a liquid crystal alignment treatment agent to produce a liquid crystal alignment film In the form, a polyimide precursor having at least one type of side chain (also collectively referred to as a specific side chain structure) selected from the structures represented by the following formula [1-1] and formula [1-2] is used. At least one kind of polymer (also referred to as specific polymer) selected from polyimide or polyimide is preferred.
[化14]-Y 7 -Y 8 [1-2](式[1-2]中,Y7表示由單鍵、-O-、-CH2O-、-CONH-、-NHCO-、-CON(CH3)-、-N(CH3)CO-、-COO-及-OCO-所選出之至少1種之鍵結基,Y8表示碳數8~22之烷基或碳數6~18之含氟烷基)。 [ Chem . 14] -Y 7 -Y 8 [1-2] (In formula [1-2], Y 7 represents a single bond, -O-, -CH 2 O-, -CONH-, -NHCO-,- CON (CH 3 )-, -N (CH 3 ) CO-, -COO- and -OCO- selected at least one kind of bonding group, Y 8 represents an alkyl group having 8 to 22 carbon atoms or 6 to 6 carbon atoms 18 of fluorine-containing alkyl).
其中,前述式[1-1]所示特定側鏈結構,為側鏈部份具有苯環、環己基環或雜環的2價之環狀基,或具有膽固醇骨架之碳數17~51的2價之有機基。該些苯環、環己基環或雜環的2價之環狀基,或具有膽固醇骨架之碳數17~51的2價之有機基,顯示出剛直之結構。如此,可提高側鏈部位對熱之安定性,可抑制製作液晶配向膜之際的燒結所造成之側鏈部位的分解,而可得到具有優良VHR的液晶配向膜。 Among them, the specific side chain structure represented by the aforementioned formula [1-1] is a divalent cyclic group having a benzene ring, a cyclohexyl ring or a heterocyclic ring in the side chain portion, or a carbon number of 17 to 51 having a cholesterol skeleton 2-valent organic radical. The divalent cyclic groups of these benzene rings, cyclohexyl rings or heterocycles, or the divalent organic groups with a carbon number of 17 to 51 having a cholesterol skeleton, show a rigid structure. In this way, the thermal stability of the side chain portion can be improved, and the decomposition of the side chain portion caused by sintering when the liquid crystal alignment film is produced can be suppressed, and a liquid crystal alignment film having excellent VHR can be obtained.
由以上各點得知,本發明之含有特定溶劑與由聚醯亞胺前驅體或聚醯亞胺所選出之至少1種的聚合物的組成物,為一種可形成優良塗膜性,且即使低溫下之燒結亦可形成聚醯亞胺膜的組成物。 From the above points, it is known that the composition of the present invention containing a specific solvent and at least one polymer selected from a polyimide precursor or polyimide is a type that can form excellent coating properties, and even The sintering at low temperature can also form the composition of polyimide film.
又,本發明之組成物所得之液晶配向處理劑,可製得具有優良塗膜性的液晶配向膜。此外,即使製作液晶配向膜之際的燒結為低溫狀態時,也可製得於液晶顯示元件中為優良VHR的液晶配向膜。因此,使用該液晶配向膜時,可提供一種具有優良顯示特性的高信賴性的 液晶顯示元件。 In addition, the liquid crystal alignment treatment agent obtained by the composition of the present invention can produce a liquid crystal alignment film having excellent coating properties. In addition, even when the sintering at the time of manufacturing the liquid crystal alignment film is in a low temperature state, a liquid crystal alignment film having excellent VHR in the liquid crystal display element can be obtained. Therefore, when the liquid crystal alignment film is used, a highly reliable liquid crystal with excellent display characteristics can be provided Liquid crystal display element.
此外,本發明之含有特定溶劑與由具有前述式[1-1]所示特定側鏈結構的聚醯亞胺前驅體或聚醯亞胺所選出之至少1種的聚合物的組成物所得之液晶配向處理劑,顯示出較前述效果為更佳之效果,即,即使製作液晶配向膜之際的燒結為低溫狀態時,也可製得於液晶顯示元件中為優良VHR的液晶配向膜。因此,使用該液晶配向膜時,可提高顯示特性更優良的高信賴性之液晶顯示元件。 In addition, the composition of the present invention containing a specific solvent and at least one polymer selected from a polyimide precursor or polyimide having a specific side chain structure represented by the aforementioned formula [1-1] The liquid crystal alignment treatment agent exhibits a better effect than the aforementioned effect, that is, even when the sintering at the time of production of the liquid crystal alignment film is in a low temperature state, a liquid crystal alignment film with excellent VHR in the liquid crystal display element can be obtained. Therefore, when this liquid crystal alignment film is used, a highly reliable liquid crystal display element with more excellent display characteristics can be improved.
以下,將對本發明之實施形態作更詳細之說明。 Hereinafter, the embodiments of the present invention will be described in more detail.
本發明之特定溶劑為下述式[A]所示之溶劑。 The specific solvent of the present invention is a solvent represented by the following formula [A].
式[A]中,X1及X2,各自獨立表示碳數1~3之烷基(例如,甲基、乙基、丙基或異丙基),較佳為表示甲基或乙基,特佳為表示甲基。 In formula [A], X 1 and X 2 each independently represent an alkyl group having 1 to 3 carbon atoms (for example, methyl, ethyl, propyl, or isopropyl), preferably methyl or ethyl, Particularly preferred is methyl.
式[A]中,X3及X4,各自獨立表示碳數1~3之烷基(例如,甲基、乙基、丙基或異丙基),較佳為表示甲基或乙基,特佳為表示甲基。 In formula [A], X 3 and X 4 each independently represent an alkyl group having 1 to 3 carbon atoms (for example, methyl, ethyl, propyl, or isopropyl), preferably methyl or ethyl, Particularly preferred is methyl.
具體而言,可列舉如,以下述式[A-1]所示者 為佳。 Specifically, for example, those represented by the following formula [A-1] Better.
本發明之特定溶劑之量,就更能提高上述對基板之塗佈溶液的擴大潤濕性之觀點,以佔組成物及液晶配向處理劑中所含溶劑全體的5~80質量%為佳。其中,又以5~75質量%為佳。較佳為5~70質量%,更佳為10~60質量%。 The amount of the specific solvent of the present invention can improve the above-mentioned expanded wettability of the coating solution on the substrate, and preferably accounts for 5 to 80% by mass of the entire solvent contained in the composition and the liquid crystal alignment treatment agent. Among them, 5 to 75% by mass is better. It is preferably 5 to 70% by mass, and more preferably 10 to 60% by mass.
組成物及液晶配向處理劑中之溶劑全體之中,本發明之特定溶劑的量越多時,本發明之效果,即,可提高對基板之塗佈溶液的擴大潤濕性,而可得到具有優良塗膜性之聚醯亞胺膜及液晶配向膜。 Among the total solvents in the composition and the liquid crystal alignment treatment agent, the greater the amount of the specific solvent of the present invention, the effect of the present invention is to increase the wettability of the coating solution to the substrate and to obtain Polyimide film and liquid crystal alignment film with excellent coating properties.
本發明之(B)成份之特定聚合物,為由聚醯亞胺前驅體及聚醯亞胺(亦統稱為聚醯亞胺系聚合物)所選出之至少1種的聚合物。其中,本發明之聚醯亞胺系聚合物,又以由二胺成份與四羧酸成份反應所得的聚醯亞胺前驅體或聚醯亞胺為佳。 The specific polymer of the component (B) of the present invention is at least one polymer selected from a polyimide precursor and a polyimide (also collectively referred to as a polyimide-based polymer). Among them, the polyimide-based polymer of the present invention is preferably a polyimide precursor or polyimide obtained by reacting a diamine component and a tetracarboxylic acid component.
聚醯亞胺前驅體為,下述式[a]所示之結構。 The polyimide precursor has a structure represented by the following formula [a].
前述二胺成份,可列舉如,分子內具有2個一級或二級的胺基之二胺化合物等。 Examples of the aforementioned diamine component include diamine compounds having two primary or secondary amine groups in the molecule.
又,前述四羧酸成份,可列舉如,四羧酸化合物、四羧酸二酐、四羧酸二鹵化物化合物、四羧酸二烷酯化合物或四羧酸二烷酯二鹵化物化合物等。 In addition, the tetracarboxylic acid component includes, for example, a tetracarboxylic acid compound, a tetracarboxylic dianhydride, a tetracarboxylic acid dihalide compound, a tetracarboxylic acid dialkyl ester compound, or a tetracarboxylic acid dialkyl ester dihalide compound. .
欲製得式[a]中之A1及A2為氫原子之聚醯胺酸時,可將前述分子內具有2個一級或二級之胺基的二胺化合物,與四羧酸化合物或四羧酸酐進行反應之方式而可製得。 To prepare the polyamido acids in which A 1 and A 2 in the formula [a] are hydrogen atoms, the diamine compound having two primary or secondary amine groups in the molecule can be combined with the tetracarboxylic acid compound or It can be prepared by reacting tetracarboxylic anhydride.
欲製得式[a]中之A1及A2為碳數1~5之烷基之聚醯胺酸烷酯時,可將前述二胺化合物,與四羧酸二鹵化物化合物、四羧酸二烷酯化合物或四羧酸二烷酯二鹵化物化合物進行反應之方式而可製得。又,前述方法所得之聚醯胺酸中,式[a]所示A1及A2中亦可導入碳數1~5之烷基。 To prepare polyalkyl amides in which A 1 and A 2 in the formula [a] are alkyl groups having 1 to 5 carbon atoms, the aforementioned diamine compound, tetracarboxylic acid dihalide compound, and tetracarboxylic acid can be used It can be prepared by reacting a dialkyl acid compound or a tetracarboxylic acid dialkyl ester dihalide compound. In addition, in the polyamic acid obtained by the above method, an alkyl group having 1 to 5 carbon atoms may be introduced into A 1 and A 2 represented by formula [a].
本發明之聚醯亞胺系聚合物,以具有由下述 式[1-1]及式[1-2]所示結構所選出之至少1種的特定側鏈結構之二胺化合物作為原料之一部份使用的由聚醯亞胺前驅體及聚醯亞胺所選出之至少1種的聚合物為佳。 The polyimide-based polymer of the present invention has the following At least one kind of diamine compound with a specific side chain structure selected from the structures represented by formula [1-1] and formula [1-2] is used as a part of the raw material from a polyimide precursor and a polyimide At least one polymer selected from amines is preferred.
式[1-1]中,Y1表示由單鍵、-(CH2)a-(a為1~15之整數)、-O-、-CH2O-、-CONH-、-NHCO-、-CON(CH3)-、-N(CH3)CO-、-COO-及-OCO-所選出之至少1種之鍵結基。其中,就原料之容易取得性或合成性之觀點,以單鍵、-(CH2)a-(a為1~15之整數)、-O-、-CH2O-或-COO-為佳。更佳者為單鍵、-(CH2)a-(a為1~10之整數)、-O-、-CH2O-或-COO-。 In formula [1-1], Y 1 represents a single bond,-(CH 2 ) a- (a is an integer from 1 to 15), -O-, -CH 2 O-, -CONH-, -NHCO-, -CON (CH 3 )-, -N (CH 3 ) CO-, -COO- and -OCO- selected at least one kind of bonding group. Among them, from the viewpoint of easy availability or synthesis of raw materials, single bonds,-(CH 2 ) a- (a is an integer of 1 to 15), -O-, -CH 2 O- or -COO- are preferred . More preferably, it is a single bond,-(CH 2 ) a- (a is an integer from 1 to 10), -O-, -CH 2 O-, or -COO-.
式[1-1]中,Y2表示單鍵或-(CH2)b-(b為1~15之整數)。其中,又以單鍵或-(CH2)b-(b為1~10之整數)為佳。 In formula [1-1], Y 2 represents a single bond or-(CH 2 ) b- (b is an integer of 1 to 15). Among them, a single bond or-(CH 2 ) b- (b is an integer of 1-10) is preferred.
式[1-1]中,Y3表示由單鍵、-(CH2)c-(c為1~15之整數)、-O-、-CH2O-、-COO-及-OCO-所選出之至少1種之鍵結基。其中,就容易合成之觀點,又以單鍵、-(CH2)c-(c為1~15之整數)、-O-、-CH2O-或-COO-為佳。更佳者為單鍵、-(CH2)c-(c為1~10之整數)、-O-、-CH2O-或-COO-。 In formula [1-1], Y 3 represents a single bond,-(CH 2 ) c- (c is an integer from 1 to 15), -O-, -CH 2 O-, -COO- and -OCO- At least one kind of bonding group selected. Among them, from the viewpoint of easy synthesis, single bond,-(CH 2 ) c- (c is an integer of 1 to 15), -O-, -CH 2 O- or -COO- is preferred. More preferably, it is a single bond,-(CH 2 ) c- (c is an integer from 1 to 10), -O-, -CH 2 O-, or -COO-.
式[1-1]中,Y4為,由苯環、環己烷環及雜環所選出之至少1種之環的2價之環狀基,該些環狀基上的任意氫原子,可被碳數1~3之烷基、碳數1~3之烷氧 基、碳數1~3之含氟烷基、碳數1~3之含氟烷氧基或氟原子所取代。又,Y4為,可由具有膽固醇骨架之碳數17~51的有機基所選出的2價之有機基。其中,就容易合成之觀點,又以苯環或環己烷環的2價之環狀基,或具有膽固醇骨架之碳數17~51的2價之有機基為佳。 In formula [1-1], Y 4 is a divalent cyclic group of at least one kind of ring selected from a benzene ring, a cyclohexane ring, and a heterocyclic ring, and any hydrogen atom on these cyclic groups, It can be substituted by C 1-3 alkyl group, C 1-3 alkoxy group, C 1-3 fluorinated alkyl group, C 1-3 fluorinated alkoxy group or fluorine atom. In addition, Y 4 is a divalent organic group selected from organic groups having a carbon number of 17 to 51 having a cholesterol skeleton. Among them, from the viewpoint of easy synthesis, a divalent cyclic group having a benzene ring or cyclohexane ring, or a divalent organic group having a carbon number of 17 to 51 having a cholesterol skeleton is preferred.
式[1-1]中,Y5表示由苯環、環己烷環及雜環所選出之至少1種之環的2價之環狀基,該些環狀基上的任意之氫原子,可被碳數1~3之烷基、碳數1~3之烷氧基、碳數1~3之含氟烷基、碳數1~3之含氟烷氧基或氟原子所取代。其中,又以苯環或環己烷環為佳。 In formula [1-1], Y 5 represents a divalent cyclic group of at least one kind of ring selected from a benzene ring, a cyclohexane ring, and a heterocyclic ring, and any hydrogen atom on these cyclic groups, It can be substituted by C 1-3 alkyl group, C 1-3 alkoxy group, C 1-3 fluorinated alkyl group, C 1-3 fluorinated alkoxy group or fluorine atom. Among them, benzene ring or cyclohexane ring is preferred.
式[1-1]中,n表示0~4之整數。其中,就原料之容易取得性或合成性之觀點,以0~3為佳。更佳者為0~2。 In formula [1-1], n represents an integer of 0 to 4. Among them, from the viewpoint of easy availability or synthesis of raw materials, 0 to 3 is preferable. The better is 0 ~ 2.
式[1-1]中,Y6表示由碳數1~22之烷基、碳數2~22之烯基、碳數1~22之含氟烷基、碳數1~22之烷氧基及碳數1~22之含氟烷氧基所選出之至少1種。其中,又以碳數1~18之烷基、碳數2~18之烯基、碳數1~10之含氟烷基、碳數1~18之烷氧基或碳數1~10之含氟烷氧基為佳。更佳為碳數1~12之烷基、碳數2~12之烯基或碳數1~12之烷氧基。特佳為碳數1~9之烷基或碳數1~9之烷氧基。 In formula [1-1], Y 6 represents an alkyl group having 1 to 22 carbon atoms, an alkenyl group having 2 to 22 carbon atoms, a fluorine-containing alkyl group having 1 to 22 carbon atoms, and an alkoxy group having 1 to 22 carbon atoms. And at least one selected from fluorine-containing alkoxy groups having 1 to 22 carbon atoms. Among them, the alkyl group having 1 to 18 carbon atoms, the alkenyl group having 2 to 18 carbon atoms, the fluorine-containing alkyl group having 1 to 10 carbon atoms, the alkoxy group having 1 to 18 carbon atoms or the carbon atom having 1 to 10 Fluoroalkoxy is preferred. More preferably, it is an alkyl group having 1 to 12 carbons, an alkenyl group having 2 to 12 carbons or an alkoxy group having 1 to 12 carbons. Particularly preferred is an alkyl group having 1 to 9 carbon atoms or an alkoxy group having 1 to 9 carbon atoms.
式[1-1]中,Y1~Y6及n之較佳組合,可列舉如,國際公開公報第2011/132751(2011.10.27公開)之13頁~34頁的表6~表47所揭示之(2-1)~(2-629)為相同之 組合等。又,國際公開公報中之各表中,相對於本發明中之Y1~Y6,為以Y1~Y6表示,但Y1~Y6可與Y1~Y6相互對等替代。又,國際公開公報之各表所揭示之(2-605)~(2-629),於本發明中表示具有膽固醇骨架之碳數17~51之有機基,為具有膽固醇骨架之碳數12~25的有機基,故具有膽固醇骨架之碳數12~25之有機基,可與本發明之具有膽固醇骨架之碳數17~51之有機基相互對等替代。 In the formula [1-1], the preferred combination of Y 1 to Y 6 and n can be exemplified by Table 6 to Table 47 on pages 13 to 34 of pages 13/1341 of the International Publication No. 2011/132751 (published on 2011.10.27) The revealed (2-1) ~ (2-629) are the same combination and so on. In addition, in the tables in the International Publication, relative to Y 1 to Y 6 in the present invention, they are represented by Y1 to Y6, but Y1 to Y6 and Y 1 to Y 6 can be replaced with each other by equivalents. In addition, (2-605) to (2-629) disclosed in the tables of the International Open Gazette, in the present invention, represent an organic group having a carbon number of 17 to 51 having a cholesterol skeleton, and a carbon number having a cholesterol skeleton of 12 to 12 The organic group of 25, so the organic group with a carbon number of 12 to 25 having a cholesterol skeleton can be replaced with the organic group with a carbon number of 17 to 51 having a cholesterol skeleton according to the present invention.
[化19]-Y 7 -Y 8 [1-2] [化 19] -Y 7 -Y 8 [1-2]
式[1-2]中,Y7為由單鍵、-O-、-CH2O-、-CONH-、-NHCO-、-CON(CH3)-、-N(CH3)CO-、-COO-及-OCO-所選出之至少1種之鍵結基。其中,又以單鍵、-O-、-CH2O-、-CONH-、-CON(CH3)-或-COO-為佳。更佳為單鍵、-O-、-CONH-或-COO-。 In formula [1-2], Y 7 is composed of a single bond, -O-, -CH 2 O-, -CONH-, -NHCO-, -CON (CH 3 )-, -N (CH 3 ) CO-, -COO- and -OCO- selected at least one bonding group. Among them, a single bond, -O-, -CH 2 O-, -CONH-, -CON (CH 3 )-or -COO- is preferred. More preferably, it is a single bond, -O-, -CONH- or -COO-.
式[1-2]中,Y8表示碳數8~22之烷基或碳數6~18之含氟烷基。其中,又以碳數8~18之烷基為佳。 In formula [1-2], Y 8 represents a C 8-22 alkyl group or a C 6-18 fluorine-containing alkyl group. Among them, the alkyl group having 8 to 18 carbon atoms is preferred.
本發明之特定側鏈結構,就可取得高安定的液晶垂直配向性之觀點,以使用式[1-1]所示結構者為佳。 For the specific side chain structure of the present invention, from the viewpoint of obtaining a highly stable liquid crystal vertical alignment, it is preferable to use the structure shown in formula [1-1].
本發明之特定側鏈結構導入特定聚合物之方法,並未有特別之限定,又以使用具有特定側鏈結構的二胺化合物作為二胺成份使用者為佳。 The method for introducing a specific polymer into a specific side chain structure of the present invention is not particularly limited, and it is preferable to use a diamine compound having a specific side chain structure as a diamine component user.
具體而言,可列舉如,以使用下述式[1a]所示二胺化合物(亦稱為特定側鏈型二胺化合物)為佳。此時, 亦可使用下述式[1a]中之胺基為二級胺基之二胺化合物。 Specifically, for example, it is preferable to use a diamine compound (also referred to as a specific side chain type diamine compound) represented by the following formula [1a]. at this time, A diamine compound in which the amine group in the following formula [1a] is a secondary amine group can also be used.
式[1a]中,Y表示由前述式[1-1]及式[1-2]所示結構所選出之至少1種之結構。又,式[1a]中之Y表示式[1-1]之情形的Y1~Y6及n之較佳組合,例如與前述為相同之內容。 In formula [1a], Y represents at least one structure selected from the structures shown in the above formula [1-1] and formula [1-2]. In addition, Y in formula [1a] represents a preferable combination of Y 1 to Y 6 and n in the case of formula [1-1], and is the same as described above, for example.
式[1a]中,m表示1~4之整數。其中,又以1為佳。 In formula [1a], m represents an integer of 1-4. Among them, 1 is better.
本發明之特定側鏈型二胺化合物之具體例,例如,下述式[1a-1]~式[1a-34]所示二胺化合物,此外,又例如該些胺基為二級胺基之二胺化合物。 Specific examples of the specific side chain type diamine compound of the present invention are, for example, the diamine compounds represented by the following formula [1a-1] to formula [1a-34], and further, for example, these amine groups are secondary amine groups The diamine compound.
前述式[1a-1]~[1a-21]、[1a-24]~[1a-35]中,特佳之結構的特定側鏈型二胺化合物為,式[1a-1]~式[1a-6]、式[1a-9]~式[1a-13]或式[1a-24]~式[1a-31]。 In the aforementioned formulas [1a-1] to [1a-21] and [1a-24] to [1a-35], the specific side chain type diamine compound of particularly excellent structure is, formula [1a-1] to formula [1a -6], formula [1a-9] ~ formula [1a-13] or formula [1a-24] ~ formula [1a-31].
本發明之特定聚合物中之特定側鏈型二胺化 合物,相對於二胺成份全體為10莫耳%以上80莫耳%以下為佳。特佳為10莫耳%以上70莫耳%以下。 The specific side chain type diamine in the specific polymer of the present invention The compound is preferably 10 mol% or more and 80 mol% or less with respect to the entire diamine component. Tejia is more than 10 mol% and less than 70 mol%.
本發明之特定側鏈型二胺化合物,就配合本發明之特定聚合物對溶劑之溶解性、組成物及液晶配向處理劑之塗佈性、作為液晶配向膜之情形中的液晶之配向性、電壓保持率、蓄積電荷等之特性時,可使用1種類或將2種類以上混合使用。 The specific side chain type diamine compound of the present invention incorporates the solubility of the specific polymer of the present invention in a solvent, the coating properties of the composition and the liquid crystal alignment treatment agent, the alignment of the liquid crystal in the case of the liquid crystal alignment film, For characteristics such as voltage retention rate and accumulated charge, one type may be used or two or more types may be used in combination.
本發明之特定聚合物中,以使用具有由羧基(COOH基)及羥基(OH基)所選出之至少1種的取代基之二胺化合物作為二胺成份使用之聚合物為佳。 Among the specific polymers of the present invention, a diamine compound having at least one substituent selected from a carboxyl group (COOH group) and a hydroxyl group (OH group) is preferably used as the diamine component.
具體而言,可列舉如,以使用下述式[2a]所示二胺化合物者為佳。此時,亦可使用下述式[2a]中之胺基為二級胺基的二胺化合物。 Specifically, for example, those using the diamine compound represented by the following formula [2a] are preferred. In this case, a diamine compound in which the amine group in the following formula [2a] is a secondary amine group can also be used.
式[2a]中,A表示由下述式[2-1]及式[2-2]所選出之至少1個結構的取代基。 In formula [2a], A represents a substituent of at least one structure selected from the following formula [2-1] and formula [2-2].
[化34]-(CH 2 ) a -COOH [2-1] -(CH 2 ) b -OH [2-2] [化 34] -(CH 2 ) a -COOH [2-1]-(CH 2 ) b -OH [2-2]
式[2-1]中,a表示0~4之整數。 In formula [2-1], a represents an integer of 0 to 4.
式[2-2]中,b表示0~4之整數。 In formula [2-2], b represents an integer of 0 ~ 4.
式[2a]中,m表示1~4之整數。 In formula [2a], m represents an integer of 1-4.
更具體而言,可列舉如,2,4-二胺基酚、3,5-二胺基酚、3,5-二胺基苄醇、2,4-二胺基苄醇、4,6-二胺基 間苯二酚、2,4-二胺基安息香酸、2,5-二胺基安息香酸或3,5-二胺基安息香酸等。其中,又以2,4-二胺基安息香酸、2,5-二胺基安息香酸或3,5-二胺基安息香酸為佳。 More specifically, for example, 2,4-diaminophenol, 3,5-diaminophenol, 3,5-diaminobenzyl alcohol, 2,4-diaminobenzyl alcohol, 4,6 -Diamine Resorcinol, 2,4-diaminobenzoic acid, 2,5-diaminobenzoic acid or 3,5-diaminobenzoic acid, etc. Among them, 2,4-diaminobenzoic acid, 2,5-diaminobenzoic acid or 3,5-diaminobenzoic acid is preferred.
又,亦可使用下述式[2a-1]~式[2a-4]所示二胺化合物及該些之胺基為二級胺基之二胺化合物。 In addition, diamine compounds represented by the following formula [2a-1] to formula [2a-4] and diamine compounds in which these amine groups are secondary amine groups can also be used.
本發明之特定聚合物中,具有由羧基(COOH基)及羥基(OH基)所選出之至少1種的取代基之二胺化合物,其相對於二胺成份全體,以10莫耳%以上80莫耳%以下為佳。特佳為10莫耳%以上70莫耳%以下。 In the specific polymer of the present invention, a diamine compound having at least one kind of substituent selected from a carboxyl group (COOH group) and a hydroxyl group (OH group), with respect to the entire diamine component, is at least 10 mole% 80 Mole% or less is preferred. Tejia is more than 10 mol% and less than 70 mol%.
本發明之具有由羧基(COOH基)及羥基(OH基)所選出之至少1種的取代基之二胺化合物,就配合本發明之特定聚合物對溶劑之溶解性、組成物及液晶配向處理劑之塗佈性、作為液晶配向膜之情形中的液晶之配向性、電壓保持率、蓄積電荷等特性時,可使用1種類或將2種類以上混合使用。 The diamine compound of the present invention having at least one substituent selected from a carboxyl group (COOH group) and a hydroxyl group (OH group) is compounded with the solubility of the specific polymer of the present invention in solvents, composition and liquid crystal alignment treatment In the case of the coating properties of the agent, the alignment properties of the liquid crystal in the case of the liquid crystal alignment film, the voltage retention rate, the accumulated charge and other characteristics, one type may be used or two or more types may be used in combination.
本發明之特定聚合物中,以使用具有下述式[3a]所示含氮雜環的二胺化合物及該些胺基為二級胺基的二胺化合物為佳。 In the specific polymer of the present invention, it is preferable to use a diamine compound having a nitrogen-containing heterocyclic ring represented by the following formula [3a] and these diamine compounds having secondary amine groups.
式[3a]中,B1表示由-O-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-CH2O-、-OCO-、-CON(CH3)-及-N(CH3)CO-所選出之至少1種之鍵結基。其中,又以-O-、-NH-、-CONH-、-NHCO-、-CH2O-、-OCO-、-CON(CH3)-或-N(CH3)CO-,就容易合成二胺化合物之觀點,而為較佳。更佳者為-O-、-NH-、-CONH-、-NHCO-、-CH2O-、-OCO-或-CON(CH3)-。特佳為-O-、-CONH-或-CH2O-。 In formula [3a], B 1 represents -O-, -NH-, -N (CH 3 )-, -CONH-, -NHCO-, -CH 2 O-, -OCO-, -CON (CH 3 ) -And-N (CH 3 ) CO- selected at least one kind of bonding group. Among them, -O-, -NH-, -CONH-, -NHCO-, -CH 2 O-, -OCO-, -CON (CH 3 )-or -N (CH 3 ) CO- are easy to synthesize From the viewpoint of a diamine compound, it is preferable. More preferred are -O-, -NH-, -CONH-, -NHCO-, -CH 2 O-, -OCO-, or -CON (CH 3 )-. Particularly preferred is -O-, -CONH- or -CH 2 O-.
式[3a]中,B2表示由單鍵、碳數1~20之脂 肪族烴的2價之基、非芳香族環式烴的2價之基及芳香族烴的2價之基所選出之至少1種。碳數1~20之脂肪族烴的2價之基,可為直鏈狀亦可、分支狀亦可。又,亦可具有不飽和鍵結。其中,又以碳數1~10之伸烷基為佳。又,非芳香族烴之具體例,可列舉如,環丙環、環丁環、環戊環、環己環、環庚環、環辛環、環壬環、環癸環、環十一環、環十二環、環十三環、環十四環、環十五環、環十六環、環十七環、環十八環、環十九環、環二十(icosene)環、三環二十(eicosene)環、三環二十二(docosane)環、二環庚環、十氫萘環、降莰烯環或金剛環等。其中,又以環丙環、環丁環、環戊環、環己環、環庚環、降莰烯環或金剛環為佳。芳香族烴基的其具體例,可列舉如,苯環、萘環、四氫萘環、薁環、茚環、茀環、蒽環、菲環或萉環等。其中,又以苯環、萘環、四氫萘環、茀環或蒽環為佳。 In formula [3a], B 2 represents a single bond, a divalent radical of an aliphatic hydrocarbon having 1 to 20 carbon atoms, a divalent radical of a non-aromatic cyclic hydrocarbon, and a divalent radical of an aromatic hydrocarbon At least one of them. The divalent base of the aliphatic hydrocarbon having 1 to 20 carbon atoms may be linear or branched. In addition, it may have an unsaturated bond. Among them, alkylene having 1 to 10 carbon atoms is preferred. In addition, specific examples of the non-aromatic hydrocarbon include cyclopropyl ring, cyclobutane ring, cyclopentane ring, cyclohexyl ring, cycloheptane ring, cyclooctane ring, cyclonon ring, cyclodecane ring, cycloundecyl ring , Ring twelve, ring thirteen, ring fourteen, ring fifteen, ring sixteen, ring seventeen, ring eighteen, ring nineteen, ring twenty (icosene), three Eicosene ring, docosane ring, bicycloheptane ring, decahydronaphthalene ring, norbornene ring or adamantane ring, etc. Among them, cyclopropyl ring, cyclobutane ring, cyclopentane ring, cyclohexyl ring, cycloheptane ring, norbornene ring or adamantane ring are preferred. Specific examples of the aromatic hydrocarbon group include benzene ring, naphthalene ring, tetrahydronaphthalene ring, azulene ring, indene ring, stilbene ring, anthracene ring, phenanthrene ring, and phlebo ring. Among them, benzene ring, naphthalene ring, tetrahydronaphthalene ring, stilbene ring or anthracene ring is preferred.
式[3a]中,較佳之B2,為單鍵、碳數1~10之伸烷基,或由環丙烷環、環丁烷環、環戊烷環、環己烷環、環庚烷環、降莰烯環、金剛烷環、苯環、萘環、四氫萘環、茀環及蒽環所選出之至少1種環的2價基。其中,又以單鍵、碳數1~5之伸烷基,或環己烷環或苯環的2價基為佳。 In formula [3a], preferred B 2 is a single bond, an alkylene group having 1 to 10 carbon atoms, or a cyclopropane ring, cyclobutane ring, cyclopentane ring, cyclohexane ring, cycloheptane ring , A bivalent group of at least one ring selected from norbornene ring, adamantane ring, benzene ring, naphthalene ring, tetrahydronaphthalene ring, stilbene ring and anthracene ring Among them, a single bond, an alkylene group having 1 to 5 carbon atoms, or a divalent group of a cyclohexane ring or a benzene ring is preferred.
式[3a]中,B3表示由單鍵、-O-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-COO-、-OCO-、-CON(CH3)-、-N(CH3)CO-及-O(CH2)m-(m為1~5之整數)所選出之至少1種之鍵結 基。其中,又以單鍵、-O-、-COO-、-OCO-或-O(CH2)m-(m為1~5之整數)為佳。更佳者為單鍵、-O-、-OCO-或-O(CH2)m-(m為1~5之整數)。 In formula [3a], B 3 represents a single bond, -O-, -NH-, -N (CH 3 )-, -CONH-, -NHCO-, -COO-, -OCO-, -CON (CH 3 )-, -N (CH 3 ) CO- and -O (CH 2 ) m- (m is an integer from 1 to 5) at least one kind of bonding group selected. Among them, single bond, -O-, -COO-, -OCO- or -O (CH 2 ) m- (m is an integer of 1 to 5) is preferred. More preferably, it is a single bond, -O-, -OCO-, or -O (CH 2 ) m- (m is an integer from 1 to 5).
式[3a]中,B4為含氮之雜環基,其為含有由下述式[3a-1]、式[3a-2]及式[3a-3]所選出之至少1種之結構的雜環之基。 In formula [3a], B 4 is a nitrogen-containing heterocyclic group, which is a structure containing at least one selected from the following formula [3a-1], formula [3a-2] and formula [3a-3] Of heterocyclic bases.
更具體而言,可列舉如,吡咯環、咪唑環、噁唑環、噻唑環、吡唑環、吡啶環、嘧啶環、喹啉環、吡唑啉環、異喹啉環、咔唑環、嘌呤環、噻二唑環、嗒環、吡唑啉環、三環、吡唑啶環、三唑環、吡環、苯併咪唑環、噌啉環、啡啉(phenanthroline)環、吲哚環、喹噁啉(quinoxaline)環、苯併噻唑環、啡噻(phenothiazine)環、氧雜二唑環或吖啶環等。其中,又以吡咯環、咪唑環、吡唑環、吡啶環、嘧啶環、嗒環、三環、三唑環、吡環或苯併咪唑環為佳。更佳者為吡咯環、咪唑環、吡唑環、吡啶環或嘧啶環。又,式[3a]中之B3,以與B4所含之式[3a-1]、式[3a-2]及式[3a-3]之結構不相鄰接之環原子鍵結者為佳。 More specifically, for example, pyrrole ring, imidazole ring, oxazole ring, thiazole ring, pyrazole ring, pyridine ring, pyrimidine ring, quinoline ring, pyrazoline ring, isoquinoline ring, carbazole ring, Purine ring, thiadiazole ring, ta Ring, pyrazoline ring, three Ring, pyrazolidine ring, triazole ring, pyridine Ring, benzimidazole ring, cinnoline ring, phenanthroline ring, indole ring, quinoxaline ring, benzothiazole ring, phenothiazine (phenothiazine) ring, oxadiazole ring or acridine ring, etc. Among them, pyrrole ring, imidazole ring, pyrazole ring, pyridine ring, pyrimidine ring, ta Ring, three Ring, triazole ring, pyridine Ring or benzimidazole ring is preferred. More preferred are pyrrole ring, imidazole ring, pyrazole ring, pyridine ring or pyrimidine ring. In addition, B 3 in formula [3a] is bonded to a ring atom that is not adjacent to the structures of formula [3a-1], formula [3a-2] and formula [3a-3] contained in B 4 Better.
式[3a]中,n為1~4之整數,就與四羧酸成 份反應性之觀點,較佳為1或2。 In formula [3a], n is an integer from 1 to 4 From the viewpoint of partial reactivity, 1 or 2 is preferable.
式[3a]中,特佳之B1~B4及n之組合為,B1表示-CONH-、B2表示碳數1~5之伸烷基、B3表示單鍵、B4表示咪唑環或吡啶環、n表示1之二胺化合物。 In formula [3a], the particularly preferred combination of B 1 to B 4 and n is that B 1 represents -CONH-, B 2 represents an alkylene group having 1 to 5 carbon atoms, B 3 represents a single bond, and B 4 represents an imidazole ring Or a pyridine ring, n represents a diamine compound of 1.
式[3a]中之二個的胺基(-NH2)之鍵結位置並未有特別限定。具體而言,可列舉如,相對於側鏈之鍵結基(-B1-),為苯環上的2,3之位置、2,4之位置、2,5之位置、2,6之位置、3,4之位置或3,5之位置等。其中,就合成聚醯胺酸時之反應性的觀點,以2,4之位置、2,5之位置或3,5之位置為佳。再加上合成二胺化合物時之容易性的觀點,又以2,4之位置或2,5之位置為較佳。 The bonding position of the two amine groups (-NH 2 ) in formula [3a] is not particularly limited. Specifically, for example, with respect to the bonding group (-B 1- ) of the side chain, it is 2,3 position, 2,4 position, 2,5 position, 2,6 on the benzene ring Position, 3,4 position or 3,5 position, etc. Among them, from the viewpoint of the reactivity when synthesizing polyamic acid, the position of 2,4, the position of 2,5, or the position of 3,5 is preferable. Coupled with the ease of synthesis of the diamine compound, the 2,4 position or the 2,5 position is preferred.
本發明之特定聚合物中,具有前述式[3a]所示含氮雜環之二胺化合物為,二胺成份全體的10莫耳%以上80莫耳%以下者為佳。特佳為10莫耳%以上70莫耳%以下。 In the specific polymer of the present invention, the diamine compound having the nitrogen-containing heterocyclic ring represented by the aforementioned formula [3a] is preferably 10 mol% or more and 80 mol% or less of the entire diamine component. Tejia is more than 10 mol% and less than 70 mol%.
本發明之具有前述式[3a]所示含氮雜環之二胺化合物,就配合本發明之特定聚合物對溶劑之溶解性、組成物及液晶配向處理劑之塗佈性、作為液晶配向膜之情形中的液晶之配向性、電壓保持率、蓄積電荷等特性時,可使用1種類或將2種類以上混合使用。 The diamine compound of the present invention having the nitrogen-containing heterocyclic ring represented by the aforementioned formula [3a], in combination with the solubility of the specific polymer of the present invention in solvents, the composition and the coating properties of the liquid crystal alignment treatment agent, is used as a liquid crystal alignment film In the case of characteristics such as alignment, voltage retention, and accumulated charge of the liquid crystal, one type may be used or two or more types may be used in combination.
本發明之特定聚合物,於無損本發明之效果之範圍,可再使用其他二胺化合物之下述式[a-1]~式[a-13]所示二胺化合物及該些之胺基為二級胺基的二胺化合物。 The specific polymer of the present invention can use other diamine compounds represented by the following formula [a-1] to formula [a-13] and these amine groups as long as the effects of the present invention are not impaired A diamine compound with a secondary amine group.
此外,其他二胺化合物,亦可使用下述二胺化合物及該些之胺基為二級胺基之二胺化合物。 In addition, as other diamine compounds, the following diamine compounds and those in which the amine groups are secondary amine groups can also be used.
具體而言,可列舉如,p-伸苯基二胺、2,3,5,6-四甲基-p-伸苯基二胺、2,5-二甲基-p-伸苯基二胺、m-伸苯基二胺、2,4-二甲基-m-伸苯基二胺、2,5-二胺基甲苯、2,6-二胺基甲苯、4,4’-二胺基聯苯、3,3’-二甲基-4,4’-二胺基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯、3,3’-二羥基-4,4’-二胺基聯苯、3,3’-二羧基-4,4’-二胺基聯苯、3,3’-二氟-4,4’-二胺基聯苯、3,3’-三氟甲基-4,4’-二胺基聯苯、3,4’-二胺基聯苯、3,3’-二胺基聯苯、2,2’-二胺基聯苯、2,3’-二胺基聯苯、4,4’-二胺基二苯基甲烷、3,3’-二胺基二苯基甲烷、3,4’-二胺基二苯基甲烷、2,2’-二胺基二苯基甲烷、2,3’-二胺基二苯基甲烷、4,4’-二胺基二苯醚、3,3’-二胺基二苯醚、3,4’-二胺基二苯醚、2,2’-二胺基二苯醚、2,3’-二胺基二苯醚、4,4’-磺醯基二苯胺、3,3’-磺醯基二苯胺、雙(4-胺基苯基)矽烷、雙(3-胺基苯基)矽烷、二 甲基-雙(4-胺基苯基)矽烷、二甲基-雙(3-胺基苯基)矽烷、4,4’-硫代二苯胺、3,3’-硫代二苯胺、4,4’-二胺基二苯胺、3,3’-二胺基二苯胺、3,4’-二胺基二苯胺、2,2’-二胺基二苯胺、2,3’-二胺基二苯胺、N-甲基(4,4’-二胺基二苯基)胺、N-甲基(3,3’-二胺基二苯基)胺、N-甲基(3,4’-二胺基二苯基)胺、N-甲基(2,2’-二胺基二苯基)胺、N-甲基(2,3’-二胺基二苯基)胺、4,4’-二胺基二苯甲酮、3,3’-二胺基二苯甲酮、3,4’-二胺基二苯甲酮、1,4-二胺基萘、2,2’-二胺基二苯甲酮、2,3’-二胺基二苯甲酮、1,5-二胺基萘、1,6-二胺基萘、1,7-二胺基萘、1,8-二胺基萘、2,5-二胺基萘、2,6-二胺基萘、2,7-二胺基萘、2,8-二胺基萘、1,2-雙(4-胺基苯基)乙烷、1,2-雙(3-胺基苯基)乙烷、1,3-雙(4-胺基苯基)丙烷、1,3-雙(3-胺基苯基)丙烷、1,4-雙(4-胺基苯基)丁烷、1,4-雙(3-胺基苯基)丁烷、雙(3,5-二乙基-4-胺基苯基)甲烷、1,4-雙(4-胺基苯氧基)苯、1,3-雙(4-胺基苯氧基)苯、1,4-雙(4-胺基苯基)苯、1,3-雙(4-胺基苯基)苯、1,4-雙(4-胺基苄基)苯、1,3-雙(4-胺基苯氧基)苯、4,4’-[1,4-伸苯基雙(伸甲基)]二苯胺、4,4’-[1,3-伸苯基雙(伸甲基)]二苯胺、3,4’-[1,4-伸苯基雙(伸甲基)]二苯胺、3,4’-[1,3-伸苯基雙(伸甲基)]二苯胺、3,3’-[1,4-伸苯基雙(伸甲基)]二苯胺、3,3’-[1,3-伸苯基雙(伸甲基)]二苯胺、1,4-伸苯基雙[(4-胺基苯基)甲醛]、1,4-伸苯基雙[(3-胺基苯基)甲醛]、1,3-伸苯基雙[(4-胺基苯基)甲醛]、1,3-伸苯基雙[(3-胺基苯基)甲醛]、1,4-伸苯基雙(4-胺基苯甲酸酯)、1,4-伸苯基 雙(3-胺基苯甲酸酯)、1,3-伸苯基雙(4-胺基苯甲酸酯)、1,3-伸苯基雙(3-胺基苯甲酸酯)、雙(4-胺基苯基)對苯二甲酸酯、雙(3-胺基苯基)對苯二甲酸酯、雙(4-胺基苯基)間苯二甲酸酯、雙(3-胺基苯基)間苯二甲酸酯、N,N’-(1,4-伸苯基)雙(4-胺基苯甲醯胺)、N,N’-(1,3-伸苯基)雙(4-胺基苯甲醯胺)、N,N’-(1,4-伸苯基)雙(3-胺基苯甲醯胺)、N,N’-(1,3-伸苯基)雙(3-胺基苯甲醯胺)、N,N’-雙(4-胺基苯基)對苯二甲醯胺、N,N’-雙(3-胺基苯基)對苯二甲醯胺、N,N’-雙(4-胺基苯基)間苯二甲醯胺、N,N’-雙(3-胺基苯基)間苯二甲醯胺、9,10-雙(4-胺基苯基)蒽、4,4’-雙(4-胺基苯氧基)二苯基碸、2,2’-雙[4-(4-胺基苯氧基)苯基]丙烷、2,2’-雙[4-(4-胺基苯氧基)苯基]六氟丙烷、2,2’-雙(4-胺基苯基)六氟丙烷、2,2’-雙(3-胺基苯基)六氟丙烷、2,2’-雙(3-胺基-4-甲基苯基)六氟丙烷、2,2’-雙(4-胺基苯基)丙烷、2,2’-雙(3-胺基苯基)丙烷、2,2’-雙(3-胺基-4-甲基苯基)丙烷、1,3-雙(4-胺基苯氧基)丙烷、1,3-雙(3-胺基苯氧基)丙烷、1,4-雙(4-胺基苯氧基)丁烷、1,4-雙(3-胺基苯氧基)丁烷、1,5-雙(4-胺基苯氧基)戊烷、1,5-雙(3-胺基苯氧基)戊烷、1,6-雙(4-胺基苯氧基)己烷、1,6-雙(3-胺基苯氧基)己烷、1,7-雙(4-胺基苯氧基)庚烷、1,7-(3-胺基苯氧基)庚烷、1,8-雙(4-胺基苯氧基)辛烷、1,8-雙(3-胺基苯氧基)辛烷、1,9-雙(4-胺基苯氧基)壬烷、1,9-雙(3-胺基苯氧基)壬烷、1,10-(4-胺基苯氧基)癸烷、1,10-(3-胺基苯氧基)癸烷、1,11-(4-胺基苯氧基)十一烷、1,11-(3-胺基苯氧基)十一 烷、1,12-(4-胺基苯氧基)十二烷、1,12-(3-胺基苯氧基)十二烷等之芳香族二胺化合物、雙(4-胺基環己基)甲烷、雙(4-胺基-3-甲基環己基)甲烷等之脂環式二胺化合物、1,3-二胺基丙烷、1,4-二胺基丁烷、1,5-二胺基戊烷、1,6-二胺基己烷、1,7-二胺基庚烷、1,8-二胺基辛烷、1,9-二胺基壬烷、1,10-二胺基癸烷、1,11-二胺基十一烷、1,12-二胺基十二烷等之脂肪族二胺化合物等。 Specifically, for example, p-phenylene diamine, 2,3,5,6-tetramethyl-p-phenylene diamine, 2,5-dimethyl-p-phenylene diamine Amine, m-phenylene diamine, 2,4-dimethyl-m-phenylene diamine, 2,5-diaminotoluene, 2,6-diaminotoluene, 4,4'-di Aminobiphenyl, 3,3'-dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl, 3,3 ' -Dihydroxy-4,4'-diaminobiphenyl, 3,3'-dicarboxy-4,4'-diaminobiphenyl, 3,3'-difluoro-4,4'-diamino Biphenyl, 3,3'-trifluoromethyl-4,4'-diaminobiphenyl, 3,4'-diaminobiphenyl, 3,3'-diaminobiphenyl, 2,2 ' -Diaminobiphenyl, 2,3'-diaminobiphenyl, 4,4'-diaminodiphenylmethane, 3,3'-diaminodiphenylmethane, 3,4'-di Aminodiphenylmethane, 2,2'-diaminodiphenylmethane, 2,3'-diaminodiphenylmethane, 4,4'-diaminodiphenyl ether, 3,3'- Diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 2,2'-diaminodiphenyl ether, 2,3'-diaminodiphenyl ether, 4,4'-sulfonamide Diphenylamine, 3,3'-sulfonyldiphenylamine, bis (4-aminophenyl) silane, bis (3- (Aminophenyl) silane, di Methyl-bis (4-aminophenyl) silane, dimethyl-bis (3-aminophenyl) silane, 4,4'-thiodiphenylamine, 3,3'-thiodiphenylamine, 4 , 4'-diaminodiphenylamine, 3,3'-diaminodiphenylamine, 3,4'-diaminodiphenylamine, 2,2'-diaminodiphenylamine, 2,3'-diamine Diphenylamine, N-methyl (4,4'-diaminodiphenyl) amine, N-methyl (3,3'-diaminodiphenyl) amine, N-methyl (3,4 '-Diaminodiphenyl) amine, N-methyl (2,2'-diaminodiphenyl) amine, N-methyl (2,3'-diaminodiphenyl) amine, 4 , 4'-diaminobenzophenone, 3,3'-diaminobenzophenone, 3,4'-diaminobenzophenone, 1,4-diaminonaphthalene, 2,2 '-Diaminobenzophenone, 2,3'-diaminobenzophenone, 1,5-diaminonaphthalene, 1,6-diaminonaphthalene, 1,7-diaminonaphthalene, 1,8-diaminonaphthalene, 2,5-diaminonaphthalene, 2,6-diaminonaphthalene, 2,7-diaminonaphthalene, 2,8-diaminonaphthalene, 1,2-bis (4-aminophenyl) ethane, 1,2-bis (3-aminophenyl) ethane, 1,3-bis (4-aminophenyl) propane, 1,3-bis (3- Aminophenyl) propane, 1,4-bis (4-aminophenyl) butane, 1,4-bis (3-aminophenyl) butane, bis (3,5-diethyl 4-amino-4-aminophenyl) methane, 1,4-bis (4-aminophenoxy) benzene, 1,3-bis (4-aminophenoxy) benzene, 1,4-bis (4 -Aminophenyl) benzene, 1,3-bis (4-aminophenyl) benzene, 1,4-bis (4-aminobenzyl) benzene, 1,3-bis (4-aminophenoxy ), Benzene, 4,4 '-[1,4-phenylene bis (methylidene)] diphenylamine, 4,4'-[1,3-phenylene bis (methylidene)] diphenylamine, 3,4 '-[1,4-phenylene bis (methylidene)] diphenylamine, 3,4'-[1,3-phenylene bis (methylidene)] diphenylamine, 3,3 ' -[1,4-Phenylbis (methyl)) diphenylamine, 3,3 '-[1,3-Phenylbis (methyl)] diphenylamine, 1,4-Phenylbis [(4-Aminophenyl) Formaldehyde], 1,4-Extenyl Bis [(3-Aminophenyl) Formaldehyde], 1,3-Extenyl Bis [(4-Aminophenyl) Formaldehyde ], 1,3-phenylene bis [(3-aminophenyl) formaldehyde], 1,4-phenylene bis (4-aminobenzoate), 1,4-phenylene Bis (3-aminobenzoate), 1,3-phenylenebis (4-aminobenzoate), 1,3-phenylenebis (3-aminobenzoate), Bis (4-aminophenyl) terephthalate, bis (3-aminophenyl) terephthalate, bis (4-aminophenyl) isophthalate, bis ( 3-aminophenyl) isophthalate, N, N '-(1,4-phenylene) bis (4-aminobenzylamide), N, N'-(1,3- Phenylene) bis (4-aminobenzylamide), N, N '-(1,4-phenylene) bis (3-aminobenzylamine), N, N'-(1, 3-Phenylphenyl) bis (3-aminobenzamide), N, N'-bis (4-aminophenyl) p-xylylenediamine, N, N'-bis (3-amino) Phenyl) p-xylylenediamine, N, N'-bis (4-aminophenyl) m-xylylenediamine, N, N'-bis (3-aminophenyl) m-xylylenediamide Amine, 9,10-bis (4-aminophenyl) anthracene, 4,4'-bis (4-aminophenoxy) diphenyl sulfone, 2,2'-bis [4- (4-amine Phenoxy) phenyl] propane, 2,2'-bis [4- (4-aminophenoxy) phenyl] hexafluoropropane, 2,2'-bis (4-aminophenyl) hexa Fluoropropane, 2,2'-bis (3-aminophenyl) hexafluoropropane, 2,2'-bis (3-amino-4-methylphenyl) hexafluoropropane, 2,2'-bis (4-aminophenyl) propane 2,2'-bis (3-aminophenyl) propane, 2,2'-bis (3-amino-4-methylphenyl) propane, 1,3-bis (4-aminophenoxy ) Propane, 1,3-bis (3-aminophenoxy) propane, 1,4-bis (4-aminophenoxy) butane, 1,4-bis (3-aminophenoxy) Butane, 1,5-bis (4-aminophenoxy) pentane, 1,5-bis (3-aminophenoxy) pentane, 1,6-bis (4-aminophenoxy) ) Hexane, 1,6-bis (3-aminophenoxy) hexane, 1,7-bis (4-aminophenoxy) heptane, 1,7- (3-aminophenoxy) ) Heptane, 1,8-bis (4-aminophenoxy) octane, 1,8-bis (3-aminophenoxy) octane, 1,9-bis (4-aminophenoxy) Group) nonane, 1,9-bis (3-aminophenoxy) nonane, 1,10- (4-aminophenoxy) decane, 1,10- (3-aminophenoxy ) Decane, 1,11- (4-aminophenoxy) undecane, 1,11- (3-aminophenoxy) undecane Aromatic diamine compounds such as alkane, 1,12- (4-aminophenoxy) dodecane, 1,12- (3-aminophenoxy) dodecane, bis (4-amino ring Alicyclic diamine compounds such as hexyl) methane, bis (4-amino-3-methylcyclohexyl) methane, 1,3-diaminopropane, 1,4-diaminobutane, 1,5 -Diaminopentane, 1,6-diaminohexane, 1,7-diaminoheptane, 1,8-diaminooctane, 1,9-diaminononane, 1,10 -Aliphatic diamine compounds such as diaminodecane, 1,11-diaminoundecane, 1,12-diaminododecane, etc.
本發明之其他二胺化合物,就配合本發明之特定聚合物對溶劑之溶解性、組成物及液晶配向處理劑之塗佈性、作為液晶配向膜之情形中的液晶之配向性、電壓保持率、蓄積電荷等之特性時,可使用1種類或將2種類以上混合使用。 The other diamine compounds of the present invention incorporate the solubility of the specific polymer of the present invention in solvents, the coating properties of the composition and the liquid crystal alignment treatment agent, the alignment of the liquid crystal in the case of the liquid crystal alignment film, and the voltage retention ratio , Characteristics such as accumulated charge, you can use 1 type or mix 2 or more types.
欲製作本發明之特定聚合物,即,該些聚醯亞胺系聚合物時之四羧酸成份,以使用下述式[4]所示四羧酸二酐為佳。此時,不僅式[4]所示四羧酸二酐,亦可使用該四羧酸衍生物之四羧酸、四羧酸二鹵化物化合物、四羧酸二烷酯化合物或四羧酸二烷酯二鹵化物化合物(式[4]所示四羧酸二酐及其衍生物亦統稱為特定四羧酸成份)。 To prepare the specific polymer of the present invention, that is, the tetracarboxylic acid component of these polyimide-based polymers, it is preferred to use the tetracarboxylic dianhydride represented by the following formula [4]. In this case, not only the tetracarboxylic dianhydride represented by the formula [4] but also tetracarboxylic acid, tetracarboxylic dihalide compound, tetracarboxylic dialkyl ester compound or tetracarboxylic dicarboxylic acid derivative of the tetracarboxylic acid derivative Alkyl ester dihalide compounds (tetracarboxylic dianhydride and its derivatives represented by formula [4] are also collectively referred to as specific tetracarboxylic acid components).
式[4a]中,Z1~Z4,各自獨立表示氫原子、甲基、乙基、丙基、氯原子或苯基。 In formula [4a], Z 1 to Z 4 each independently represent a hydrogen atom, a methyl group, an ethyl group, a propyl group, a chlorine atom, or a phenyl group.
式[4g]中,Z5及Z6,各自獨立表示氫原子或甲基。 In formula [4g], Z 5 and Z 6 each independently represent a hydrogen atom or a methyl group.
式[4]中之Z中,就合成之容易性或製造聚合物之際的聚合反應性之容易性等觀點,以式[4a]、式[4c]~式[4g]或式[4k]所示結構之四羧酸二酐及其四羧酸衍生物為佳。更佳者為式[4a]或式[4e]~式[4g]所示結構者。特佳為[4a]、式[4e]或式[4f]所示結構之四羧酸二酐及其四羧酸衍生物。 In Z in formula [4], from the viewpoints of the ease of synthesis or the ease of polymerization reactivity when manufacturing a polymer, the formula [4a], formula [4c] to formula [4g] or formula [4k] Tetracarboxylic dianhydride and its tetracarboxylic acid derivatives of the structure shown are preferred. More preferred is the structure shown in formula [4a] or formula [4e] ~ formula [4g]. Particularly preferred are tetracarboxylic dianhydrides and their tetracarboxylic acid derivatives of the structure shown in [4a], formula [4e] or formula [4f].
本發明之特定聚合物中之特定四羧酸成份,於全部四羧酸成份100莫耳%中,以1莫耳%~100莫耳%為佳。其中,又以5莫耳%~95莫耳%為佳。更佳者為20莫耳%~80莫耳%。 The specific tetracarboxylic acid component in the specific polymer of the present invention is preferably 1 mol% to 100 mol% in 100 mol% of all tetracarboxylic acid components. Among them, 5 mol% to 95 mol% is better. The better ones are 20 mol% to 80 mol%.
本發明之特定四羧酸成份,就配合本發明之特定聚合物對溶劑之溶解性、組成物及液晶配向處理劑之塗佈性、作為液晶配向膜之情形中的液晶之配向性、電壓保持率、 蓄積電荷等之特性時,可使用1種類或將2種類以上混合使用。 The specific tetracarboxylic acid component of the present invention, in combination with the solubility of the specific polymer of the present invention in solvents, the coating properties of the composition and the liquid crystal alignment treatment agent, the alignment of the liquid crystal in the case of the liquid crystal alignment film, and the voltage retention rate, When accumulating characteristics such as electric charges, one type may be used or two or more types may be used in combination.
本發明之特定聚合物中,於無損本發明之效果之範圍,可使用特定四羧酸成份以外的其他之四羧酸成份。其他之四羧酸成份,可列舉如,以下所示四羧酸化合物、四羧酸二酐、四羧酸二鹵化物化合物、四羧酸二烷酯化合物或四羧酸二烷酯二鹵化物化合物等。 In the specific polymer of the present invention, tetracarboxylic acid components other than the specific tetracarboxylic acid component can be used as long as the effect of the present invention is not impaired. Other tetracarboxylic acid components include, for example, the following tetracarboxylic acid compounds, tetracarboxylic dianhydrides, tetracarboxylic acid dihalide compounds, tetracarboxylic acid dialkyl ester compounds or tetracarboxylic acid dialkyl ester dihalides Compounds etc.
即,其他四羧酸成份,可列舉如,1,2,5,6-萘四羧酸、1,4,5,8-萘四羧酸、1,2,5,6-蒽四羧酸、3,3’,4,4’-聯苯四羧酸、2,3,3’,4-聯苯四羧酸、雙(3,4-二羧基苯基)醚、3,3’,4,4’-二苯甲酮四羧酸、雙(3,4-二羧基苯基)碸、雙(3,4-二羧基苯基)甲烷、2,2-雙(3,4-二羧基苯基)丙烷、1,1,1,3,3,3-六氟-2,2-雙(3,4-二羧基苯基)丙烷、雙(3,4-二羧基苯基)二甲基矽烷、雙(3,4-二羧基苯基)二苯基矽烷、2,3,4,5-吡啶四羧酸、2,6-雙(3,4-二羧基苯基)吡啶、3,3’,4,4’-二苯基碸四羧酸、3,4,9,10-苝四羧酸或1,3-二苯基-1,2,3,4-環丁烷四羧酸等。 That is, other tetracarboxylic acid components include, for example, 1,2,5,6-naphthalene tetracarboxylic acid, 1,4,5,8-naphthalene tetracarboxylic acid, 1,2,5,6-anthracene tetracarboxylic acid , 3,3 ', 4,4'-biphenyltetracarboxylic acid, 2,3,3', 4-biphenyltetracarboxylic acid, bis (3,4-dicarboxyphenyl) ether, 3,3 ', 4,4'-benzophenone tetracarboxylic acid, bis (3,4-dicarboxyphenyl) ash, bis (3,4-dicarboxyphenyl) methane, 2,2-bis (3,4-di Carboxyphenyl) propane, 1,1,1,3,3,3-hexafluoro-2,2-bis (3,4-dicarboxyphenyl) propane, bis (3,4-dicarboxyphenyl) di Methylsilane, bis (3,4-dicarboxyphenyl) diphenylsilane, 2,3,4,5-pyridinetetracarboxylic acid, 2,6-bis (3,4-dicarboxyphenyl) pyridine, 3,3 ', 4,4'-diphenylbenzene tetracarboxylic acid, 3,4,9,10-perylene tetracarboxylic acid or 1,3-diphenyl-1,2,3,4-cyclobutane Tetracarboxylic acid, etc.
本發明之其他四羧酸成份,就配合本發明之特定聚合物對溶劑之溶解性、組成物及液晶配向處理劑之塗佈性、作為液晶配向膜之情形中的液晶之配向性、電壓保持率、蓄積電荷等之特性時,可使用1種類或將2種類以上混合使用。 The other tetracarboxylic acid components of the present invention, in combination with the solubility of the specific polymer of the present invention in solvents, the coating properties of the composition and the liquid crystal alignment treatment agent, the liquid crystal alignment film in the case of the liquid crystal alignment film, and the voltage retention For characteristics such as the rate and the accumulated charge, one type may be used or two or more types may be used in combination.
本發明中,製作特定聚合物,即,製作該些聚醯亞胺系聚合物之方法,並未有特別之限定。通常,可由二胺成份與四羧酸成份反應而得。一般而言,為將由四羧酸二酐及其四羧酸之衍生物所成群所選出之至少1種的四羧酸成份,與1種或複數種的二胺化合物所形成之二胺成份進行反應,以製得聚醯胺酸之方法等。具體而言,例如可使用,使四羧酸二酐與一級或二級之二胺化合物進行聚縮合而製得聚醯胺酸之方法、使四羧酸與一級或二級之二胺化合物進行脫水聚縮合反應而製得聚醯胺酸之方法或使四羧酸二鹵化物與一級或二級之二胺化合物進行聚縮合而製得聚醯胺酸之方法。 In the present invention, the method for producing specific polymers, that is, the production of these polyimide-based polymers is not particularly limited. Generally, it can be obtained by reacting the diamine component with the tetracarboxylic acid component. Generally speaking, the diamine component formed by combining at least one kind of tetracarboxylic acid component selected from the group consisting of tetracarboxylic dianhydride and its derivatives with one or more diamine compounds Carrying out the reaction to prepare the method of polyamide. Specifically, for example, a method of producing polyamic acid by polycondensing a tetracarboxylic dianhydride with a primary or secondary diamine compound, or using a tetracarboxylic acid with a primary or secondary diamine compound A method of producing polyamic acid by dehydration polycondensation reaction or a method of polycondensing tetracarboxylic acid dihalide with a primary or secondary diamine compound to produce polyamic acid.
欲製得聚醯胺酸烷酯時,例如可使用,使羧酸基二烷酯化所得之四羧酸與一級或二級之二胺化合物進行聚縮合之方法、使羧酸基二烷酯化所得之四羧酸二鹵化物與一級或二級之二胺化合物進行聚縮合之方法或使聚醯胺酸之羧基變換為酯之方法。 In order to obtain a polyalkyl amide, for example, a method of polycondensing a tetracarboxylic acid obtained by esterifying a carboxylic acid dialkyl with a primary or secondary diamine compound, using a carboxylic acid dialkyl ester The method of polycondensing the obtained tetracarboxylic acid dihalide and the primary or secondary diamine compound or the method of converting the carboxyl group of the polyamic acid into an ester.
欲製得聚醯亞胺時,例如可使用使前述聚醯胺酸或聚醯胺酸烷酯閉環而形成聚醯亞胺之方法。 When polyimide is to be produced, for example, a method of forming a polyimide by ring-closing the aforementioned polyamic acid or polyalkyl amide can be used.
二胺成份與四羧酸成份之反應,通常為使二胺成份與四羧酸成份於溶劑中進行。此時所使用的溶劑,亦可使用本發明之特定溶劑,但只要可溶解所生成之聚醯亞胺前驅體之溶劑時,並未有特別之限定。下述為列舉反應所使用的溶劑之具體例,但並非僅限定於該些例示。 The reaction of the diamine component and the tetracarboxylic acid component is usually carried out by making the diamine component and the tetracarboxylic acid component in a solvent. The solvent used at this time may also use the specific solvent of the present invention, but it is not particularly limited as long as it can dissolve the produced polyimide precursor solvent. The following are specific examples of the solvents used in the reaction, but they are not limited to these examples.
例如,N-甲基-2-吡咯啶酮、N-乙基-2-吡咯啶 酮或γ-丁內酯、N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、二甲基亞碸或1,3-二甲基-四氫咪唑酮等。又,聚醯亞胺前驅體具有高溶劑溶解性之情形,可使用甲基乙酮、環己酮、環戊酮、4-羥基-4-甲基-2-戊酮或下述式[D-1]~式[D-3]所示溶劑等。 For example, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidine Ketone or γ-butyrolactone, N, N-dimethylformamide, N, N-dimethylacetamide, dimethyl sulfoxide or 1,3-dimethyl-tetrahydroimidazolone, etc. In addition, when the polyimide precursor has high solvent solubility, methyl ethyl ketone, cyclohexanone, cyclopentanone, 4-hydroxy-4-methyl-2-pentanone or the following formula [D -1] ~ Solvent shown in formula [D-3].
該些溶劑可單獨使用亦可、混合使用亦可。此外,即使為不會溶解聚醯亞胺前驅體之溶劑,只要不會使所生成之聚醯亞胺前驅體析出之範圍,亦可與前述溶劑混合使用亦可。又,溶劑中之水分會阻礙聚合反應,且為造成所生成之聚醯亞胺前驅體水解之原因,故溶劑以使用脫水乾燥者為佳。 These solvents may be used alone or in combination. In addition, even if it is a solvent that does not dissolve the polyimide precursor, it may be mixed with the aforementioned solvent as long as the produced polyimide precursor is not precipitated within a range. In addition, the moisture in the solvent will hinder the polymerization reaction, and it is the cause of the hydrolysis of the polyimide precursor produced, so the solvent is preferably dehydrated and dried.
二胺成份與四羧酸成份於溶劑中進行反應之際,可列舉如,使二胺成份分散或溶解於溶劑所得之溶液於進行攪拌中,將四羧酸成份,或將其分散或溶解於溶劑之方式添加之方法,或相反地使四羧酸成份分散或溶解於溶劑所得之溶液中,添加二胺成份之方法,或使二胺成份與四羧酸成份互相添加之方法等,而可使用該些中任一之 方法。又,使二胺成份或四羧酸成份分別使用多數種以進行反應之情形,可先以混合之狀態進行反應亦可,或個別地依序進行反應亦可,或將個別進行反應後的低分子量體進行混合反應而形成聚合物亦可。此時之聚合溫度可於-20℃~150℃之任意溫度中進行選擇,但較佳為-5℃~100℃之範圍。又,反應可於任意之濃度下進行,但若濃度過低時,將不容易生成高分子量之聚合物,濃度過高時,則因反應液的黏性過高而不容易進行均勻的攪拌。因此,較佳為1~50質量%,更佳為5~30質量%。反應初期可以高濃度進行,隨後,再追加溶劑亦可。 When the diamine component and the tetracarboxylic acid component are reacted in a solvent, for example, the solution obtained by dispersing or dissolving the diamine component in the solvent is stirred to disperse or dissolve the tetracarboxylic acid component or The method of adding by solvent, or the method of dispersing or dissolving the tetracarboxylic acid component in the solution obtained by the solvent, adding the diamine component, or the method of adding the diamine component and the tetracarboxylic acid component to each other, etc. Use any of these method. In addition, when a plurality of diamine components or tetracarboxylic acid components are used to carry out the reaction, the reaction may be carried out in a mixed state first, or the reaction may be sequentially performed individually, or the low The molecular weight body may be mixed to form a polymer. The polymerization temperature at this time can be selected from any temperature of -20 ° C to 150 ° C, but it is preferably in the range of -5 ° C to 100 ° C. In addition, the reaction can be carried out at any concentration, but if the concentration is too low, it will not be easy to produce high molecular weight polymers, and if the concentration is too high, the viscosity of the reaction solution will be too high to make uniform stirring difficult. Therefore, it is preferably 1 to 50% by mass, and more preferably 5 to 30% by mass. The reaction may be carried out at a high concentration in the initial stage, and then, a solvent may be added.
聚醯亞胺前驅體之聚合反應中,二胺成份之合計莫耳數與四羧酸成份的合計莫耳數之比,以0.8~1.2為佳。其與通常之聚縮合反應相同般,其莫耳比越接近1.0時,其所生成之聚醯亞胺前驅體之分子量越大。 In the polymerization reaction of the polyimide precursor, the ratio of the total number of moles of the diamine component to the total number of moles of the tetracarboxylic acid component is preferably 0.8 to 1.2. It is the same as the normal polycondensation reaction. The closer the molar ratio is to 1.0, the larger the molecular weight of the polyimide precursor produced.
本發明之聚醯亞胺為由前述聚醯亞胺前驅體經閉環而得之聚醯亞胺,該聚醯亞胺中,醯胺酸基的閉環率(亦稱為醯亞胺化率)並非必須為100%,其可配合用途或目的作任意之調整。 The polyimide of the present invention is a polyimide obtained by ring-closing the aforementioned polyimide precursor. In this polyimide, the ring-closing rate of the amide acid group (also referred to as the imidate rate) It does not have to be 100%, and it can be adjusted arbitrarily according to the purpose or purpose.
使聚醯亞胺前驅體醯亞胺化之方法,例如,將聚醯亞胺前驅體之溶液直接加熱,使其熱醯亞胺化或於聚醯亞胺前驅體的溶液中添加觸媒進行觸媒醯亞胺化等。 The method of imidizing the polyimide precursor, for example, directly heating the solution of the polyimide precursor to make it thermally imidized or adding a catalyst to the solution of the polyimide precursor Catalysts such as imidization.
聚醯亞胺前驅體於溶液中進行熱醯亞胺化之情形中,其溫度為100℃~400℃,較佳為120℃~250℃,又以將醯亞胺化反應所生成之水持續排除於反應 系外之方式進行者為佳。 In the case where the polyimide precursor is thermally imidized in solution, its temperature is 100 ° C to 400 ° C, preferably 120 ° C to 250 ° C, and the water produced by the imidization reaction is continued Excluded from reaction It is better to proceed outside the system.
聚醯亞胺前驅體之觸媒醯亞胺化,例如,於聚醯亞胺前驅體之溶液中,添加鹼性觸媒與酸酐,並於-20℃~250℃、較佳為0℃~180℃下攪拌之方式進行。鹼性觸媒之量為醯胺酸基的0.5莫耳倍~30莫耳倍、較佳為2莫耳倍~20莫耳倍,酸酐之量為醯胺酸基的1莫耳倍~50莫耳倍、較佳為3莫耳倍~30莫耳倍。鹼性觸媒可列舉如,吡啶、三乙胺、三甲胺、三丁胺或三辛胺等,其中,又以吡啶於反應進行中可維持適度之鹼性等而為較佳。酸酐可列舉如,乙酸酐、偏苯三酸酐或苯均四酸二酐等,其中又以使用乙酸酐時,於反應結束後容易進行精製等而為較佳。觸媒醯亞胺化時之醯亞胺化率,可以調節觸媒量與反應溫度、反應時間之方式進行控制。 The catalyst of the polyimide precursor is imidized. For example, in the solution of the polyimide precursor, an alkaline catalyst and an acid anhydride are added, and the temperature is -20 ° C ~ 250 ° C, preferably 0 ° C ~ Stir at 180 ° C. The amount of the alkaline catalyst is 0.5 mole times to 30 mole times of the amide acid group, preferably 2 mole times to 20 mole times, and the amount of the anhydride is 1 mole times to 50 mole times of the amide acid group Molar times, preferably 3 mole times to 30 mole times. Examples of the basic catalyst include pyridine, triethylamine, trimethylamine, tributylamine, and trioctylamine. Among them, pyridine can preferably maintain a moderate basicity during the reaction, and the like is preferred. Examples of the acid anhydride include acetic anhydride, trimellitic anhydride, and pyromellitic dianhydride. Among these, when acetic anhydride is used, it is preferably purified after the completion of the reaction. When the catalyst is imidized, the imidization rate can be controlled by adjusting the amount of catalyst, reaction temperature and reaction time.
由聚醯亞胺前驅體或聚醯亞胺之反應溶液中回收所生成之聚醯亞胺前驅體或聚醯亞胺之情形,只要將反應溶液投入溶劑中使其沈澱即可。沈澱所使用的溶劑可列舉如,甲醇、乙醇、異丙醇、丙酮、己烷、丁基溶纖劑、庚烷、甲基乙酮、甲基異丁酮、甲苯、苯、水等。投入溶劑進行沈澱之聚合物可於過濾回收後,於常壓或減壓下,以常溫或加熱進行乾燥。又,沈澱回收後之聚合物可經由重複2次~10次於溶劑中再溶解、再沈澱回收之操作,而可降低聚合物中之雜質。此時之溶劑,可列舉如,醇類、酮類或烴等,而使用由該些內容中所選出之3種類以上的溶劑時,以可使精製之效率更向上提高,而為更 佳。 In the case of recovering the generated polyimide precursor or polyimide from the reaction solution of the polyimide precursor or polyimide, it is sufficient to put the reaction solution in a solvent to precipitate it. Examples of the solvent used for precipitation include methanol, ethanol, isopropanol, acetone, hexane, butyl cellosolve, heptane, methyl ethyl ketone, methyl isobutyl ketone, toluene, benzene, and water. The polymer deposited by the solvent for precipitation can be recovered by filtration, and then dried under normal pressure or reduced pressure at normal temperature or under heating. In addition, the polymer after precipitation recovery can be re-dissolved in the solvent 2 to 10 times and re-precipitated and recovered to reduce impurities in the polymer. The solvent at this time may be, for example, alcohols, ketones, or hydrocarbons. When using more than three types of solvents selected from these contents, the efficiency of purification can be further improved. good.
本發明之組成物及使用其之液晶配向處理劑,為形成聚醯亞胺膜及液晶配向膜(亦統稱為樹脂被膜)所使用的塗佈溶液,其為形成特定溶劑及含有特定聚合物的樹脂被膜所使用的塗佈溶液。 The composition of the present invention and the liquid crystal alignment treatment agent using the same are coating solutions used for forming polyimide films and liquid crystal alignment films (also collectively referred to as resin coatings), which are used to form specific solvents and contain specific polymers The coating solution used for the resin coating.
本發明之特定聚合物,可使用聚醯胺酸、聚醯胺酸烷酯及聚醯亞胺之任一種聚醯亞胺系聚合物皆可。其中,又以聚醯胺酸烷酯或聚醯亞胺為佳。更佳為聚醯亞胺。 For the specific polymer of the present invention, any of polyimide-based polymers such as polyamic acid, polyalkyl amide and polyimide can be used. Among them, polyalkyl amide or polyimide is preferred. More preferably, it is polyimide.
本發明之組成物及液晶配向處理劑中的全部聚合物成份,可全部為本發明之特定聚合物。此時,本發明之特定聚合物可使用2種類以上混合者亦可。又,特定聚合物與其以外的其他聚合物混合所得者亦可。其以外的聚合物,可列舉如,纖維素系聚合物、丙烯酸聚合物、甲基丙烯酸聚合物、聚苯乙烯、聚醯胺或聚矽氧烷等。此時,其以外的其他聚合物之含量,相對於本發明之特定聚合物100質量份,為0.5質量份~30質量份。其中,又以1質量份~20質量份為佳。 All the polymer components in the composition of the present invention and the liquid crystal alignment treatment agent may be all the specific polymers of the present invention. In this case, the specific polymer of the present invention may use two or more types of blends. In addition, the specific polymer may be obtained by mixing with other polymers. Other polymers include, for example, cellulose-based polymers, acrylic polymers, methacrylic polymers, polystyrene, polyamide, polysiloxane, and the like. At this time, the content of the other polymers is 0.5 to 30 parts by mass relative to 100 parts by mass of the specific polymer of the present invention. Among them, 1 to 20 parts by mass is better.
又,本發明之組成物作為液晶配向處理劑,以形成液晶配向膜之情形,該特定聚合物中,以使用具有本發明之前述式[1-1]所示特定側鏈結構的特定聚合物者為佳。其中,又以使用「使用具有式[1-1]所示特定側鏈結構 的式[1a]所示特定側鏈型二胺化合物所得的特定聚合物」為佳。特別是,對於TN(Twisted Nematic)模式或VA(Vertical Alignment)模式等,以液晶之預傾角為必要模式的液晶配向膜,以使用特定側鏈型二胺化合物的特定聚合物者為佳。又,此時,可將使用特定側鏈型二胺化合物的特定聚合物,與不使用特定側鏈型二胺化合物的特定聚合物混合使用亦可。該情形中,不使用特定側鏈型二胺化合物的特定聚合物之含量,相對於使用特定側鏈型二胺化合物的特定聚合物100質量份,以10質量份~300質量份為佳。其中,又以20質量份~200質量份為佳。 In addition, in the case where the composition of the present invention is used as a liquid crystal alignment treatment agent to form a liquid crystal alignment film, a specific polymer having a specific side chain structure represented by the aforementioned formula [1-1] of the present invention is used as the specific polymer The better. Among them, the use of "use has a specific side chain structure shown in formula [1-1] The specific polymer obtained by the specific side chain type diamine compound represented by the formula [1a] is preferred. In particular, for a TN (Twisted Nematic) mode or a VA (Vertical Alignment) mode, etc., a liquid crystal alignment film in which a pretilt angle of liquid crystal is a necessary mode is preferably a specific polymer using a specific side chain type diamine compound. In this case, a specific polymer using a specific side chain type diamine compound may be used in combination with a specific polymer not using a specific side chain type diamine compound. In this case, the content of the specific polymer without using the specific side chain type diamine compound is preferably 10 to 300 parts by mass relative to 100 parts by mass of the specific polymer using the specific side chain type diamine compound. Among them, 20 to 200 parts by mass is better.
本發明之組成物及液晶配向處理劑中之溶劑,就經由塗佈可形成均勻樹脂被膜之觀點,該溶劑之含量以70~99.9質量%為佳。該含量,可配合作為目的之聚醯亞胺膜及液晶配向膜之膜厚作適當之變更。 The solvent in the composition of the present invention and the liquid crystal alignment treatment agent can form a uniform resin film by coating, and the content of the solvent is preferably 70 to 99.9% by mass. This content can be appropriately changed in accordance with the film thickness of the polyimide film and the liquid crystal alignment film as the purpose.
又,此時之溶劑,可全部為本發明之特定溶劑亦可,與可溶解本發明之特定聚合物的溶劑,即良溶劑同時使用亦可。以下將列舉良溶劑之具體例,但並不僅限定於該些內容。 In addition, the solvent at this time may be all the specific solvent of the present invention, and may be used together with a solvent that can dissolve the specific polymer of the present invention, that is, a good solvent. The following will list specific examples of good solvents, but not limited to these contents.
例如,N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯啶酮、N-乙基-2-吡咯啶酮、二甲基亞碸、γ-丁內酯、1,3-二甲基-四氫咪唑酮、甲基乙酮、環己酮、環戊酮或4-羥基-4-甲基-2-戊酮等。 For example, N, N-dimethylformamide, N, N-dimethylacetamide, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, dimethylmethylene Ash, γ-butyrolactone, 1,3-dimethyl-tetrahydroimidazolone, methyl ethyl ketone, cyclohexanone, cyclopentanone or 4-hydroxy-4-methyl-2-pentanone, etc.
其中,又以使用N-甲基-2-吡咯啶酮、N-乙基-2-吡咯啶酮或γ-丁基內酯(以上,亦稱為(C)成份)為佳。 Among them, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone or γ-butyl lactone (the above, also referred to as (C) component) is preferably used.
該些(C)成份,以組成物及液晶配向處理劑所含之溶劑全體的1~70質量%者為佳。其中,又以5~65質量%為佳。較佳為5~60質量%,更佳為10~60質量%。 These (C) components are preferably 1 to 70% by mass of the total solvent contained in the composition and the liquid crystal alignment treatment agent. Among them, 5 to 65% by mass is better. It is preferably 5 to 60% by mass, and more preferably 10 to 60% by mass.
前述良溶劑,就配合本發明之特定聚合物對溶劑之溶解性、組成物及液晶配向處理劑之塗佈性時,可使用1種類或將2種類以上混合使用。 When the aforementioned good solvent is blended with the solubility of the specific polymer of the present invention in the solvent, the composition and the coating properties of the liquid crystal alignment treatment agent, one kind or two or more kinds may be used in combination.
本發明之組成物及液晶配向處理劑中,無損本發明效果之範圍,亦可使用於塗佈組成物及液晶配向處理劑之際,可提高樹脂被膜之塗膜性或表面平滑性之有機溶劑,即貧溶劑。下述為貧溶劑之具體例示,但並不僅限定於該些內容。 The composition and liquid crystal alignment treatment agent of the present invention, without impairing the scope of the effects of the present invention, can also be used as an organic solvent that can improve the coating properties or surface smoothness of the resin coating when coating the composition and liquid crystal alignment treatment agent , That is, poor solvent. The following is a specific example of a poor solvent, but it is not limited to these contents.
例如,乙醇、異丙醇、1-丁醇、2-丁醇、異丁醇、tert-丁醇、1-戊醇、2-戊醇、3-戊醇、2-甲基-1-丁醇、異戊醇、tert-戊醇、3-甲基-2-丁醇、新戊醇、1-己醇、2-甲基-1-戊醇、2-甲基-2-戊醇、2-乙基-1-丁醇、1-庚醇、2-庚醇、3-庚醇、1-辛醇、2-辛醇、2-乙基-1-己醇、環己醇、1-甲基環己醇、2-甲基環己醇、3-甲基環己醇、1,2-乙二醇、1,2-丙二醇、1,3-丙二醇、1,2-丁二醇、1,3-丁二醇、1,4-丁二醇、2,3-丁二醇、1,5-戊二醇、2-甲基-2,4-戊二醇、2-乙基-1,3-己二醇、二丙醚、二丁醚、二己醚、二噁烷、乙二醇二甲醚、乙二醇二乙醚、乙二醇二丁醚、1,2-丁氧基乙烷、二乙二醇二甲醚、二乙二醇二乙醚、二乙二醇甲基乙醚、二乙二醇二丁醚、2-戊酮、3-戊 酮、2-己酮、2-庚酮、4-庚酮、3-乙氧基丁基乙酸酯、1-甲基戊基乙酸酯、2-乙基丁基乙酸酯、2-乙基己基乙酸酯、乙二醇單乙酸酯、乙二醇二乙酸酯、伸丙基碳酸酯、伸乙基碳酸酯、2-(甲氧基甲氧基)乙醇、乙二醇單丁醚、乙二醇單異戊醚、乙二醇單己醚、2-(己基氧代)乙醇、糠基醇、二乙二醇、丙二醇、丙二醇單丁醚、1-(丁氧基乙氧基)丙醇、丙二醇單甲醚乙酸酯、二丙二醇、二丙二醇單甲醚、二丙二醇單乙醚、二丙二醇二甲醚、三丙二醇單甲醚、乙二醇單甲醚乙酸酯、乙二醇單乙醚乙酸酯、乙二醇單丁醚乙酸酯、乙二醇單乙酸酯、乙二醇二乙酸酯、二乙二醇單乙醚乙酸酯、二乙二醇單丁醚乙酸酯、2-(2-乙氧基乙氧基)乙基乙酸酯、二乙二醇乙酸酯、三乙二醇、三乙二醇單甲醚、三乙二醇單乙醚、乙酸甲基、乙酸乙酯、乙酸n-丁基、乙酸丙二醇單乙醚、丙酮酸甲酯、丙酮酸乙酯、3-甲氧基丙酸甲酯、3-乙氧基丙酸甲基乙酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸、3-甲氧基丙酸、3-甲氧基丙酸丙酯、3-甲氧基丙酸丁酯、乳酸甲酯、乳酸乙酯、乳酸n-丙酯、乳酸n-丁酯、乳酸異戊酯或前述式[D-1]~式[D-3]所示溶劑等。 For example, ethanol, isopropanol, 1-butanol, 2-butanol, isobutanol, tert-butanol, 1-pentanol, 2-pentanol, 3-pentanol, 2-methyl-1-butanol Alcohol, isoamyl alcohol, tert-pentanol, 3-methyl-2-butanol, neopentyl alcohol, 1-hexanol, 2-methyl-1-pentanol, 2-methyl-2-pentanol, 2-ethyl-1-butanol, 1-heptanol, 2-heptanol, 3-heptanol, 1-octanol, 2-octanol, 2-ethyl-1-hexanol, cyclohexanol, 1 -Methylcyclohexanol, 2-methylcyclohexanol, 3-methylcyclohexanol, 1,2-ethylene glycol, 1,2-propanediol, 1,3-propanediol, 1,2-butanediol , 1,3-butanediol, 1,4-butanediol, 2,3-butanediol, 1,5-pentanediol, 2-methyl-2,4-pentanediol, 2-ethyl -1,3-hexanediol, dipropyl ether, dibutyl ether, dihexyl ether, dioxane, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, ethylene glycol dibutyl ether, 1,2-butane Oxyethane, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol methyl ether, diethylene glycol dibutyl ether, 2-pentanone, 3-pentane Ketone, 2-hexanone, 2-heptanone, 4-heptanone, 3-ethoxybutyl acetate, 1-methylpentyl acetate, 2-ethylbutyl acetate, 2- Ethylhexyl acetate, ethylene glycol monoacetate, ethylene glycol diacetate, propyl carbonate, ethyl carbonate, 2- (methoxymethoxy) ethanol, ethylene glycol Monobutyl ether, ethylene glycol monoisoamyl ether, ethylene glycol monohexyl ether, 2- (hexyl oxo) ethanol, furfuryl alcohol, diethylene glycol, propylene glycol, propylene glycol monobutyl ether, 1- (butoxy) Ethoxy) propanol, propylene glycol monomethyl ether acetate, dipropylene glycol, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol dimethyl ether, tripropylene glycol monomethyl ether, ethylene glycol monomethyl ether acetate , Ethylene glycol monoethyl ether acetate, ethylene glycol monobutyl ether acetate, ethylene glycol monoacetate, ethylene glycol diacetate, diethylene glycol monoethyl ether acetate, diethylene glycol Monobutyl ether acetate, 2- (2-ethoxyethoxy) ethyl acetate, diethylene glycol acetate, triethylene glycol, triethylene glycol monomethyl ether, triethylene glycol Monoethyl ether, methyl acetate, ethyl acetate, n-butyl acetate, propylene glycol monoethyl ether, propylene acetate Methyl ketoate, ethyl pyruvate, methyl 3-methoxypropionate, methyl ethyl 3-ethoxypropionate, ethyl 3-methoxypropionate, 3-ethoxypropionic acid, 3-methoxypropionic acid, propyl 3-methoxypropionate, butyl 3-methoxypropionate, methyl lactate, ethyl lactate, n-propyl lactate, n-butyl lactate, isolactic lactate Amyl ester or the solvent represented by the aforementioned formula [D-1] to formula [D-3], etc.
其中,又以使用1-己醇、環己醇、1,2-乙二醇、1,2-丙二醇、丙二醇單丁醚、乙二醇單丁醚、二丙二醇二甲醚或前述式[D-1]~式[D-3]所示溶劑(以上,亦稱為(D)成份)為佳。 Among them, 1-hexanol, cyclohexanol, 1,2-ethylene glycol, 1,2-propylene glycol, propylene glycol monobutyl ether, ethylene glycol monobutyl ether, dipropylene glycol dimethyl ether or the aforementioned formula [D -1] The solvent represented by formula [D-3] (the above, also referred to as (D) component) is preferred.
該些(D)成份,以組成物及液晶配向處理劑所 含有之溶劑全體的10~80質量%為佳。其中,又以10~70質量%為佳。較佳為20~70質量%,更佳為20~60質量%。 These (D) components are based on the composition and liquid crystal alignment treatment agent. It is preferably 10 to 80% by mass of the total contained solvent. Among them, 10 to 70% by mass is better. It is preferably 20 to 70% by mass, and more preferably 20 to 60% by mass.
前述貧溶劑,就配合本發明之特定聚合物對溶劑之溶解性、組成物及液晶配向處理劑之塗佈性時,可使用1種類或將2種類以上混合使用。 When the aforementioned poor solvent is combined with the solubility of the specific polymer of the present invention in the solvent, the composition and the coating properties of the liquid crystal alignment treatment agent, one type or two or more types may be used in combination.
本發明之組成物及液晶配向處理劑中,以導入具有具有由環氧基、異氰酸酯基、環氧丙烷基或環碳酸酯基的交聯性化合物、羥基、羥基烷基及低級烷氧基烷基所選出之至少1種的取代基之交聯性化合物,或導入具有聚合性不飽和鍵結的交聯性化合物者為佳。該些取代基或聚合性不飽和鍵結,於交聯性化合物中必須具有2個以上。 In the composition and liquid crystal alignment treatment agent of the present invention, a crosslinkable compound having an epoxy group, an isocyanate group, a propylene oxide group or a cyclocarbonate group, a hydroxyl group, a hydroxyalkyl group and a lower alkoxyalkyl group are introduced A crosslinkable compound of at least one kind of substituent selected from the group or a crosslinkable compound having a polymerizable unsaturated bond is preferably introduced. These substituents or polymerizable unsaturated bonds must have two or more in the crosslinkable compound.
具有環氧基或異氰酸酯基之交聯性化合物,例如,二酚丙酮縮水甘油醚、酚-酚醛清漆環氧樹脂、甲酚-酚醛清漆環氧樹脂、三縮水甘油異三聚氰酸酯、四縮水甘油胺基二苯酯、四縮水甘油-m-二甲苯二胺、四縮水甘油-1,3-雙(胺基乙基)環己烷、四苯基縮水甘油醚乙烷、三苯基縮水甘油醚乙烷、二酚六氟丙酮二縮水甘油醚、1,3-雙(1-(2,3-環氧基丙氧基)-1-三氟甲基-2,2,2-三氟甲基)苯、4,4-雙(2,3-環氧基丙氧基)八氟聯苯、三縮水甘油-p-胺基酚、四縮水甘油甲基二甲苯二胺、2-(4-(2,3-環氧基丙氧基)苯基)-2-(4-(1,1-雙(4-(2,3-環氧基丙氧基)苯基)乙基)苯基)丙烷或1,3-雙(4-(1-(4-(2,3-環氧基丙氧基)苯基)-1- (4-(1-(4-(2,3-環氧基丙氧基)苯基)-1-甲基乙基)苯基)乙基)苯氧基)-2-丙醇等。 Crosslinkable compounds with epoxy or isocyanate groups, for example, diphenol acetone glycidyl ether, phenol novolac epoxy resin, cresol novolac epoxy resin, triglycidyl isocyanurate, tetra Glycidylaminodiphenyl ester, tetraglycidyl-m-xylenediamine, tetraglycidyl-1,3-bis (aminoethyl) cyclohexane, tetraphenylglycidyl ether ethane, triphenyl Glycidyl ether ethane, diphenol hexafluoroacetone diglycidyl ether, 1,3-bis (1- (2,3-epoxypropoxy) -1-trifluoromethyl-2,2,2- Trifluoromethyl) benzene, 4,4-bis (2,3-epoxypropoxy) octafluorobiphenyl, triglycidyl-p-aminophenol, tetraglycidylmethylxylenediamine, 2 -(4- (2,3-epoxypropoxy) phenyl) -2- (4- (1,1-bis (4- (2,3-epoxypropoxy) phenyl) ethyl Yl) phenyl) propane or 1,3-bis (4- (1- (4- (2,3-epoxypropoxy) phenyl) -1- (4- (1- (4- (2,3-epoxypropoxy) phenyl) -1-methylethyl) phenyl) ethyl) phenoxy) -2-propanol and the like.
具有環氧丙烷基之交聯性化合物,為至少具有2個下述式[4A]所示環氧丙烷基的交聯性化合物。 The crosslinkable compound having a glycidyl group is a crosslinkable compound having at least two glycidyl groups represented by the following formula [4A].
具體而言,可列舉如,國際公開公報第2011/132751(2011.10.27公開)之第58項~59項所揭示之式[4a]~式[4k]所示交聯性化合物等。 Specifically, for example, the cross-linkable compounds represented by the formula [4a] to the formula [4k] disclosed in Items 58 to 59 of International Publication No. 2011/132751 (published on October 27, 2011) are listed.
具有環碳酸酯基之交聯性化合物,為至少具有2個下述式[5A]所示環碳酸酯基的交聯性化合物。 The crosslinkable compound having a cyclic carbonate group is a crosslinkable compound having at least two cyclic carbonate groups represented by the following formula [5A].
具體而言,可列舉如,國際公開公報第2012/014898(2012.2.2公開)之第76項~82項所揭示之式[5-1]~式[5-42]所示交聯性化合物等。 Specifically, the cross-linkable compounds shown in Formula [5-1] to Formula [5-42] disclosed in Items 76 to 82 of International Publication No. 2012/014898 (published on 2012.2.2) can be cited. Wait.
具有由羥基及烷氧基所成群所選出之至少1種的取代基之交聯性化合物,例如,具有羥基或烷氧基之胺基樹脂,例如,三聚氰胺樹脂、尿素樹脂、呱樹脂、乙炔脲-甲醛樹脂、琥珀醯胺-甲醛樹脂或乙烯尿素-甲醛樹脂等。具體而言,可列舉如,可使用胺基的氫原子被羥甲基或烷氧基甲基或其二者所取代之三聚氰胺衍生物、苯併呱衍生物,或乙炔脲等。該三聚氰胺衍生物或苯併呱 衍生物,可以二聚物或三聚物形式存在。該些之中,每一個三環,以平均具有3個以上6個以下之羥甲基或烷氧基甲基者為佳。 Cross-linkable compounds having at least one substituent selected from the group consisting of hydroxy and alkoxy groups, for example, amine-based resins having hydroxy or alkoxy groups, for example, melamine resin, urea resin, qua Resin, acetylene urea-formaldehyde resin, succinylamide-formaldehyde resin or ethylene urea-formaldehyde resin, etc. Specifically, for example, melamine derivatives and benzoxazines in which the hydrogen atom of the amine group is substituted with methylol or alkoxymethyl or both can be used. Derivatives, or acetylene urea. The melamine derivative or benzox Derivatives can exist in the form of dimers or trimers. Of these, every three The ring is preferably one having 3 to 6 hydroxymethyl groups or alkoxymethyl groups on average.
該些三聚氰胺衍生物或苯併呱衍生物之例,可列舉如,市售品之每一個三環,被平均3.7個甲氧基甲基所取代的MX-750、每一個三環,被平均5.8個甲氧基甲基所取代的MW-30(以上、三和化學公司製)或CYMEL 300、301、303、350、370、771、325、327、703、712等之甲氧基甲基化三聚氰胺、CYMEL 235、236、238、212、253、254等之甲氧基甲基化丁氧基甲基化三聚氰胺、CYMEL 506、508等之丁氧基甲基化三聚氰胺、CYMEL 1141等含有羧基之甲氧基甲基化異丁氧基甲基化三聚氰胺、CYMEL 1123等甲氧基甲基化乙氧基甲基化苯併呱、CYMEL 1123-10等甲氧基甲基化丁氧基甲基化苯併呱、CYMEL 1128等丁氧基甲基化苯併呱、CYMEL 1125-80等含有羧基之甲氧基甲基化乙氧基甲基化苯併呱(以上、三井氰胺公司製)等。又,乙炔脲之例如,CYMEL 1170等丁氧基甲基化乙炔脲、CYMEL 1172斗羥甲基化乙炔脲等,POWERLINK 1174等甲氧基羥甲基化乙炔脲等。 The melamine derivatives or benzox Examples of derivatives include, for example, each of the three commercially available products Ring, MX-750 substituted by an average of 3.7 methoxymethyl groups, each three Ring, MW-30 (above, manufactured by Sanwa Chemical Co., Ltd.) or CYMEL 300, 301, 303, 350, 370, 771, 325, 327, 703, 712, etc. substituted with an average of 5.8 methoxymethyl groups Methoxymethylated melamine, CYMEL 235, 236, 238, 212, 253, 254, etc. Methoxymethylated butoxymethylated melamine, CYMEL 506, 508 etc. butoxymethylated melamine, CYMEL Methoxymethylated isobutoxymethylated melamine containing carboxyl group such as 1141, methoxymethylated ethoxymethylated benzoxabene such as CYMEL 1123 , CYMEL 1123-10 and other methoxymethylated butoxymethylated benzox , CYMEL 1128 and other butoxymethylated benzoxa , CYMEL 1125-80 and other carboxyl-containing methoxymethylated ethoxymethylated benzox (Above, manufactured by Mitsui Cyanamide Co., Ltd.), etc. Examples of acetylene urea include butoxymethylated acetylene urea such as CYMEL 1170, hydroxymethylated acetylene urea such as CYMEL 1172, and methoxymethylated acetylene urea such as POWERLINK 1174.
具有羥基或烷氧基之苯或酚性化合物,例如,1,3,5-參(甲氧基甲基)苯、1,2,4-參(異丙氧基甲基)苯、1,4-雙(sec-丁氧基甲基)苯或2,6-二羥基甲基-p-tert-丁基酚等。 Benzene or phenolic compounds with hydroxyl or alkoxy groups, for example, 1,3,5-ginseng (methoxymethyl) benzene, 1,2,4-ginseng (isopropoxymethyl) benzene, 1, 4-bis (sec-butoxymethyl) benzene or 2,6-dihydroxymethyl-p-tert-butylphenol, etc.
更具體而言,可列舉如,國際公開公報第2011/132751(2011.10.27公開)之第62頁~66頁所揭示之式[6-1]~式[6-48]所示交聯性化合物等。 More specifically, the crosslinkability as shown in the formula [6-1] to formula [6-48] disclosed in pages 62 to 66 of International Publication No. 2011/132751 (published on 2011.10.27) can be cited. Compounds etc.
具有聚合性不飽和鍵結的交聯性化合物,可列舉如,分子內具有3個三羥甲基丙烷三(甲基)丙烯酸酯、季戊四醇三(甲基)丙烯酸酯、二季戊四醇五(甲基)丙烯酸酯、三(甲基)丙烯醯氧代乙氧基三羥甲基丙烷或丙三醇聚縮水甘油醚聚(甲基)丙烯酸酯等之聚合性不飽和基的交聯性化合物,又如分子內具有2個乙二醇二(甲基)丙烯酸酯、二乙二醇二(甲基)丙烯酸酯、四乙二醇二(甲基)丙烯酸酯、聚乙二醇二(甲基)丙烯酸酯、丙二醇二(甲基)丙烯酸酯、聚丙二醇二(甲基)丙烯酸酯、丁二醇二(甲基)丙烯酸酯、新戊基乙二醇二(甲基)丙烯酸酯、氧化乙烯二酚A型二(甲基)丙烯酸酯、氧化丙烯二酚型二(甲基)丙烯酸酯、1,6-己二醇二(甲基)丙烯酸酯、丙三醇二(甲基)丙烯酸酯、季戊四醇二(甲基)丙烯酸酯、乙二醇二縮水甘油醚二(甲基)丙烯酸酯、二乙二醇二縮水甘油醚二(甲基)丙烯酸酯、苯二甲酸二縮水甘油酯二(甲基)丙烯酸酯或羥基叔戊酸新戊基乙二醇二(甲基)丙烯酸酯等之聚合性不飽和基的交聯性化合物,又如,分子內具有1個2-羥基乙基(甲基)丙烯酸酯、2-羥基丙基(甲基)丙烯酸酯、2-羥基丁基(甲基)丙烯酸酯、2- 苯氧基-2-羥基丙基(甲基)丙烯酸酯、2-(甲基)丙烯醯氧代-2-羥基丙基苯甲酸酯、3-氯-2-羥基丙基(甲基)丙烯酸酯、丙三醇單(甲基)丙烯酸酯、2-(甲基)丙烯醯氧代乙基磷酸酯或N-羥甲基(甲基)丙烯醯胺等聚合性不飽和基的交聯性化合物等。 Examples of crosslinkable compounds having polymerizable unsaturated bonds include three trimethylolpropane tri (meth) acrylates, pentaerythritol tri (meth) acrylates, and dipentaerythritol penta (methyl) ) A crosslinkable compound of a polymerizable unsaturated group such as acrylate, tri (meth) acryloyloxyethoxytrimethylolpropane or glycerol polyglycidyl ether poly (meth) acrylate, and Such as having 2 ethylene glycol di (meth) acrylates, diethylene glycol di (meth) acrylates, tetraethylene glycol di (meth) acrylates, polyethylene glycol di (meth) in the molecule Acrylate, propylene glycol di (meth) acrylate, polypropylene glycol di (meth) acrylate, butylene glycol di (meth) acrylate, neopentyl glycol di (meth) acrylate, ethylene oxide di Phenol A type di (meth) acrylate, oxypropylene diphenol type di (meth) acrylate, 1,6-hexanediol di (meth) acrylate, glycerin di (meth) acrylate, Pentaerythritol di (meth) acrylate, ethylene glycol diglycidyl ether di (meth) acrylate, diethylene glycol diglycidyl ether di (meth) propylene Crosslinkable compounds of polymerizable unsaturated groups such as acid esters, diglycidyl phthalate di (meth) acrylate or hydroxytert-valeric acid neopentyl glycol di (meth) acrylate, etc. , With one 2-hydroxyethyl (meth) acrylate, 2-hydroxypropyl (meth) acrylate, 2-hydroxybutyl (meth) acrylate, 2- Phenoxy-2-hydroxypropyl (meth) acrylate, 2- (meth) acryloyloxy-2-hydroxypropyl benzoate, 3-chloro-2-hydroxypropyl (methyl) Crosslinking of polymerizable unsaturated groups such as acrylate, glycerol mono (meth) acrylate, 2- (meth) acryloyloxyethyl phosphate or N-methylol (meth) acrylamide Sex compounds.
此外,亦可使用下述式[7A]所示之化合物。 In addition, a compound represented by the following formula [7A] can also be used.
上述化合物為交聯性化合物之一例示,但並不僅限定於該內容。又,本發明之組成物及液晶配向處理劑所使用的交聯性化合物,可僅為1種類,或為2種類以上之組合亦可。 The above compound is an example of a crosslinkable compound, but it is not limited to this content. In addition, the crosslinkable compound used in the composition of the present invention and the liquid crystal alignment treatment agent may be only one type, or a combination of two or more types.
本發明之組成物及液晶配向處理劑中,交聯性化合物之含量,相對於全部的聚合物成份100質量份,以0.1質量份~150質量份為佳。其中,就進行交聯反應可達成目的性效果之觀點,相對於全部聚合物成份100質量份,以0.1質量份~100質量份為佳。更佳者為1質量 份~50質量份。 In the composition and liquid crystal alignment treatment agent of the present invention, the content of the crosslinkable compound is preferably 0.1 to 150 parts by mass relative to 100 parts by mass of the entire polymer component. Among them, from the viewpoint of achieving the intended effect by performing the cross-linking reaction, it is preferably 0.1 to 100 parts by mass relative to 100 parts by mass of the entire polymer component. Better is 1 quality ~ 50 parts by mass.
本發明之組成物及液晶配向處理劑中,於無損本發明之效果之範圍,亦可使用於塗佈組成物及液晶配向處理劑之際,可提高樹脂被膜的膜厚均勻性或表面平滑性之化合物。 The composition and liquid crystal alignment treatment agent of the present invention can also be used when coating the composition and liquid crystal alignment treatment agent within a range that does not impair the effects of the present invention, and can improve the film thickness uniformity or surface smoothness of the resin coating Of compounds.
可提高樹脂被膜之膜厚均勻性或表面平滑性之化合物,可列舉如,氟系界面活性劑、聚矽氧系界面活性劑、非質子系界面活性劑等。 Compounds that can improve the film thickness uniformity or surface smoothness of the resin coating include, for example, fluorine-based surfactants, polysiloxane-based surfactants, and aprotic surfactants.
更具體而言,可列舉如,F-TOP EF301、EF303、EF352(以上、陶氏化學製程公司製)、美格氟F171、F173、R-30(以上、大日本塗料公司製)、FLUORAD FC430、FC431(以上、住友3M公司製)、ASAHIGARD AG710、Surflon S-382、SC101、SC102、SC103、SC104、SC105、SC106(以上、旭硝子公司製)等。 More specifically, for example, F-TOP EF301, EF303, EF352 (above, manufactured by Dow Chemical Process Co., Ltd.), Magnesium F171, F173, R-30 (above, manufactured by Dainippon Paint Co., Ltd.), FLUORAD FC430 , FC431 (above, manufactured by Sumitomo 3M Corporation), ASAHIGARD AG710, Surflon S-382, SC101, SC102, SC103, SC104, SC105, SC106 (above, manufactured by Asahi Glass), etc.
該些界面活性劑之使用比例,相對於組成物及液晶配向處理劑所含有的全部聚合物成份100質量份,較佳為0.01質量份~2質量份,更佳為0.01質量份~1質量份。 The use ratio of these surfactants is preferably 0.01 to 2 parts by mass, more preferably 0.01 to 1 part by mass relative to 100 parts by mass of all polymer components contained in the composition and the liquid crystal alignment treatment agent .
此外,本發明之組成物及液晶配向處理劑中,促進樹脂被膜中之電荷移動以促進元件之電荷解離之化合物,可添加國際公開公報第2011/132751(2011.10.27公開)之第69頁~73頁所揭示之式[M1]~式[M156]所示含氮雜環胺化合物。該胺化合物,可直接添加於組成物及液晶配向處理劑中亦可,又以使用適當溶劑溶解為濃度 0.1質量%~10質量%,較佳為1質量%~7質量%之溶液後再予添加為佳。該溶劑,只要可溶解上述特定聚合物之溶劑時,並未有特別之限定。 In addition, in the composition of the present invention and the liquid crystal alignment treatment agent, a compound that promotes charge movement in the resin film to promote dissociation of charge of the element can be added to page 69 of International Publication No. 2011/132751 (published on 2011.10.27) The nitrogen-containing heterocyclic amine compounds represented by formula [M1] to formula [M156] disclosed on page 73. The amine compound may be directly added to the composition and the liquid crystal alignment treatment agent, and may be dissolved in a suitable solvent as a concentration A solution of 0.1% by mass to 10% by mass, preferably 1% by mass to 7% by mass, is preferably added afterwards. The solvent is not particularly limited as long as it can dissolve the above-mentioned specific polymer.
本發明之組成物及液晶配向處理劑中,除可提高上述貧溶劑、交聯性化合物、樹脂被膜之膜厚均勻性或表面平滑性的化合物及促進電荷解離之化合物以外,於無損本發明效果之範圍時,可添加以改變樹脂被膜的介電係數或導電性等電氣特性為目的之介電體或導電物質。 The composition and liquid crystal alignment treatment agent of the present invention, in addition to the compound that can improve the film thickness uniformity or surface smoothness of the above-mentioned poor solvent, crosslinkable compound, resin coating, and the compound that promotes charge dissociation, do not impair the effects of the present invention Within the range, a dielectric or conductive substance may be added for the purpose of changing the electrical characteristics such as the dielectric constant and conductivity of the resin film.
本發明之組成物,於塗佈於基板上並經燒結後,可作為聚醯亞胺膜使用。此時所使用的基板,可配合目的之裝置,而使用玻璃基板、矽晶圓、丙烯酸基板、聚碳酸酯基板或PET(聚乙烯對苯二甲酸酯)基板等之塑膠基板等。又,亦可以聚醯亞胺膜作為薄膜基板使用。組成物之塗佈方法,並未有特別之限定,就工業上而言,一般為使用浸漬法、輥塗佈法、縫狀塗佈法、旋轉法、噴霧法、網版印刷、平版印刷、凸版(Flexo)印刷或噴墨法等方法進行。該些可配合其目的,適當使用即可。 The composition of the present invention can be used as a polyimide film after being coated on a substrate and sintered. The substrate used at this time may be a plastic substrate such as a glass substrate, a silicon wafer, an acrylic substrate, a polycarbonate substrate, or a PET (polyethylene terephthalate) substrate according to the intended device. In addition, a polyimide film can also be used as a thin film substrate. The coating method of the composition is not particularly limited, and industrially, the dipping method, roll coating method, slot coating method, spin method, spray method, screen printing, lithographic printing, Flexo printing or inkjet method. These can be used appropriately according to their purpose.
組成物於塗佈於基板上之後,可經使用加熱板、熱循環型烘箱或IR(紅外線)型烘箱等加熱手段,以50~300℃、較佳為80~250℃下,將溶劑蒸發而形成聚醯亞胺膜。使用本發明之特定溶劑所得之組成物的情形,即使於200℃以下的溫度下亦可製作聚醯亞胺膜。燒結後 之聚醯亞胺膜的厚度,可配合目的,調整至0.01~100μm。 After the composition is coated on the substrate, the solvent can be evaporated at 50 to 300 ° C, preferably 80 to 250 ° C by using heating means such as a hot plate, a thermal cycle oven or an IR (infrared) oven. A polyimide film is formed. In the case of using the composition obtained by the specific solvent of the present invention, a polyimide film can be produced even at a temperature of 200 ° C or lower. After sintering The thickness of the polyimide film can be adjusted to 0.01 ~ 100μm according to the purpose.
本發明之組成物的液晶配向處理劑,可經由塗佈於基板上、燒結後,經由摩擦處理或光照射等配向處理後,作為液晶配向膜使用。又,VA模式等垂直配向用途之情形中,即使無需配向處理也可以作為液晶配向膜使用。此時所使用的基板,只要為具有高透明性之基板時,並未有特別之限定,除玻璃基板以外,例如,亦可使用丙烯酸基板、聚碳酸酯基板或PET(聚乙烯對苯二甲酸酯)基板等塑膠基板等。就製程簡易化之觀點,以形成有為進行液晶驅動所使用的ITO(氧化銦錫)電極等的基板為佳。又,反射型的液晶顯示元件中,只要為單側之基板時,亦可使用矽晶圓等不透明之基板,該情形的電極,例如亦可使用鋁等可反射光線之材料。 The liquid crystal alignment treatment agent of the composition of the present invention can be used as a liquid crystal alignment film after being coated on a substrate, sintered, and subjected to alignment treatment such as rubbing treatment or light irradiation. Moreover, in the case of vertical alignment applications such as VA mode, it can be used as a liquid crystal alignment film even without alignment treatment. The substrate used at this time is not particularly limited as long as it has a high transparency. In addition to the glass substrate, for example, an acrylic substrate, a polycarbonate substrate, or PET (polyethylene terephthalate) can also be used Acid ester) plastic substrates such as substrates. From the viewpoint of simplification of the manufacturing process, it is preferable to form a substrate on which an ITO (indium tin oxide) electrode or the like used for liquid crystal driving is formed. In addition, in the reflective liquid crystal display element, as long as it is a single-sided substrate, an opaque substrate such as a silicon wafer may also be used. In this case, for example, a material that reflects light such as aluminum may also be used.
液晶配向處理劑之塗佈方法,並未有特別之限定,就工業上而言,一般為使用網版印刷、平版印刷、凸版(Flexo)印刷或噴墨法等進行之方法。其他塗佈方法,可列舉如,浸漬法、輥塗佈法、縫狀塗佈法、旋轉法或噴霧法等,其可配合目的適當使用即可。 The coating method of the liquid crystal alignment treatment agent is not particularly limited, and industrially, it is generally a method performed using screen printing, lithographic printing, flexo printing, or inkjet method. Other coating methods include, for example, a dipping method, a roll coating method, a slit coating method, a spin method, and a spray method, etc., which may be appropriately used according to the purpose.
液晶配向處理劑於塗佈於基板上之後,可利用加熱板、熱循環型烘箱或IR(紅外線)型烘箱等加熱手段,使配合液晶配向處理劑使用的溶劑,於30~300℃、 較佳為30~250℃之溫度下使溶劑蒸發,而形成液晶配向膜。使用本發明之特定溶劑的液晶配向處理劑之情形,即使於200℃以下的溫度時也可以製作液晶配向膜。燒結後之液晶配向膜的厚度,過厚時就液晶顯示元件之消費電力觀點為不利,過薄時將會有降低液晶顯示元件之信賴性的情形,故較佳為5~300nm,更佳為10~150mm。液晶為水平配向或傾斜配向之情形,可將燒結後之液晶配向膜進行摩擦或偏光紫外線照射等處理。 After the liquid crystal alignment treatment agent is coated on the substrate, a heating plate, a thermal cycle oven, or an IR (infrared) oven or other heating means can be used to make the solvent used with the liquid crystal alignment treatment agent at 30 to 300 ° C. Preferably, the solvent is evaporated at a temperature of 30 to 250 ° C to form a liquid crystal alignment film. In the case of using the liquid-crystal alignment treatment agent of the specific solvent of this invention, a liquid-crystal alignment film can be produced even at the temperature of 200 degrees C or less. The thickness of the liquid crystal alignment film after sintering is unfavorable from the viewpoint of power consumption of the liquid crystal display element when it is too thick. When it is too thin, the reliability of the liquid crystal display element will be reduced, so it is preferably 5 to 300 nm, more preferably 10 ~ 150mm. When the liquid crystal is horizontally or obliquely aligned, the sintered liquid crystal alignment film can be subjected to rubbing or polarized ultraviolet irradiation.
本發明之液晶顯示元件,為依前述之手法,由本發明之液晶配向處理劑製得附有液晶配向膜之基板後,依公知之方法製作液晶晶胞而作為液晶顯示元件者。 The liquid crystal display device of the present invention is a liquid crystal cell manufactured as a liquid crystal display element by a well-known method after preparing a substrate with a liquid crystal alignment film from the liquid crystal alignment treatment agent of the present invention according to the aforementioned method.
液晶晶胞之製作方法,可列舉如,首先準備形成液晶配向膜的一對基板,並於單側基板之液晶配向膜上散佈間隔器,以液晶配向膜面為內側之方式,與另一單側之基板貼合,將液晶減壓注入其中後,予以密封的方法,或於散佈間隔器之液晶配向膜面上,滴入液晶之後,將基板貼合,進行密封等方法等。 The manufacturing method of the liquid crystal cell may include, for example, first preparing a pair of substrates forming a liquid crystal alignment film, and spreading spacers on the liquid crystal alignment film of the single-sided substrate, with the liquid crystal alignment film surface as the inner side, and the other single It is a method of bonding the substrates on the side and injecting the liquid crystal under reduced pressure, and then sealing, or on the liquid crystal alignment film surface of the spacer, after the liquid crystal is dropped, the substrates are bonded and sealed.
又,本發明之液晶配向處理劑為適合使用於,一種具備電極的一對基板之間具有液晶層,並於一對之基板之間配置可經由活性能量線及熱中至少一者而聚合的含有聚合性化合物之液晶組成物,經由於電極間持續施加電壓中照射活性能量線及加熱中之至少一者,使聚合性化合物聚合的步驟而製得的液晶顯示元件者。其中,活性能量線又以紫外線為佳。紫外線之波長為300~400nm、 較佳為310~360nm。經由加熱而聚合之情形,加熱溫度為40~120℃、較佳為60~80℃。又,亦可同時進行紫外線照射與加熱。 In addition, the liquid crystal alignment treatment agent of the present invention is suitable for use. A liquid crystal layer is provided between a pair of substrates provided with electrodes, and is disposed between a pair of substrates to be polymerizable via at least one of active energy rays and heat. The liquid crystal composition of the polymerizable compound is a liquid crystal display device produced by the step of polymerizing the polymerizable compound by irradiating at least one of active energy rays and heating while continuously applying a voltage between the electrodes. Among them, the active energy ray is preferably ultraviolet. The wavelength of UV is 300 ~ 400nm, It is preferably 310 to 360 nm. In the case of polymerization by heating, the heating temperature is 40 to 120 ° C, preferably 60 to 80 ° C. In addition, ultraviolet irradiation and heating may be performed simultaneously.
前述液晶顯示元件,為一種可經由PSA(Polymer Sustained Alignment)方式,控制液晶分子的預傾角者。PSA方式中,可於液晶材料中混入少量的光聚合性化合物,例如光聚合性單體,組合液晶晶胞之後,對液晶層於施加特定電壓的狀態下,對光聚合性化合物照射紫外線等,以所生成之聚合物控制液晶分子的預傾角。生成聚合物時之液晶分子的配向狀態,即使去除電壓之後仍被記憶著,故經由控制液晶層所形成之電場等之方式,而可調整液晶分子的預傾角。又,PSA方式中,因不需經由摩擦處理,故適合使用於形成不容易使用摩擦處理控制預傾角的垂直配向型之液晶層。 The aforementioned liquid crystal display device is a type that can control the pretilt angle of liquid crystal molecules through a PSA (Polymer Sustained Alignment) method. In the PSA method, a small amount of photopolymerizable compound, such as a photopolymerizable monomer, can be mixed into the liquid crystal material, and after combining the liquid crystal cell, the photopolymerizable compound can be irradiated with ultraviolet rays to the liquid crystal layer under a specific voltage. The pre-tilt angle of liquid crystal molecules is controlled by the generated polymer. The alignment state of the liquid crystal molecules when the polymer is generated is remembered even after the voltage is removed, so the pretilt angle of the liquid crystal molecules can be adjusted by controlling the electric field formed by the liquid crystal layer. In addition, in the PSA method, since no rubbing treatment is required, it is suitable for forming a vertical alignment type liquid crystal layer that is not easy to control the pretilt angle by rubbing treatment.
即,本發明之液晶顯示元件,為依前述手法由本發明之液晶配向處理劑製得附有液晶配向膜的基板之後,製作液晶晶胞,並經紫外線之照射及加熱終至至少一者使聚合性化合物聚合,而可控制液晶分子之配向者。 That is, the liquid crystal display element of the present invention is a substrate with a liquid crystal alignment film prepared from the liquid crystal alignment treatment agent of the present invention according to the aforementioned method, a liquid crystal cell is fabricated, and the polymerization is terminated by at least one of ultraviolet irradiation and heating until polymerization It can polymerize and control the alignment of liquid crystal molecules.
舉一例說明PSA方式之液晶晶胞的製作例,即,可列舉如,準備形成有液晶配向膜的一對基板,並於單側基板之液晶配向膜上散佈間隔器,以液晶配向膜面向內側之方式,貼合另一單側的基板,將液晶進行減壓注入後密封之方法,或將散佈有間隔器的液晶配向膜面滴入液晶之後,使基板貼合進行密封之方法等。 An example of manufacturing a liquid crystal cell of the PSA method will be described, that is, for example, a pair of substrates on which a liquid crystal alignment film is formed, and a spacer is spread on the liquid crystal alignment film of a single-sided substrate, with the liquid crystal alignment film facing inward The method is to stick the other one-sided substrate, inject the liquid crystal under reduced pressure and then seal, or drop the liquid crystal alignment film surface with the spacer dispersed into the liquid crystal, and then stick the substrate to seal.
液晶中,可混合經由熱或紫外線照射而聚合的聚合性化合物。聚合性化合物,例如,分子內具有1個以上的丙烯酸酯基或甲基丙烯酸酯基等聚合性不飽和基的化合物等。此時,聚合性化合物,相對於液晶成份100質量份,以0.01~10質量份為佳,更佳為0.1~5質量份。聚合性化合物未達0.01質量份時,聚合性化合物不會產生聚合而無法控制液晶之配向,多於10質量份時,因未反應的聚合性化合物過多,故會造成液晶顯示元件之殘影特性降低。 In the liquid crystal, a polymerizable compound that is polymerized by heat or ultraviolet irradiation can be mixed. The polymerizable compound is, for example, a compound having one or more polymerizable unsaturated groups such as an acrylate group or a methacrylate group in the molecule. At this time, the polymerizable compound is preferably 0.01 to 10 parts by mass, and more preferably 0.1 to 5 parts by mass relative to 100 parts by mass of the liquid crystal component. When the polymerizable compound is less than 0.01 parts by mass, the polymerizable compound will not be polymerized and the alignment of the liquid crystal cannot be controlled. When it is more than 10 parts by mass, the unreacted polymerizable compound is excessive, which may cause the afterimage characteristics of the liquid crystal display element reduce.
而製得液晶晶胞後,於對液晶晶胞持續施加交流或直流之電壓中,經由熱或照射紫外線而可使聚合性化合物聚合。如此,即可控制液晶分子的配向。 After the liquid crystal cell is prepared, the polymerizable compound can be polymerized by applying heat or ultraviolet rays while continuously applying an AC or DC voltage to the liquid crystal cell. In this way, the alignment of the liquid crystal molecules can be controlled.
又,本發明之液晶配向處理劑亦可使用於,一種具備電極的一對基板之間具有液晶層,於前述一對基板之間,配置可經由活性能量線及熱中至少一者而聚合的含有聚合性基之液晶配向膜,經由於電極間施加電壓之步驟而製得的液晶顯示元件,即,SC-PVA模式為佳。其中,活性能量線,又以紫外線為佳。紫外線之波長為300~400nm、較佳為310~360nm。經由加熱而聚合之情形,加熱溫度為40~120℃、較佳為60~80℃。又,也可同時進行紫外線照射與加熱。 In addition, the liquid crystal alignment treatment agent of the present invention can also be used for a liquid crystal layer between a pair of substrates having electrodes, and between the pair of substrates, a content polymerizable via at least one of active energy rays and heat is disposed The polymerizable liquid crystal alignment film is preferably a liquid crystal display device produced by applying a voltage between electrodes, that is, the SC-PVA mode. Among them, the active energy ray is preferably ultraviolet. The wavelength of ultraviolet rays is 300 to 400 nm, preferably 310 to 360 nm. In the case of polymerization by heating, the heating temperature is 40 to 120 ° C, preferably 60 to 80 ° C. In addition, ultraviolet irradiation and heating may be performed simultaneously.
就製得含有經由活性能量線及熱中至少一者而聚合的聚合性基之液晶配向膜之方法,可列舉如,將含有此聚合性基的化合物添加於液晶配向處理劑中之方法, 或使用含有聚合性基的聚合物成份之方法等。 The method for producing a liquid crystal alignment film containing a polymerizable group polymerized by at least one of active energy rays and heat includes, for example, a method of adding a compound containing this polymerizable group to a liquid crystal alignment treatment agent, Or a method of using a polymer component containing a polymerizable group.
製作SC-PVA模式之液晶晶胞之例,可列舉如,準備形成有本發明之液晶配向膜的一對基板,於單側基板之液晶配向膜上散佈間隔器,以液晶配向膜面向內側之方式,將另一單側面之基板貼合,將液晶減壓注入後予以密封之方法,或於散佈間隔器之液晶配向膜面滴入液晶之後,進行將基板貼合密封之方法等。 An example of manufacturing the liquid crystal cell of the SC-PVA mode may include, for example, preparing a pair of substrates on which the liquid crystal alignment film of the present invention is formed, spreading spacers on the liquid crystal alignment film of the single-sided substrate, with the liquid crystal alignment film facing inward The method is to stick another one-sided substrate, inject liquid crystal under reduced pressure and seal it, or after the liquid crystal alignment film surface of the spacer is dropped into liquid crystal, and then the method of bonding and sealing the substrate.
而製得液晶晶胞後,於對液晶晶胞持續施加交流或直流之電壓中,經由熱或照射紫外線之方式,而可控制液晶分子之配向。 After the liquid crystal cell is fabricated, the liquid crystal cell can be continuously applied with AC or DC voltage, and the alignment of the liquid crystal molecules can be controlled by heat or ultraviolet radiation.
如以上所述般,本發明之液晶配向處理劑可形成具有優良塗膜性之液晶配向膜,此外,即使製作液晶配向膜之際的燒結為低溫狀態時,也可得到於液晶顯示元件中作為電氣特性之VHR為優良的液晶配向膜。因此,具有本發明之液晶配向處理劑所得之液晶配向膜的液晶顯示元件,為具有優良信賴性者,而適合使用於大畫面且高精細度之液晶電視或中小型的汽車導航系統或智慧手機等。 As described above, the liquid crystal alignment treatment agent of the present invention can form a liquid crystal alignment film having excellent coating properties. In addition, even when the sintering at the time of manufacturing the liquid crystal alignment film is in a low temperature state, it can be obtained as a liquid crystal display element The electrical characteristics of VHR are excellent liquid crystal alignment films. Therefore, the liquid crystal display device having the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present invention is suitable for large-screen and high-definition LCD TVs or small and medium-sized car navigation systems or smart phones, with excellent reliability. Wait.
以下將列舉實施例對本發明作更詳細之說明,但本發明並非僅限定於該內容中。 The present invention will be described in more detail with examples below, but the present invention is not limited to this content.
合成例、實施例及比較例所使用之簡稱,係如以下所示。 The abbreviations used in Synthesis Examples, Examples, and Comparative Examples are shown below.
A1:1,3-二胺基-4-[4-(反式-4-n-庚基環己基)苯氧基]苯(具有本發明之式[1-1]所示特定側鏈結構的特定側鏈型二胺化合物) A1: 1,3-diamino-4- [4- (trans-4-n-heptylcyclohexyl) phenoxy] benzene (having a specific side chain structure represented by formula [1-1] of the present invention The specific side chain type diamine compound)
A2:1,3-二胺基-4-[4-(反式-4-n-庚基環己基)苯氧基甲基]苯(具有本發明之式[1-1]所示特定側鏈結構的特定側鏈型二胺化合物) A2: 1,3-diamino-4- [4- (trans-4-n-heptylcyclohexyl) phenoxymethyl] benzene (having a specific side of formula [1-1] of the present invention (Chain structure specific side chain type diamine compound)
A3:1,3-二胺基-4-{4-[反式-4-(反式-4-n-戊基環己基)環己基]苯氧基}苯(具有本發明之式[1-1]所示特定側鏈結構的特定側鏈型二胺化合物) A3: 1,3-diamino-4- {4- [trans-4- (trans-4-n-pentylcyclohexyl) cyclohexyl] phenoxy} benzene (having the formula [1 of the present invention -1] The specific side chain type diamine compound shown in the specific side chain structure)
A4:下述式[A4]所示二胺化合物(具有本發明之式[1-1]所示特定側鏈結構的特定側鏈型二胺化合物) A4: diamine compound represented by the following formula [A4] (specific side chain type diamine compound having a specific side chain structure represented by formula [1-1] of the present invention)
A5:1,3-二胺基-4-十八烷基氧代苯(具有本發明之式[1-2]所示特定側鏈結構的特定側鏈型二胺化合物)
B1:3,5-二胺基安息香酸(具有本發明之式[2a]所示羧基(COOH基)的二胺化合物)
C1:下述式[C1]所示二胺化合物(具有本發明之式[3a]所示含氮雜環的二胺化合物) C1: a diamine compound represented by the following formula [C1] (a diamine compound having a nitrogen-containing heterocyclic ring represented by the formula [3a] of the present invention)
C2:下述式[C2]所示二胺化合物(具有本發明之式[3a]所示含氮雜環的二胺化合物)
D1:p-伸苯基二胺 D1: p-phenylene diamine
D2:m-伸苯基二胺
E1:1,2,3,4-環丁烷四羧酸二酐 E1: 1,2,3,4-cyclobutane tetracarboxylic dianhydride
E2:二環[3,3,0]辛烷-2,4,6,8-四羧酸二酐 E2: Bicyclo [3,3,0] octane-2,4,6,8-tetracarboxylic dianhydride
E3:下述式[E3]所示四羧酸二酐 E3: Tetracarboxylic dianhydride represented by the following formula [E3]
E4:下述式[E4]所示四羧酸二酐 E4: Tetracarboxylic dianhydride represented by the following formula [E4]
E5:下述式[E5]所示四羧酸二酐
K1:下述式[K1]所示交聯性化合物
S1:下述式[S1]所示溶劑(本發明之式[A-1]所示特定溶劑)
NMP:N-甲基-2-吡咯啶酮 NMP: N-methyl-2-pyrrolidone
NEP:N-乙基-2-吡咯啶酮 NEP: N-ethyl-2-pyrrolidone
γ-BL:γ-丁內酯 γ-BL: γ-butyrolactone
BCS:乙二醇單丁醚 BCS: ethylene glycol monobutyl ether
PB:丙二醇單丁醚 PB: Propylene glycol monobutyl ether
EC:二乙二醇單乙醚 EC: Diethylene glycol monoethyl ether
DME:二丙二醇二甲醚 DME: Dipropylene glycol dimethyl ether
合成例中之聚醯亞胺前驅體及聚醯亞胺之分子量,為使用常溫凝膠滲透色層分析法(GPC)裝置(GPC-101)(昭和電工公司製)、管柱(KD-803,KD-805)(Shodex公司製),並依以下方式測定者。 The molecular weights of the polyimide precursor and polyimide in the synthesis example are the room temperature gel permeation chromatography (GPC) device (GPC-101) (manufactured by Showa Denko) and the column (KD-803) , KD-805) (manufactured by Shodex), and measured in the following manner.
管柱溫度:50℃ Column temperature: 50 ℃
溶離液:N,N-二甲基甲醯胺(添加劑為,溴化鋰-水和 物(LiBr‧H2O)為30mmol/L(公升)、磷酸‧無水結晶(o-磷酸)為30mmol/L、四氫呋喃(THF)為10ml/L) Dissolution solution: N, N-dimethylformamide (additive is lithium bromide-hydrate (LiBr‧H 2 O) 30mmol / L (liter)), phosphoric acid‧ anhydrous crystal (o-phosphoric acid) 30mmol / L , Tetrahydrofuran (THF) is 10ml / L)
流速:1.0ml/分鐘 Flow rate: 1.0ml / min
製作檢量線之標準樣品:TSK標準聚乙烯氧化物(分子量;約900,000、150,000、100,000及30,000)(東曹公司製)及聚乙二醇(分子量;約12,000、4,000及1,000)(聚合物實驗公司製)。 Standard samples for making calibration lines: TSK standard polyethylene oxide (molecular weight; approximately 900,000, 150,000, 100,000, and 30,000) (manufactured by Tosoh Corporation) and polyethylene glycol (molecular weight; approximately 12,000, 4,000, and 1,000) (polymer (Made by the experimental company).
合成例中之聚醯亞胺的醯亞胺化率則依以下方式測定。將聚醯亞胺粉末20mg加入NMR(核磁氣共震)樣品管(NMR採樣標準試管, 5(草野科學公司製))中,添加重氫化二甲基亞碸(DMSO-d6,0.05質量%TMS(四甲基矽烷)混合品)(0.53ml),施加超音波使其完全溶解。此溶液使用NMR測定機(JNW-ECA500)(日本電子DATUM公司製)測定500MHz之質子NMR。醯亞胺化率為以醯亞胺化前後未變化之結構所產生之質子作為基準質子而決定,其為使用該質子的波峰積算值,與9.5ppm~10.0ppm附近出現之由醯胺酸的NH基所產生的質子波峰積算值,並依下式而求得者。 The imidization ratio of polyimide in the synthesis example was measured in the following manner. Add 20 mg of polyimide powder to NMR (nuclear magnetic resonance) sample tube (NMR sampling standard test tube, 5 (manufactured by Kusano Scientific Co., Ltd.)) was added heavy dimethyl sulfoxide (DMSO-d 6 , 0.05% by mass TMS (tetramethylsilane) mixed product) (0.53 ml), and ultrasonic waves were applied to completely dissolve it. This solution was measured for a 500 MHz proton NMR using an NMR measuring machine (JNW-ECA500) (manufactured by JEOL DATUM Corporation). The imidization rate is determined based on the protons generated by the unchanged structure before and after imidization as the reference protons. It is the peak integration value using the protons, and it is caused by the amide acid occurring near 9.5 ppm to 10.0 ppm. The total value of the proton peak generated by the NH group is obtained according to the following formula.
醯亞胺化率(%)=(1-α‧x/y)×100 Amidification rate (%) = (1-α‧x / y) × 100
上述式中,x為由醯胺酸的NH基所產生的質子波峰積算值、y為基準質子的波峰積算值、α為聚醯胺酸(醯亞胺化率為0%)之情形中,相對於1個醯胺酸的NH 基質子,其基準質子的個數比例。 In the above formula, x is the integrated peak value of protons generated from the NH group of the amidic acid, y is the integrated peak value of the reference proton, and α is the polyamic acid (acid imidization rate is 0%). NH relative to 1 amide acid Matrix protons, the ratio of the number of reference protons.
將E1(5.21g,26.6mmol)、A1(5.12g,13.5mmol)及B1(2.05g,13.5mmol)於S1(37.1g)中混合,於40℃下反應8小時,得樹脂固體成份濃度為25質量%之聚醯胺酸溶液(1)。此聚醯胺酸的數平均分子量為25,800、重量平均分子量為86,900。 Mix E1 (5.21g, 26.6mmol), A1 (5.12g, 13.5mmol) and B1 (2.05g, 13.5mmol) in S1 (37.1g), and react at 40 ° C for 8 hours to obtain a resin solid content concentration of 25% by mass of polyamic acid solution (1). The number average molecular weight of this polyamide was 25,800 and the weight average molecular weight was 86,900.
將E2(3.40g,13.6mmol)、B1(4.19g,27.6mmol)及D1(0.74g,6.89mmol)於S1(24.7g)中混合,於80℃下反應5小時後,加入E1(4.00g,20.4mmol)與S1(12.3g),於40℃下,反應6小時,得樹脂固體成份濃度為25質量%之聚醯胺酸溶液(2)。此聚醯胺酸的數平均分子量為26,200、重量平均分子量為86,400。 E2 (3.40g, 13.6mmol), B1 (4.19g, 27.6mmol) and D1 (0.74g, 6.89mmol) were mixed in S1 (24.7g), after reacting at 80 ° C for 5 hours, E1 (4.00g) was added , 20.4mmol) and S1 (12.3g), at 40 ℃, 6 hours of reaction, to obtain a resin solid content concentration of 25% by mass of polyamic acid solution (2). The number average molecular weight of this polyamide was 26,200, and the weight average molecular weight was 86,400.
於依合成例2之合成方法所得之聚醯胺酸溶液(2)(30.0g)中,加入NMP稀釋至6質量%之後,加入作為醯亞胺化觸媒之乙酸酐(3.95g)及吡啶(2.50g),於60℃下反應2小時。將此反應溶液投入甲醇(460ml)中,將所得沈澱物濾出。此沈澱物以甲醇洗淨,於100℃下進行減壓乾 燥後得聚醯亞胺粉末(3)。此聚醯亞胺之醯亞胺化率為53%,數平均分子量為22,100、重量平均分子量為60,900。 To the polyamic acid solution (2) (30.0 g) obtained according to the synthesis method of Synthesis Example 2, after adding NMP to dilute to 6% by mass, add acetic anhydride (3.95 g) and pyridine as the amide imidization catalyst (2.50g), react at 60 ° C for 2 hours. This reaction solution was poured into methanol (460 ml), and the resulting precipitate was filtered off. This precipitate was washed with methanol and dried under reduced pressure at 100 ° C After drying, polyimide powder (3) is obtained. The polyimide has an imidization ratio of 53%, a number average molecular weight of 22,100, and a weight average molecular weight of 60,900.
將E2(3.96g,15.8mmol)、B1(4.14g,27.2mmol)、C1(0.39g,1.60mmol)及D2(0.35g,3.20mmol)於NEP(24.2g)中混合,於80℃下反應5小時後,加入E1(3.10g,15.8mmol)與NEP(12.1g),於40℃下,反應6小時,得樹脂固體成份濃度為25質量%之聚醯胺酸溶液。 Mix E2 (3.96g, 15.8mmol), B1 (4.14g, 27.2mmol), C1 (0.39g, 1.60mmol) and D2 (0.35g, 3.20mmol) in NEP (24.2g), and react at 80 ℃ After 5 hours, E1 (3.10g, 15.8mmol) and NEP (12.1g) were added and reacted at 40 ° C for 6 hours to obtain a polyamic acid solution with a resin solid content concentration of 25% by mass.
於所得之聚醯胺酸溶液(30.0g)中加入NEP,稀釋至6質量%之後,加入作為醯亞胺化觸媒之乙酸酐(4.40g)及吡啶(3.30g),於80℃下反應3.5小時。將此反應溶液投入甲醇(460ml)中,將所得沈澱物濾出。此沈澱物以甲醇洗淨,於100℃下進行減壓乾燥後得聚醯亞胺粉末(4)。此聚醯亞胺之醯亞胺化率為80%,數平均分子量為19,900、重量平均分子量為55,100。 NEP was added to the obtained polyamic acid solution (30.0 g), diluted to 6% by mass, and then acetic anhydride (4.40 g) and pyridine (3.30 g) as an imidization catalyst were added and reacted at 80 ° C 3.5 hours. This reaction solution was poured into methanol (460 ml), and the resulting precipitate was filtered off. This precipitate was washed with methanol and dried under reduced pressure at 100 ° C to obtain polyimide powder (4). The polyimide has an imidization rate of 80%, a number average molecular weight of 19,900, and a weight average molecular weight of 55,100.
將E2(3.22g,12.9mmol)、A2(4.62g,11.7mmol)、B1(1.78g,11.7mmol)及D1(0.28g,2.60mmol)於S1(24.8g)中混合,於80℃下反應5小時後,加入E1(2.52g,12.9mmol)與S1(12.4g),於40℃下,反應6小時,得樹脂固體成份濃度為25質量%之聚醯胺酸溶液(5)。此聚醯胺酸 的數平均分子量為20,900、重量平均分子量為72,100。 E2 (3.22g, 12.9mmol), A2 (4.62g, 11.7mmol), B1 (1.78g, 11.7mmol) and D1 (0.28g, 2.60mmol) were mixed in S1 (24.8g) and reacted at 80 ° C After 5 hours, E1 (2.52g, 12.9mmol) and S1 (12.4g) were added and reacted at 40 ° C for 6 hours to obtain a polyamic acid solution (5) with a resin solid content concentration of 25% by mass. Polyamide Has a number average molecular weight of 20,900 and a weight average molecular weight of 72,100.
於依合成例5之合成方法所得之聚醯胺酸溶液(5)(30.0g)中,加入NMP稀釋至6質量%之後,加入作為醯亞胺化觸媒之乙酸酐(3.95g)及吡啶(2.40g),於70℃下反應3.5小時。此反應溶液投入甲醇(460ml)中,將所得沈澱物濾出。此沈澱物以甲醇洗淨,於100℃下進行減壓乾燥後得聚醯亞胺粉末(6)。此聚醯亞胺之醯亞胺化率為73%,數平均分子量為19,900、重量平均分子量為53,900。 To the polyamic acid solution (5) (30.0 g) obtained according to the synthesis method of Synthesis Example 5, after adding NMP to dilute to 6% by mass, acetic anhydride (3.95 g) and pyridine as the amide imidization catalyst were added (2.40g), reacted at 70 ° C for 3.5 hours. This reaction solution was poured into methanol (460 ml), and the resulting precipitate was filtered off. This precipitate was washed with methanol and dried under reduced pressure at 100 ° C to obtain polyimide powder (6). The polyimide had an imidization ratio of 73%, a number average molecular weight of 19,900, and a weight average molecular weight of 53,900.
將E2(1.31g,5.23mmol)、A3(3.44g,7.94mmol)、C1(2.57g,10.6mmol)及D2(0.86g,7.94mmol)於NMP(24.5g)中混合,於80℃下反應5小時後,加入E1(4.10g,20.9mmol)與NMP(12.3g),於40℃下,反應6小時,得樹脂固體成份濃度為25質量%之聚醯胺酸溶液。 Mix E2 (1.31g, 5.23mmol), A3 (3.44g, 7.94mmol), C1 (2.57g, 10.6mmol) and D2 (0.86g, 7.94mmol) in NMP (24.5g), and react at 80 ℃ After 5 hours, E1 (4.10g, 20.9mmol) and NMP (12.3g) were added and reacted at 40 ° C for 6 hours to obtain a polyamic acid solution with a resin solid content concentration of 25% by mass.
於所得之聚醯胺酸溶液(30.0g)中,加入NMP稀釋至6質量%之後,加入作為醯亞胺化觸媒之乙酸酐(4.50g)及吡啶(3.30g),於80℃下反應3.5小時。將此反應溶液投入甲醇(460ml)中,將所得沈澱物濾出。此沈澱物以甲醇洗淨,於100℃下進行減壓乾燥後得聚醯亞胺粉末(7)。此聚醯亞胺之醯亞胺化率為80%,數平均分子量為 15,900、重量平均分子量為43,800。。 To the obtained polyamic acid solution (30.0 g), after adding NMP to dilute to 6% by mass, acetic anhydride (4.50 g) and pyridine (3.30 g) as an imidization catalyst were added and reacted at 80 ° C 3.5 hours. This reaction solution was poured into methanol (460 ml), and the resulting precipitate was filtered off. This precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain polyimide powder (7). The polyimide has an imidization rate of 80% and a number average molecular weight of 15,900, weight average molecular weight is 43,800. .
將E2(1.23g,4.91mmol)、A2(3.92g,9.94mmol)、C2(2.58g,9.94mmol)及D2(0.54g,4.97mmol)於NMP(24.2g)中混合,於80℃下反應5小時後,加入E1(3.85g,19.6mmol)與NMP(12.1g),於40℃下,反應6小時,得樹脂固體成份濃度為25質量%之聚醯胺酸溶液。 Mix E2 (1.23g, 4.91mmol), A2 (3.92g, 9.94mmol), C2 (2.58g, 9.94mmol) and D2 (0.54g, 4.97mmol) in NMP (24.2g), and react at 80 ℃ After 5 hours, E1 (3.85g, 19.6mmol) and NMP (12.1g) were added and reacted at 40 ° C for 6 hours to obtain a polyamic acid solution with a resin solid content concentration of 25% by mass.
於所得聚醯胺酸溶液(30.0g)中,加入NMP稀釋至6質量%之後,加入作為醯亞胺化觸媒之乙酸酐(3.85g)及吡啶(2.50g),於60℃下反應2小時。將此反應溶液投入甲醇(460ml)中,將所得沈澱物濾出。此沈澱物以甲醇洗淨,於100℃下進行減壓乾燥後得聚醯亞胺粉末(8)。此聚醯亞胺之醯亞胺化率為55%,數平均分子量為16,900、重量平均分子量為46,900。 To the obtained polyamic acid solution (30.0g), after adding NMP to dilute to 6% by mass, acetic anhydride (3.85g) and pyridine (2.50g) as an imidization catalyst were added and reacted at 60 ° C 2 hour. This reaction solution was poured into methanol (460 ml), and the resulting precipitate was filtered off. This precipitate was washed with methanol and dried under reduced pressure at 100 ° C to obtain polyimide powder (8). The polyimide had an imidization ratio of 55%, a number average molecular weight of 16,900, and a weight average molecular weight of 46,900.
將E2(2.55g,10.2mmol)、A4(2.55g,5.17mmol)、B1(0.39g,2.58mmol)、C2(3.35g,12.9mmol)及D2(0.56g,5.17mmol)於NEP(24.8g)中混合,於80℃下反應5小時後,加入E1(3.00g,15.3mmol)與NEP(12.4g),於40℃下,反應6小時,得樹脂固體成份濃度為25質量%之聚醯胺酸溶液。 E2 (2.55g, 10.2mmol), A4 (2.55g, 5.17mmol), B1 (0.39g, 2.58mmol), C2 (3.35g, 12.9mmol) and D2 (0.56g, 5.17mmol) in NEP (24.8g ), Mixed at 80 ° C for 5 hours, added E1 (3.00g, 15.3mmol) and NEP (12.4g), and reacted at 40 ° C for 6 hours to obtain polyacrylamide with a resin solid content concentration of 25% by mass Amino acid solution.
於所得聚醯胺酸溶液(30.5g)中,加入NEP稀 釋至6質量%後,加入作為醯亞胺化觸媒之乙酸酐(3.95g)及吡啶(2.55g),於60℃下,反應3小時。將此反應溶液投入甲醇(460ml)中,將所得沈澱物濾出。此沈澱物以甲醇洗淨,於100℃下進行減壓乾燥後得聚醯亞胺粉末(9)。此聚醯亞胺之醯亞胺化率為61%,數平均分子量為16,000、重量平均分子量為44,800。 To the obtained polyamic acid solution (30.5g), add NEP dilute After releasing to 6% by mass, acetic anhydride (3.95g) and pyridine (2.55g) as an amide imidization catalyst were added and reacted at 60 ° C for 3 hours. This reaction solution was poured into methanol (460 ml), and the resulting precipitate was filtered off. This precipitate was washed with methanol and dried under reduced pressure at 100 ° C to obtain polyimide powder (9). The polyimide has an imidization rate of 61%, a number average molecular weight of 16,000, and a weight average molecular weight of 44,800.
將E2(1.20g,4.78mmol)、A5(3.65g,9.69mmol)、C2(2.51g,9.69mmol)及D2(0.52g,4.84mmol)於NMP(23.3g)中混合,於80℃下反應5小時後,加入E1(3.75g,19.1mmol)與NMP(11.6g),於40℃下,反應6小時,得樹脂固體成份濃度為25質量%之聚醯胺酸溶液。 Mix E2 (1.20g, 4.78mmol), A5 (3.65g, 9.69mmol), C2 (2.51g, 9.69mmol) and D2 (0.52g, 4.84mmol) in NMP (23.3g) and react at 80 ℃ After 5 hours, E1 (3.75 g, 19.1 mmol) and NMP (11.6 g) were added and reacted at 40 ° C. for 6 hours to obtain a polyamic acid solution with a resin solid content concentration of 25% by mass.
於所得之聚醯胺酸溶液(30.0g)中,加入NMP稀釋至6質量%之後,加入作為醯亞胺化觸媒之乙酸酐(3.80g)及吡啶(2.55g),於60℃下,反應2小時。將此反應溶液投入甲醇(460ml)中,將所得沈澱物濾出。此沈澱物以甲醇洗淨,於100℃下進行減壓乾燥後得聚醯亞胺粉末(10)。此聚醯亞胺之醯亞胺化率為56%,數平均分子量為16,200、重量平均分子量為48,100。 To the obtained polyamic acid solution (30.0g), after adding NMP to dilute to 6% by mass, acetic anhydride (3.80g) and pyridine (2.55g) as an imidization catalyst were added at 60 ° C. React for 2 hours. This reaction solution was poured into methanol (460 ml), and the resulting precipitate was filtered off. This precipitate was washed with methanol and dried under reduced pressure at 100 ° C to obtain polyimide powder (10). The polyimide has an imidization rate of 56%, a number average molecular weight of 16,200, and a weight average molecular weight of 48,100.
將E3(7.50g,33.5mmol)、B1(3.61g,23.7mmol)、C1(0.41g,1.69mmol)及D1(0.92g,8.47mmol)於NMP(37.3g)中混 合,於40℃下,反應8小時,得樹脂固體成份濃度為25質量%之聚醯胺酸溶液。 Mix E3 (7.50g, 33.5mmol), B1 (3.61g, 23.7mmol), C1 (0.41g, 1.69mmol) and D1 (0.92g, 8.47mmol) in NMP (37.3g) Combine and react at 40 ° C for 8 hours to obtain a polyamic acid solution with a resin solid content concentration of 25% by mass.
於所得聚醯胺酸溶液(30.0g)中加入NMP,稀釋至6質量%之後,加入作為醯亞胺化觸媒之乙酸酐(4.20g)及吡啶(3.10g),於80℃下反應2.5小時。將此反應溶液投入甲醇(460ml)中,將所得沈澱物濾出。此沈澱物以甲醇洗淨,於100℃下進行減壓乾燥後得聚醯亞胺粉末(11)。此聚醯亞胺之醯亞胺化率為75%,數平均分子量為19,800、重量平均分子量為53,900。 NMP was added to the obtained polyamic acid solution (30.0g) and diluted to 6% by mass, then acetic anhydride (4.20g) and pyridine (3.10g) as an imidization catalyst were added and reacted at 80 ° C for 2.5 hour. This reaction solution was poured into methanol (460 ml), and the resulting precipitate was filtered off. This precipitate was washed with methanol and dried under reduced pressure at 100 ° C to obtain polyimide powder (11). The polyimide has an imidization rate of 75%, a number average molecular weight of 19,800, and a weight average molecular weight of 53,900.
將E3(5.90g,26.3mmol)、A2(4.21g,10.7mmol)、B1(0.41g,2.67mmol)及D2(1.44g,13.3mmol)於NMP(35.9g)中混合,於40℃下,進行8小時反應,得樹脂固體成份濃度為25質量%之聚醯胺酸溶液。 Mix E3 (5.90g, 26.3mmol), A2 (4.21g, 10.7mmol), B1 (0.41g, 2.67mmol) and D2 (1.44g, 13.3mmol) in NMP (35.9g) at 40 ° C, The reaction was carried out for 8 hours to obtain a polyamic acid solution with a resin solid content concentration of 25% by mass.
於所得聚醯胺酸溶液(30.0g)中加入NMP,稀釋至6質量%之後,加入作為醯亞胺化觸媒之乙酸酐(4.50g)及吡啶(3.35g),於80℃下反應3.5小時。將此反應溶液投入甲醇(460ml)中,將所得沈澱物濾出。此沈澱物以甲醇洗淨,於100℃下進行減壓乾燥後得聚醯亞胺粉末(12)。此聚醯亞胺之醯亞胺化率為81%,數平均分子量為18,200、重量平均分子量為51,600。 NMP was added to the obtained polyamic acid solution (30.0 g), diluted to 6% by mass, then acetic anhydride (4.50 g) and pyridine (3.35 g) as an imidization catalyst were added, and reacted at 80 ° C for 3.5 hour. This reaction solution was poured into methanol (460 ml), and the resulting precipitate was filtered off. This precipitate was washed with methanol and dried under reduced pressure at 100 ° C to obtain polyimide powder (12). The polyimide had an imidization rate of 81%, a number average molecular weight of 18,200, and a weight average molecular weight of 51,600.
將E3(5.50g,24.5mmol)、A4(2.45g,4.97mmol)、B1(0.19g,1.24mmol)、C2(3.54g,13.7mmol)及D2(0.54g,4.97mmol)於NMP(36.7g)中混合,於40℃下,進行8小時反應,得樹脂固體成份濃度為25質量%之聚醯胺酸溶液。 E3 (5.50g, 24.5mmol), A4 (2.45g, 4.97mmol), B1 (0.19g, 1.24mmol), C2 (3.54g, 13.7mmol) and D2 (0.54g, 4.97mmol) in NMP (36.7g ), Mixed at 40 ° C for 8 hours to obtain a polyamic acid solution with a resin solid content concentration of 25% by mass.
於所得聚醯胺酸溶液(30.5g)中加入NMP,稀釋至6質量%之後,加入作為醯亞胺化觸媒之乙酸酐(3.90g)及吡啶(2.60g),於60℃下,反應3.5小時。將此反應溶液投入甲醇(460ml)中,將所得沈澱物濾出。此沈澱物以甲醇洗淨,於100℃下進行減壓乾燥後得聚醯亞胺粉末(13)。此聚醯亞胺之醯亞胺化率為65%,數平均分子量為18,500、重量平均分子量為50,200。 NMP was added to the obtained polyamic acid solution (30.5g), diluted to 6% by mass, then acetic anhydride (3.90g) and pyridine (2.60g) as an imidization catalyst were added, and reacted at 60 ° C 3.5 hours. This reaction solution was poured into methanol (460 ml), and the resulting precipitate was filtered off. This precipitate was washed with methanol and dried under reduced pressure at 100 ° C to obtain polyimide powder (13). The polyimide has an imidization rate of 65%, a number average molecular weight of 18,500, and a weight average molecular weight of 50,200.
將E4(5.21g,17.3mmol)、A1(4.60g,12.1mmol)、B1(0.67g,4.39mmol)及D1(0.59g,5.49mmol)於NEP(23.8g)中混合,於80℃下反應6小時後,加入E1(0.85g,4.33mmol)與NEP(11.9g),於40℃下,反應6小時,得樹脂固體成份濃度為25質量%之聚醯胺酸溶液。 Mix E4 (5.21g, 17.3mmol), A1 (4.60g, 12.1mmol), B1 (0.67g, 4.39mmol) and D1 (0.59g, 5.49mmol) in NEP (23.8g), and react at 80 ℃ After 6 hours, E1 (0.85g, 4.33mmol) and NEP (11.9g) were added and reacted at 40 ° C for 6 hours to obtain a polyamic acid solution with a resin solid content concentration of 25% by mass.
於所得聚醯胺酸溶液(30.0g)中,加入NEP稀釋至6質量%之後,加入作為醯亞胺化觸媒之乙酸酐(3.80g)及吡啶(2.50g),於60℃下,反應2小時。將此反應溶液投入甲醇(460ml)中,將所得沈澱物濾出。此沈澱物以甲醇洗淨,於100℃下進行減壓乾燥後得聚醯亞胺粉 末(14)。此聚醯亞胺之醯亞胺化率為55%,數平均分子量為16,800、重量平均分子量為45,300。 To the obtained polyamic acid solution (30.0g), after adding NEP to dilute to 6% by mass, acetic anhydride (3.80g) and pyridine (2.50g) as an imidization catalyst were added and reacted at 60 ° C. 2 hours. This reaction solution was poured into methanol (460 ml), and the resulting precipitate was filtered off. This precipitate was washed with methanol and dried under reduced pressure at 100 ° C to obtain polyimide powder End (14). The polyimide has an imidization rate of 55%, a number average molecular weight of 16,800, and a weight average molecular weight of 45,300.
將E4(3.29g,11.0mmol)、A2(3.51g,8.88mmol)、C1(1.61g,6.66mmol)、C2(1.15g,4.44mmol)及D2(0.24g,2.22mmol)於NMP(23.9g)中混合,於80℃下反應6小時後,加入E1(2.15g,11.0mmol)與NMP(12.0g),於40℃下,反應6小時,得樹脂固體成份濃度為25質量%之聚醯胺酸溶液。 Combine E4 (3.29g, 11.0mmol), A2 (3.51g, 8.88mmol), C1 (1.61g, 6.66mmol), C2 (1.15g, 4.44mmol) and D2 (0.24g, 2.22mmol) in NMP (23.9g) ), Mixed at 80 ° C for 6 hours, added E1 (2.15g, 11.0mmol) and NMP (12.0g), and reacted at 40 ° C for 6 hours to obtain polyacrylamide with a resin solid content concentration of 25% by mass Amino acid solution.
於所得之聚醯胺酸溶液(30.1g)中,加入NMP稀釋至6質量%之後,加入作為醯亞胺化觸媒之乙酸酐(4.20g)及吡啶(3.15g),於80℃下反應2.5小時。將此反應溶液投入甲醇(460ml)中,將所得沈澱物濾出。此沈澱物以甲醇洗淨,於100℃下進行減壓乾燥後得聚醯亞胺粉末(15)。此聚醯亞胺之醯亞胺化率為73%,數平均分子量為15,900、重量平均分子量為43,800。 To the obtained polyamic acid solution (30.1g), after adding NMP to dilute to 6% by mass, acetic anhydride (4.20g) and pyridine (3.15g) as an imidization catalyst were added and reacted at 80 ° C 2.5 hours. This reaction solution was poured into methanol (460 ml), and the resulting precipitate was filtered off. This precipitate was washed with methanol and dried under reduced pressure at 100 ° C to obtain polyimide powder (15). The polyimide had an imidization rate of 73%, a number average molecular weight of 15,900, and a weight average molecular weight of 43,800.
將E5(4.30g,20.3mmol)、A3(3.89g,8.98mmol)、C2(1.33g,5.13mmol)及D2(1.25g,11.6mmol)於NMP(23.5g)中混合,於80℃下反應6小時後,加入E1(0.99g,5.07mmol)與NMP(11.8g),於40℃下,反應6小時,得樹脂固體成份濃度為25質量%之聚醯胺酸溶液。 Mix E5 (4.30g, 20.3mmol), A3 (3.89g, 8.98mmol), C2 (1.33g, 5.13mmol) and D2 (1.25g, 11.6mmol) in NMP (23.5g), and react at 80 ℃ After 6 hours, E1 (0.99g, 5.07mmol) and NMP (11.8g) were added and reacted at 40 ° C for 6 hours to obtain a polyamic acid solution with a resin solid content concentration of 25% by mass.
於所得之聚醯胺酸溶液(30.0g)中,加入NMP稀釋至6質量%之後,加入作為醯亞胺化觸媒之乙酸酐(3.85g)及吡啶(2.40g),於60℃下,反應2小時。將此反應溶液投入甲醇(460ml)中,將所得沈澱物濾出。此沈澱物以甲醇洗淨,於100℃下進行減壓乾燥後得聚醯亞胺粉末(16)。此聚醯亞胺之醯亞胺化率為51%,數平均分子量為15,700、重量平均分子量為44,500。 To the obtained polyamic acid solution (30.0g), after adding NMP to dilute to 6% by mass, acetic anhydride (3.85g) and pyridine (2.40g) as an imidization catalyst were added at 60 ° C. React for 2 hours. This reaction solution was poured into methanol (460 ml), and the resulting precipitate was filtered off. This precipitate was washed with methanol and dried under reduced pressure at 100 ° C to obtain polyimide powder (16). The polyimide has an imidization rate of 51%, a number average molecular weight of 15,700, and a weight average molecular weight of 44,500.
將E5(4.10g,19.3mmol)、B1(4.47g,29.4mmol)及D2(0.35g,3.26mmol)於NMP(24.3g)中混合,於80℃下反應6小時後,加入E2(3.22g,12.9mmol)與NMP(12.1g),於80℃下反應6小時,得樹脂固體成份濃度為25質量%之聚醯胺酸溶液。 E5 (4.10g, 19.3mmol), B1 (4.47g, 29.4mmol) and D2 (0.35g, 3.26mmol) were mixed in NMP (24.3g). After reacting at 80 ° C for 6 hours, E2 (3.22g) was added , 12.9mmol) and NMP (12.1g), reacted at 80 ℃ for 6 hours to obtain a polyamic acid solution with a resin solid content concentration of 25% by mass.
於所得之聚醯胺酸溶液(30.0g)中,加入NMP稀釋至6質量%之後,加入作為醯亞胺化觸媒之乙酸酐(4.20g)及吡啶(3.20g),於80℃下反應2.5小時。將此反應溶液投入甲醇(460ml)中,將所得沈澱物濾出。此沈澱物以甲醇洗淨,於100℃下進行減壓乾燥後得聚醯亞胺粉末(17)。此聚醯亞胺之醯亞胺化率為73%,數平均分子量為16,200、重量平均分子量為48,100。 To the obtained polyamic acid solution (30.0g), after adding NMP to dilute to 6% by mass, acetic anhydride (4.20g) and pyridine (3.20g) as an imidization catalyst were added and reacted at 80 ° C 2.5 hours. This reaction solution was poured into methanol (460 ml), and the resulting precipitate was filtered off. This precipitate was washed with methanol and dried under reduced pressure at 100 ° C to obtain polyimide powder (17). The polyimide has an imidization rate of 73%, a number average molecular weight of 16,200, and a weight average molecular weight of 48,100.
將E5(2.95g,13.9mmol)、A2(3.71g,9.39mmol)、B1 (0.36g,2.35mmol)、C1(1.14g,4.70mmol)、C2(1.22g,4.70mmol)及D1(0.25g,2.35mmol)於NEP(23.9g)中混合,於80℃下反應6小時後,加入E2(2.32g,9.27mmol)與NEP(11.9g),於80℃下反應6小時,得樹脂固體成份濃度為25質量%之聚醯胺酸溶液。 E5 (2.95g, 13.9mmol), A2 (3.71g, 9.39mmol), B1 (0.36g, 2.35mmol), C1 (1.14g, 4.70mmol), C2 (1.22g, 4.70mmol) and D1 (0.25g, 2.35mmol) were mixed in NEP (23.9g) and reacted at 80 ° C for 6 hours After that, E2 (2.32g, 9.27mmol) and NEP (11.9g) were added and reacted at 80 ° C for 6 hours to obtain a polyamic acid solution with a resin solid content concentration of 25% by mass.
於所得聚醯胺酸溶液(30.0g)中,加入NMP稀釋至6質量%之後,加入作為醯亞胺化觸媒之乙酸酐(4.20g)及吡啶(3.20g),於80℃下反應2小時。將此反應溶液投入甲醇(460ml)中,將所得沈澱物濾出。此沈澱物以甲醇洗淨,於100℃下進行減壓乾燥後得聚醯亞胺粉末(18)。此聚醯亞胺之醯亞胺化率為68%,數平均分子量為15,500、重量平均分子量為45,100。 To the obtained polyamic acid solution (30.0g), after adding NMP to dilute to 6% by mass, acetic anhydride (4.20g) and pyridine (3.20g) as an imidization catalyst were added and reacted at 80 ° C 2 hour. This reaction solution was poured into methanol (460 ml), and the resulting precipitate was filtered off. This precipitate was washed with methanol and dried under reduced pressure at 100 ° C to obtain polyimide powder (18). The polyimide had an imidization ratio of 68%, a number average molecular weight of 15,500, and a weight average molecular weight of 45,100.
將E2(3.10g,12.4mmol)、B1(3.82g,25.1mmol)及D1(0.68g,6.28mmol)於NMP(22.5g)中混合,於80℃下反應5小時後,加入E1(3.65g,18.6mmol)與NMP(11.3g),於40℃下,反應6小時,得樹脂固體成份濃度為25質量%之聚醯胺酸溶液(19)。此聚醯胺酸的數平均分子量為27,900、重量平均分子量為88,900。 E2 (3.10g, 12.4mmol), B1 (3.82g, 25.1mmol) and D1 (0.68g, 6.28mmol) were mixed in NMP (22.5g). After reacting at 80 ° C for 5 hours, E1 (3.65g) was added , 18.6mmol) and NMP (11.3g), at 40 ℃, 6 hours of reaction, to obtain a resin solid content concentration of 25% by mass of polyamic acid solution (19). The number average molecular weight of this polyamide was 27,900, and the weight average molecular weight was 88,900.
將E2(3.13g,12.5mmol)、A2(4.49g,11.4mmol)、B1(1.73g,11.4mmol)及D1(0.27g,2.53mmol)於NMP(24.2g) 中混合,於80℃下反應5小時後,加入E1(2.45g,12.5mmol)與NMP(12.1g),於40℃下,反應6小時,得樹脂固體成份濃度為25質量%之聚醯胺酸溶液(20)。此聚醯胺酸的數平均分子量為22,200、重量平均分子量為76,900。 Combine E2 (3.13g, 12.5mmol), A2 (4.49g, 11.4mmol), B1 (1.73g, 11.4mmol) and D1 (0.27g, 2.53mmol) in NMP (24.2g) After mixing for 5 hours at 80 ° C, E1 (2.45g, 12.5mmol) and NMP (12.1g) were added and reacted at 40 ° C for 6 hours to obtain polyamidoamine with a resin solid concentration of 25% by mass Acid solution (20). The number average molecular weight of this polyamide was 22,200, and the weight average molecular weight was 76,900.
本發明之聚醯亞胺系聚合物係如表1及表2所示。 The polyimide-based polymers of the present invention are shown in Table 1 and Table 2.
下述實施例1~實施例20、比較例1~比較例4中,為揭示組成物之製造例。又,該些組成物亦被作為液晶配向處理劑之評估使用。 The following Examples 1 to 20 and Comparative Examples 1 to 4 are examples of manufacturing compositions disclosed. In addition, these compositions are also used as evaluation agents for liquid crystal alignment treatment agents.
本發明之組成物及液晶配向處理劑係如表3~表5所示。 The composition and liquid crystal alignment treatment agent of the present invention are shown in Tables 3 to 5.
使用本發明之實施例及比較例所得之組成物及液晶配向處理劑,進行「組成物及液晶配向處理劑之印刷性評估(沙孔之評估)」、「組成物及液晶配向處理劑之印刷性評估(塗膜端部之評估)」、「電壓保持率(VHR)之評估(一般晶胞)」、「液晶配向處理劑之噴墨塗佈性評估」、「液晶晶胞之製作及液晶配向性之評估(PSA晶胞)」及「液晶晶胞之製作及液晶配向性之評估(SC-PVA 晶胞)」。 Using the composition and liquid crystal alignment treatment agent obtained in the examples and comparative examples of the present invention, "printability evaluation of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)" and "printing of the composition and liquid crystal alignment treatment agent" Property evaluation (evaluation of coating film end), "evaluation of voltage retention (VHR) (general cell)", "evaluation of inkjet coatability of liquid crystal alignment treatment agent", "production of liquid crystal cell and liquid crystal Alignment evaluation (PSA cell) "and" Fabrication of liquid crystal cell and evaluation of liquid crystal alignment (SC-PVA Unit cell) ".
使用依本發明之實施例及比較例之方法所得之組成物,進行聚醯亞胺膜沙孔之評估。具體而言,例如,將該些組成物使用細孔徑1μm之膜式過濾器加壓過濾,對未洗淨之Cr蒸鍍基板(縱100mm×橫100mm,厚度1.0mm)進行印刷。印刷機為使用簡易印刷機S15型(日本照相印刷公司製),印刷面積為相對於基板中心為80×80mm之範圍、印壓為0.2mm、拋棄式基板為5片、由印刷至預乾燥為止之時間為90秒、預乾燥為於加熱板上以70℃進行5分鐘、正式燒結為於熱循環型無塵烘箱中,於160℃下,15分鐘之條件進行。 Using the compositions obtained according to the methods of the examples and comparative examples of the present invention, the evaluation of polyimide membrane sand holes was carried out. Specifically, for example, these compositions are pressure-filtered using a membrane filter with a pore size of 1 μm, and printed on an unwashed Cr vapor-deposited substrate (length 100 mm × width 100 mm, thickness 1.0 mm). The printing machine is a simple printing machine S15 (manufactured by Japan Photographic Printing Co., Ltd.), the printing area is 80 x 80 mm relative to the center of the substrate, the printing pressure is 0.2 mm, and the disposable substrate is 5 pieces. From printing to pre-drying The time was 90 seconds, the pre-drying was performed on a hot plate at 70 ° C for 5 minutes, and the main sintering was performed in a heat-circulating dust-free oven at 160 ° C for 15 minutes.
隨後,確認附於所得之附有聚醯亞胺膜之基板上的沙孔之數目。具體而言,例如,將使附有聚醯亞胺膜之基板於鈉燈下以目視觀察,並計算聚醯亞胺膜上的沙孔數目。又,沙孔數目越少時,表示組成物中之析出物更少,而於本評估中為優良者。 Subsequently, the number of sand holes attached to the obtained polyimide film-attached substrate was confirmed. Specifically, for example, the substrate with the polyimide film attached will be visually observed under a sodium lamp, and the number of sand holes on the polyimide film will be calculated. In addition, the smaller the number of sand holes, the less precipitates in the composition, and the better in this evaluation.
表6~表8中,為標示實施例及比較例所得之沙孔數目。 Tables 6 to 8 indicate the number of sand holes obtained in the examples and comparative examples.
又,本發明之實施例及比較例所得之組成物,可使用於液晶配向處理劑。因此,本發明之實施例及比較例所得之組成物的聚醯亞胺膜之沙孔的評估,可適用作為液晶配向膜之沙孔的評估。 In addition, the compositions obtained in Examples and Comparative Examples of the present invention can be used for liquid crystal alignment treatment agents. Therefore, the evaluation of the sand holes of the polyimide film of the composition obtained in the examples and comparative examples of the present invention can be suitably used as the evaluation of the sand holes of the liquid crystal alignment film.
使用前述「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」所得之附有聚醯亞胺膜之基板,評估聚醯亞胺膜的塗膜端部,即,進行聚醯亞胺膜端部之直線性評估(亦稱為直線性評估)及聚醯亞胺膜端部膨大(亦稱為膨大評估)之評估。 Using the polyimide film-attached substrate obtained from the aforementioned "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)", the coating film end of the polyimide film was evaluated, that is, polyimide Evaluation of the linearity of the end of the imine membrane (also known as linearity evaluation) and the evaluation of the swelling of the end of the polyimide membrane (also known as the evaluation of swelling).
聚醯亞胺膜端部直線性之評估,為使用光學顯微鏡由相對於印刷方向為右側端部之聚醯亞胺膜進行觀察。更具體而言,例如,使用光學顯微鏡倍率為25倍觀察所得之聚醯亞胺膜畫像之圖1中之(1)與(2)之差,即,測定圖1中之A的長度。此時,全部的聚醯亞胺膜之畫像,可得到同一倍率。該A之長度越短時,表示聚醯亞胺膜之端部直線性更為優良。 The linearity of the end of the polyimide film was evaluated by using an optical microscope to observe the polyimide film at the right end with respect to the printing direction. More specifically, for example, the difference between (1) and (2) in FIG. 1 of the polyimide film image obtained by observation using an optical microscope magnification of 25 times, that is, the length of A in FIG. 1 is measured. At this time, all the portraits of the polyimide film can obtain the same magnification. The shorter the length of A, the better the linearity of the end of the polyimide film.
聚醯亞胺膜端部膨大之評估,為使用光學顯微鏡由相對於印刷方向為右側端部之聚醯亞胺膜進行觀察。具體而言,例如,使用光學顯微鏡倍率為25倍觀察,測定所得之聚醯亞胺膜畫像之圖2中之B的長度。此時,全部聚醯亞胺膜畫像皆可得到同一倍率。該B之長度越短時,表示聚醯亞胺膜端部的膨大狀態更為優良。 The evaluation of the swelling at the end of the polyimide film was performed using an optical microscope to observe the polyimide film at the right end with respect to the printing direction. Specifically, for example, observation using an optical microscope magnification of 25 times, and the length of B in FIG. 2 of the obtained polyimide film portrait are measured. At this time, all the polyimide film images can get the same magnification. The shorter the length of B, the better the expansion of the end of the polyimide film.
表6~表8中,為揭示實施例及比較例所得之前述A的長度及B的長度。 In Table 6 to Table 8, the length of A and the length of B obtained in Examples and Comparative Examples are disclosed.
又,本發明之實施例及比較例所得之組成 物,可供液晶配向處理劑使用。因此,本實施例及比較例所得之聚醯亞胺膜的塗膜端部之評估,亦作為液晶配向膜塗膜端部之評估。 In addition, the composition of the examples and comparative examples of the present invention It can be used for liquid crystal alignment treatment agent. Therefore, the evaluation of the coating film end of the polyimide film obtained in this example and the comparative example is also used as the evaluation of the coating film end of the liquid crystal alignment film.
使用本發明之實施例及比較例所得之液晶配向處理劑,進行電壓保持率(VHR)之評估。具體而言,可列舉如,將該些液晶配向處理劑使用細孔徑1μm之膜式過濾器加壓過濾後,將其旋轉塗佈於經進行純水及IPA(異丙醇)洗淨的附有ITO電極之基板(縱40mm×橫30mm、厚度0.7mm))之ITO面上,於加熱板上以80℃、3分鐘,熱循環型無塵烘箱中進行160℃,15分鐘之加熱處理,得膜厚為100nm之附有液晶配向膜之ITO基板。該ITO基板的塗膜面使用滾筒徑120mm之摩擦裝置,使用化纖布以滾筒回轉數:300rpm、滾筒行進速度:20mm/sec、擠壓量:0.4mm之條件下進行摩擦處理。 Using the liquid crystal alignment treatment agents obtained in Examples and Comparative Examples of the present invention, the voltage retention rate (VHR) was evaluated. Specifically, for example, after these liquid crystal alignment treatment agents are pressure-filtered using a membrane filter with a pore size of 1 μm, they are spin-coated on an auxiliary membrane washed with pure water and IPA (isopropyl alcohol). On the ITO surface of the substrate with an ITO electrode (40mm in length x 30mm in width and 0.7mm in thickness), heat treatment at 160 ° C for 15 minutes in a heat-circulating dust-free oven at 80 ° C for 3 minutes on a hot plate, An ITO substrate with a liquid crystal alignment film with a film thickness of 100 nm was obtained. A rubbing device with a roller diameter of 120 mm was used for the coating film surface of the ITO substrate, and a chemical fiber cloth was used to perform rubbing treatment under the conditions of roller rotation number: 300 rpm, roller travel speed: 20 mm / sec, and extrusion amount: 0.4 mm.
準備2片附有所製得之液晶配向膜的ITO基板,以液晶配向膜面向內側之方式挾夾6μm之間隔器方式組合,再印刷紫外線硬化型之封閉劑。其次,將另一側之基板以與液晶配向膜面面對面之方式貼合後,進行使紫外線硬化型之封閉劑硬化之處理,而製得空晶胞。具體而言,可列舉如,使用照度60mW的金屬鹵化物燈,阻隔310nm以下的波長,照射換算為365nm波長之紫外線5J/cm2,其後,於熱循環型無塵烘箱中進行120℃、60分 鐘加熱處理,而製得空晶胞。使用減壓注入法將向列型液晶注入此空晶胞中,而製得液晶晶胞(一般晶胞)。 Prepare two ITO substrates with the prepared liquid crystal alignment film, combine the liquid crystal alignment film facing inwards with a spacer of 6 μm, and print the ultraviolet curing type sealer. Next, after bonding the substrate on the other side face-to-face with the liquid crystal alignment film, a curing treatment of an ultraviolet curing type sealing agent is performed to produce an empty cell. Specifically, for example, using a metal halide lamp with an illuminance of 60 mW, blocking a wavelength of 310 nm or less, irradiating 5 J / cm 2 of ultraviolet light converted to a wavelength of 365 nm, and then performing 120 ° C. in a thermal cycle type dust-free oven. After 60 minutes of heat treatment, an empty cell was prepared. The nematic liquid crystal is injected into this empty cell using a reduced pressure injection method to produce a liquid crystal cell (general cell).
又,使用依實施例2~實施例4之方法所得之液晶配向處理劑(2)~液晶配向處理劑(4)、依實施例12之方法所得之液晶配向處理劑(12)、依實施例19之方法所得之液晶配向處理劑(19)、依比較例1之方法所得之液晶配向處理劑(21)及依比較例2之方法所得之液晶配向處理劑(22)的液晶晶胞中,液晶為使用MLC-2003(馬克‧日本製)。 In addition, the liquid crystal alignment treatment agent (2) to the liquid crystal alignment treatment agent (4) obtained by the method of Example 2 to Example 4, the liquid crystal alignment treatment agent (12) obtained by the method of Example 12, and the example The liquid crystal alignment treatment agent (19) obtained by the method of 19, the liquid crystal alignment treatment agent (21) obtained by the method of Comparative Example 1 and the liquid crystal alignment treatment agent (22) obtained by the method of Comparative Example 2, The liquid crystal uses MLC-2003 (made by Marc Japan).
又,使用前述以外的實施例及比較例所得之液晶配向處理劑的液晶晶胞中,液晶為使用MLC-6608(馬克‧日本製)。 In addition, in the liquid crystal cell using the liquid crystal alignment agent obtained in Examples and Comparative Examples other than the foregoing, MLC-6608 (manufactured by Mark Japan) was used as the liquid crystal.
於80℃之溫度下,對所得之液晶晶胞施加1V之電壓60μs,測定50ms後的電壓,計算電壓究竟可保持多少之結果作為電壓保持率(VHR)。又,測定為使用電壓保持率測定裝置(VHR-1)(東陽科技公司製),並於Voltage:±1V、Pulse Width:60μs、Flame Period:50ms之設定下進行。 At a temperature of 80 ° C, a voltage of 1 V was applied for 60 μs to the resulting liquid crystal cell, the voltage after 50 ms was measured, and the result of calculating how much the voltage could be retained was regarded as the voltage retention rate (VHR). In addition, the measurement was performed using a voltage retention measurement device (VHR-1) (manufactured by Dongyang Technology Co., Ltd.) under the settings of Voltage: ± 1 V, Pulse Width: 60 μs, and Flame Period: 50 ms.
此外,將VHR測定結束後的液晶晶胞,存放於溫度80℃之高溫槽內720小時之後,再度依與上述為相同之條件進行VHR之測定(亦稱為高溫槽保管後)。 In addition, after storing the liquid crystal cell after the VHR measurement in a high-temperature bath at a temperature of 80 ° C. for 720 hours, the VHR measurement was performed again under the same conditions as above (also referred to as after high-temperature bath storage).
評估為,加上製作液晶晶胞後即刻的VHR之值,對於製作液晶晶胞後即刻的VHR之值而言,高溫槽內保管後的VHR之值降低數越小者為良好。 It is evaluated that the value of VHR immediately after the production of the liquid crystal cell is added, and the value of the VHR immediately after the production of the liquid crystal cell is smaller, the smaller the number of reductions in the value of VHR after storage in the high-temperature bath is better.
表9~表11中,為標記實施例及比較例所得之電壓保持率(VHR)之值。 In Table 9 to Table 11, the values of the voltage retention rate (VHR) obtained in the examples and comparative examples are indicated.
使用本發明之實施例4之方法所得之液晶配向處理劑(4)、實施例7之方法所得之液晶配向處理劑(7)及實施例15之方法所得之液晶配向處理劑(15),進行噴墨塗佈性之評估。具體而言,例如,將該些液晶配向處理劑使用細孔徑1μm的膜式過濾器進行加壓過濾,噴墨塗佈機為使用HIS-200(日立機械科技公司製),於經純水及IPA洗淨的ITO(氧化銦錫)蒸鍍基板上,以塗佈面積70×70mm、噴嘴間距0.423mm、掃描間距0.5mm、塗佈速度40mm/秒、塗佈至預乾燥為止的時間為60秒、預乾燥為於加熱板上以70℃進行5分鐘、正式燒結為於熱循環型無塵烘箱中,以160℃、15分鐘之條件進行。 Using the liquid crystal alignment treatment agent (4) obtained by the method of Example 4 of the present invention, the liquid crystal alignment treatment agent (7) obtained by the method of Example 7, and the liquid crystal alignment treatment agent (15) obtained by the method of Example 15, Evaluation of inkjet coatability. Specifically, for example, the liquid crystal alignment treatment agent is subjected to pressure filtration using a membrane filter with a pore size of 1 μm, and the inkjet coater uses HIS-200 (manufactured by Hitachi Machinery Technology Co., Ltd.), which is purified by pure water and IPA-cleaned ITO (indium tin oxide) vapor-deposited substrate with a coating area of 70 × 70 mm, a nozzle pitch of 0.423 mm, a scanning pitch of 0.5 mm, a coating speed of 40 mm / sec, and a coating time to pre-drying of 60 Seconds, pre-drying is performed on a hot plate at 70 ° C for 5 minutes, and formal sintering is performed in a heat-circulating dust-free oven at 160 ° C for 15 minutes.
於鈉燈下以目視觀察所得之附有液晶配向膜之基板,並計算液晶配向膜上之沙孔數目結果,得知,無論任一實施例所得之液晶配向膜,其沙孔皆未達5個。又,任一實施例皆可製得具有優良均勻塗膜性的液晶配向膜。 Observe the obtained substrate with liquid crystal alignment film under sodium lamp, and calculate the result of the number of sand holes on the liquid crystal alignment film. It is known that no matter how the liquid crystal alignment film obtained in any embodiment, the number of sand holes is less than 5 . Furthermore, in any of the embodiments, a liquid crystal alignment film having excellent uniform coating properties can be produced.
另外,使用所得之附有液晶配向膜之基板,依前述「電壓保持率(VHR)之評估(一般晶胞)」之條件進行VHR(一般晶胞)之評估。 In addition, using the obtained substrate with a liquid crystal alignment film, the VHR (general unit cell) evaluation was performed according to the conditions of the aforementioned "voltage retention rate (VHR) evaluation (general unit cell)".
使用本發明之實施例6之方法所得之液晶配向處理劑(6)、實施例9之方法所得之液晶配向處理劑(9)及實施例14之方法所得之液晶配向處理劑(14),進行液晶晶胞之製作及液晶配向性之評估(PSA晶胞)。具體而言,例如,將該些液晶配向處理劑使用細孔徑1μm的膜式過濾器進行加壓過濾,旋轉塗佈於經純水及IPA洗淨之中心附有10×10mm圖型間隔20μm的ITO電極之基板(縱40mm×橫30mm、厚度0.7mm)與中心附有10×40mm之ITO電極之基板(縱40mm×橫30mm、厚度0.7mm)之ITO面後,再於加熱板上以80℃、3分鐘、熱循環型無塵烘箱160℃、15分鐘加熱處理,而製得膜厚100nm之附有液晶配向膜之基板。 Using the liquid crystal alignment treatment agent (6) obtained by the method of Example 6 of the present invention, the liquid crystal alignment treatment agent (9) obtained by the method of Example 9, and the liquid crystal alignment treatment agent (14) obtained by the method of Example 14, Production of liquid crystal cell and evaluation of liquid crystal alignment (PSA cell). Specifically, for example, the liquid crystal alignment treatment agent is subjected to pressure filtration using a membrane filter with a pore size of 1 μm, and spin-coated on a center washed with pure water and IPA with a 10 × 10 mm pattern interval of 20 μm After the ITO electrode substrate (length 40mm × 30mm, thickness 0.7mm) and the ITO surface of the substrate with a 10 × 40mm ITO electrode in the center (length 40mm × 30mm, thickness 0.7mm), and then 80 on the heating plate ℃, 3 minutes, heat cycle type dust-free oven 160 ℃, 15 minutes heat treatment, and the substrate with liquid crystal alignment film with a film thickness of 100nm was prepared.
將該些附有液晶配向膜之基板,以液晶配向膜面向內側之方式,挾夾6μm之間隔器予以組合,以封閉劑黏著周圍以製作空晶胞。此空晶胞以減壓注入法之方式,將下述式所示聚合性化合物(1)以相對於向列型液晶(MLC-6608)之100質量%,聚合性化合物(1)為0.3質量%混合所得之液晶注入向列型液晶(MLC-6608)(馬克‧日本公司製),將注入口密封,而製得液晶晶胞。 The substrates with the liquid crystal alignment film are combined with a 6 μm spacer sandwiched with the liquid crystal alignment film facing inward, and the surrounding is adhered with a sealant to make an empty cell. In this empty cell, the polymerizable compound (1) represented by the following formula is 100% by mass with respect to the nematic liquid crystal (MLC-6608) by a reduced pressure injection method, and the polymerizable compound (1) is 0.3 mass % The liquid crystal obtained by mixing is injected into a nematic liquid crystal (MLC-6608) (manufactured by Mark Japan), and the injection port is sealed to produce a liquid crystal cell.
對所得之液晶晶胞,於持續施加交流5V的電壓中,使用照度60mW的金屬鹵化物燈,阻隔350nm以下的波長,照射換算為365nm之紫外線20J/cm2,製得液晶的配向方向受到控制之液晶晶胞(PSA晶胞)。使用紫外線照射液晶晶胞之際的照射裝置內之溫度,為50℃。 To the obtained liquid crystal cell, using a metal halide lamp with an illuminance of 60mW while continuously applying an alternating voltage of 5V, blocking a wavelength below 350nm, irradiating ultraviolet light 20J / cm 2 converted to 365nm, the alignment direction of the resulting liquid crystal is controlled The liquid crystal cell (PSA cell). When the ultraviolet ray is used to irradiate the liquid crystal cell, the temperature in the irradiation device is 50 ° C.
測定該液晶晶胞於紫外線照射前與紫外線照射後之液晶的應答速度。應答速度為測定透過率90%至透過率10%為止的T90→T10。 The response speed of the liquid crystal of the liquid crystal cell before and after ultraviolet irradiation was measured. The response speed is T90 → T10 from 90% transmittance to 10% transmittance.
無論任一實施例所得之PSA晶胞,與紫外線照射前之液晶晶胞相比較時,該紫外線照射後之液晶晶胞的應答速度皆更為快速之結果得知,確認液晶之配向方向為受到控制者。又,無論任一之液晶晶胞,於使用偏光顯微鏡(ECLIPSE E600WPOL)(尼康公司製)觀察結果,皆確認液晶呈均勻地配向。 Regardless of the PSA cell obtained in any of the examples, the response speed of the liquid crystal cell after the ultraviolet irradiation is faster when compared with the liquid crystal cell before the ultraviolet irradiation. The result shows that the alignment direction of the liquid crystal is affected by controller. In addition, regardless of any liquid crystal cell, observation results using a polarizing microscope (ECLIPSE E600WPOL) (manufactured by Nikon Corporation) confirmed that the liquid crystals were uniformly aligned.
使用本發明之實施例6之方法所得之液晶配向處理劑(6)、實施例9之方法所得之液晶配向處理劑(9)及實施例14之方法所得之液晶配向處理劑(14),進行液晶晶胞之製作及液晶配向性之評估(SC-PVA晶胞)。具體而言,例 如,將前述所示聚合性化合物(1),以相對於液晶配向處理劑中之全聚合物成份100質量%為2質量%之量加入該些液晶配向處理劑中,於25℃下攪拌4小時。其後,將所得之液晶配向處理劑使用細孔徑1μm的膜式過濾器進行加壓過濾,旋轉塗佈於經純水及IPA洗淨之中心附有10×10mm之圖型間隔20μm的ITO電極之基板(縱40mm×橫30mm、厚度0.7mm)與中心附有10×40mm之ITO電極的基板(縱40mm×橫30mm、厚度0.7mm)之ITO面,於加熱板上以80℃、3分鐘、熱循環型無塵烘箱中以160℃、15分鐘加熱處理後,得膜厚為100nm之附有液晶配向膜之基板。 Using the liquid crystal alignment treatment agent (6) obtained by the method of Example 6 of the present invention, the liquid crystal alignment treatment agent (9) obtained by the method of Example 9, and the liquid crystal alignment treatment agent (14) obtained by the method of Example 14, Production of liquid crystal cell and evaluation of liquid crystal alignment (SC-PVA cell). Specifically, examples For example, the aforementioned polymerizable compound (1) is added to these liquid crystal alignment treatment agents in an amount of 2% by mass with respect to 100% by mass of the total polymer component in the liquid crystal alignment treatment agent, and stirred at 25 ° C. 4 hour. Thereafter, the obtained liquid crystal alignment treatment agent was subjected to pressure filtration using a membrane filter with a pore size of 1 μm, and was spin-coated on an ITO electrode with a pattern spacing of 10 × 10 mm and a pitch of 20 μm washed with pure water and IPA. The ITO surface of the substrate (40mm in length × 30mm in width and 0.7mm in thickness) and the ITO surface of the substrate (40mm in length × 30mm in width and 0.7mm in thickness) with an ITO electrode of 10 × 40mm in the center, at 80 ° C for 3 minutes on a hot plate After heat treatment at 160 ° C for 15 minutes in a heat-circulating dust-free oven, a substrate with a liquid crystal alignment film with a film thickness of 100 nm is obtained.
將該些附有液晶配向膜之基板,以液晶配向膜面向內側之方式,挾夾6μm之間隔器予以組合,以封閉劑黏著周圍以製作空晶胞。此空晶胞以減壓注入法之方式,注入向列型液晶(MLC-6608)(馬克‧日本公司製),將注入口密封,而製得液晶晶胞。 The substrates with the liquid crystal alignment film are combined with a 6 μm spacer sandwiched with the liquid crystal alignment film facing inward, and the surrounding is adhered with a sealant to make an empty cell. This empty cell was injected into a nematic liquid crystal (MLC-6608) (manufactured by Mark Japan) by a method of reduced pressure injection, and the injection port was sealed to produce a liquid crystal cell.
對所得之液晶晶胞,於持續施加交流5V的電壓中,使用照度60mW的金屬鹵化物燈,阻隔350nm以下的波長,照射換算為365nm之紫外線20J/cm2,製得液晶的配向方向受到控制之液晶晶胞(SC-PVA晶胞)。使用紫外線照射液晶晶胞之際的照射裝置內之溫度為50℃。 To the obtained liquid crystal cell, using a metal halide lamp with an illuminance of 60mW while continuously applying an alternating voltage of 5V, blocking a wavelength below 350nm, irradiating ultraviolet light 20J / cm 2 converted to 365nm, the alignment direction of the resulting liquid crystal is controlled The liquid crystal cell (SC-PVA cell). When the ultraviolet ray is used to irradiate the liquid crystal cell, the temperature in the irradiation device is 50 ° C.
測定該液晶晶胞於紫外線照射前與紫外線照射後之液晶的應答速度。應答速度為測定透過率90%至透過率10%為止的T90→T10。 The response speed of the liquid crystal of the liquid crystal cell before and after ultraviolet irradiation was measured. The response speed is T90 → T10 from 90% transmittance to 10% transmittance.
無論任一實施例所得之SC-PVA晶胞,與紫外線照射前之液晶晶胞相比較時,該紫外線照射後之液晶晶胞的應答速度皆更為快速之結果得知,確認液晶之配向方向為受到控制者。又,無論任一之液晶晶胞,於使用偏光顯微鏡(ECLIPSE E600WPOL)(尼康公司製)觀察結果,皆確認液晶呈均勻地配向。 Regardless of the SC-PVA cell obtained in any example, the response speed of the liquid crystal cell after the ultraviolet irradiation is faster when compared with the liquid crystal cell before the ultraviolet irradiation. The result is known. Confirm the alignment direction of the liquid crystal For those under control. In addition, regardless of any liquid crystal cell, observation results using a polarizing microscope (ECLIPSE E600WPOL) (manufactured by Nikon Corporation) confirmed that the liquid crystals were uniformly aligned.
於合成例1之合成方法所得之樹脂固體成份濃度25質量%之聚醯胺酸溶液(1)(10.0g)中,加入S1(8.17g)、K1(0.18g)、NEP(3.92g)及PB(19.6g),於25℃下攪拌8小時,得組成物(1)。此組成物中,確認未發現混濁或析出物等異常,而為均勻之溶液。又,該組成物(1)亦作為液晶配向處理劑(1)之評估用。 S1 (8.17g), K1 (0.18g), NEP (3.92g) and S1 (8.17g), K1 (0.18g), and NEP (3.92g) were added to the polyamic acid solution (1) (10.0g) with a resin solid content concentration of 25% by mass obtained by the synthesis method of Synthesis Example 1. PB (19.6g) was stirred at 25 ° C for 8 hours to obtain composition (1). In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a homogeneous solution. In addition, this composition (1) is also used for evaluation of the liquid crystal alignment treatment agent (1).
使用所得之組成物(1)及液晶配向處理劑(1),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「組成物及液晶配向處理劑印刷性之評估(塗膜端部之評估)」及「電壓保持率(VHR)之評估(一般晶胞)」。 Using the obtained composition (1) and liquid crystal alignment treatment agent (1), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)" and "evaluation of the printability of the composition and liquid crystal alignment treatment agent" (Evaluation of coating film end) "and" Evaluation of voltage retention rate (VHR) (general cell) ".
於依合成例2之合成方法所得之樹脂固體成份濃度25質量%之聚醯胺酸溶液(2)(10.5g)中,加入S1(16.8g)及BCS(16.4g),於25℃下攪拌4小時,得組成物(2)。該組成物中,確認未發現混濁或析出物等異常,而為均勻之溶 液。又,該組成物(2)亦作為液晶配向處理劑(2)之評估用。 To the polyamic acid solution (2) (10.5g) with a resin solid content concentration of 25% by mass obtained according to the synthesis method of Synthesis Example 2, S1 (16.8g) and BCS (16.4g) were added and stirred at 25 ° C After 4 hours, the composition (2) was obtained. In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a uniform solution liquid. In addition, the composition (2) is also used for evaluation of the liquid crystal alignment treatment agent (2).
使用所得之組成物(2)及液晶配向處理劑(2),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「組成物及液晶配向處理劑印刷性之評估(塗膜端部之評估)」及「電壓保持率(VHR)之評估(一般晶胞)」。 Using the obtained composition (2) and liquid crystal alignment treatment agent (2), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)" and "evaluation of the printability of the composition and liquid crystal alignment treatment agent" (Evaluation of coating film end) "and" Evaluation of voltage retention rate (VHR) (general cell) ".
於合成例3之合成方法所得之聚醯亞胺粉末(3)(1.60g)中,加入S1(13.8g),於70℃下攪拌24小時使其溶解。於此溶液中,加入BCS(11.3g),於40℃下攪拌3小時,得組成物(3)。此組成物中,確認未發現混濁或析出物等異常,而為均勻之溶液。又,該組成物(3)亦作為液晶配向處理劑(3)之評估用。 To the polyimide powder (3) (1.60 g) obtained by the synthesis method of Synthesis Example 3, S1 (13.8 g) was added and stirred at 70 ° C for 24 hours to dissolve. To this solution, BCS (11.3g) was added and stirred at 40 ° C for 3 hours to obtain a composition (3). In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a homogeneous solution. In addition, this composition (3) is also used for evaluation of the liquid crystal alignment treatment agent (3).
使用所得組成物(3)及液晶配向處理劑(3),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「組成物及液晶配向處理劑印刷性之評估(塗膜端部之評估)」及「電壓保持率(VHR)之評估(一般晶胞)」。 Using the obtained composition (3) and liquid crystal alignment treatment agent (3), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)" and "evaluation of the composition and liquid crystal alignment treatment agent printability ( "Evaluation of coating film ends" and "Evaluation of voltage retention (VHR) (general cell)".
於合成例4之合成方法所得之聚醯亞胺粉末(4)(1.70g)中,加入S1(14.1g)及NEP(9.37g),於70℃下攪拌24小時使其溶解。於此溶液中,加入BCS(9.37g)及PB(14.1g),於40℃下,攪拌3小時,得組成物(4)。此組成 物中,確認未發現混濁或析出物等異常,而為均勻之溶液。又,此組成物(4)亦作為液晶配向處理劑(4)之評估用。 To the polyimide powder (4) (1.70 g) obtained by the synthesis method of Synthesis Example 4, S1 (14.1 g) and NEP (9.37 g) were added, followed by stirring at 70 ° C for 24 hours to dissolve. To this solution, BCS (9.37g) and PB (14.1g) were added and stirred at 40 ° C for 3 hours to obtain a composition (4). This composition Among the materials, it was confirmed that no abnormalities such as turbidity or precipitates were found, but a homogeneous solution. In addition, this composition (4) is also used for evaluation of the liquid crystal alignment treatment agent (4).
使用所得之組成物(4)及液晶配向處理劑(4),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「電壓保持率(VHR)之評估(一般晶胞)」及「液晶配向處理劑噴墨塗佈性之評估」。 Using the obtained composition (4) and liquid crystal alignment treatment agent (4), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand hole)" and "voltage retention rate (VHR) evaluation (general crystal Cell) "and" Evaluation of Inkjet Coating Properties of Liquid Crystal Alignment Treatment Agent ".
於合成例5之合成方法所得之樹脂固體成份濃度25質量%之聚醯胺酸溶液(5)(10.0g)中,加入S1(14.0g)及BCS(17.7g),於25℃下攪拌4小時,得組成物(5)。此組成物中,確認未發現混濁或析出物等異常,而為均勻之溶液。又,此組成物(5)亦作為液晶配向處理劑(5)之評估用。 To the polyamic acid solution (5) (10.0g) with a resin solid content concentration of 25% by mass obtained by the synthesis method of Synthesis Example 5, S1 (14.0g) and BCS (17.7g) were added and stirred at 25 ° C 4 Hour, the composition (5). In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a homogeneous solution. In addition, this composition (5) is also used for evaluation of the liquid crystal alignment treatment agent (5).
使用所得之組成物(5)及液晶配向處理劑(5),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「組成物及液晶配向處理劑印刷性之評估(塗膜端部之評估)」及「電壓保持率(VHR)之評估(一般晶胞)」。 Using the obtained composition (5) and liquid crystal alignment treatment agent (5), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)" and "evaluation of the printability of the composition and liquid crystal alignment treatment agent (Evaluation of coating film end) "and" Evaluation of voltage retention rate (VHR) (general cell) ".
於合成例6之合成方法所得之聚醯亞胺粉末(6)(1.70g)中,加入S1(14.7g),於70℃下攪拌24小時使其溶解。於此溶液中,加入BCS(12.0g),於40℃下,攪拌3 小時,得組成物(6)。此組成物中,確認未發現混濁或析出物等異常,而為均勻之溶液。又,此組成物(6)亦作為液晶配向處理劑(6)之評估用。 To the polyimide powder (6) (1.70 g) obtained by the synthesis method of Synthesis Example 6, S1 (14.7 g) was added and stirred at 70 ° C for 24 hours to dissolve. To this solution, add BCS (12.0g) and stir at 40 ° C for 3 In hours, the composition (6) is obtained. In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a homogeneous solution. In addition, this composition (6) is also used for evaluation of the liquid crystal alignment treatment agent (6).
使用所得之組成物(6)及液晶配向處理劑(6),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「組成物及液晶配向處理劑印刷性之評估(塗膜端部之評估)」、「電壓保持率(VHR)之評估(一般晶胞)」、「液晶晶胞之製作及液晶配向性之評估(PSA晶胞)」及「液晶晶胞之製作及液晶配向性之評估(SC-PVA晶胞)」。 Using the obtained composition (6) and liquid crystal alignment treatment agent (6), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)" and "evaluation of the printability of the composition and liquid crystal alignment treatment agent" (Evaluation of coating film end), "Evaluation of voltage retention rate (VHR) (general cell)", "Fabrication of liquid crystal cell and evaluation of liquid crystal alignment (PSA cell)" and "Evaluation of liquid crystal cell Production and evaluation of liquid crystal alignment (SC-PVA cell) ".
於合成例6之合成方法所得之聚醯亞胺粉末(6)(1.65g)中,加入S1(9.10g)及NEP(13.7g),於70℃下攪拌24小時使其溶解。於此溶液中,加入PB(22.8g),於40℃下,攪拌3小時,得組成物(7)。此組成物中,確認未發現混濁或析出物等異常,而為均勻之溶液。又,此組成物(7)亦作為液晶配向處理劑(7)之評估用。 To the polyimide powder (6) (1.65 g) obtained by the synthesis method of Synthesis Example 6, S1 (9.10 g) and NEP (13.7 g) were added, and stirred at 70 ° C for 24 hours to dissolve. To this solution, PB (22.8g) was added and stirred at 40 ° C for 3 hours to obtain a composition (7). In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a homogeneous solution. In addition, this composition (7) is also used for evaluation of the liquid crystal alignment treatment agent (7).
使用所得之組成物(7)及液晶配向處理劑(7),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「電壓保持率(VHR)之評估(一般晶胞)」及「液晶配向處理劑噴墨塗佈性之評估」。 Using the obtained composition (7) and liquid crystal alignment treatment agent (7), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)" and "voltage retention rate (VHR) evaluation (general crystal Cell) "and" Evaluation of Inkjet Coating Properties of Liquid Crystal Alignment Treatment Agent ".
於合成例7之合成方法所得之聚醯亞胺粉末(7)(1.60g)中,加入S1(6.27g)及NEP(7.52g),於70℃下攪拌24小時使其溶解。於此溶液中,加入BCS(2.51g)及PB(8.77g),於40℃下,攪拌3小時,得組成物(8)。此組成物中,確認未發現混濁或析出物等異常,而為均勻之溶液。又,此組成物(8)亦作為液晶配向處理劑(8)之評估用。 To the polyimide powder (7) (1.60 g) obtained by the synthesis method of Synthesis Example 7, S1 (6.27 g) and NEP (7.52 g) were added and stirred at 70 ° C for 24 hours to dissolve. To this solution, BCS (2.51g) and PB (8.77g) were added and stirred at 40 ° C for 3 hours to obtain a composition (8). In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a homogeneous solution. In addition, this composition (8) is also used for evaluation of the liquid crystal alignment treatment agent (8).
使用所得之組成物(8)及液晶配向處理劑(8),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「組成物及液晶配向處理劑印刷性之評估(塗膜端部之評估)」及「電壓保持率(VHR)之評估(一般晶胞)」。 Using the obtained composition (8) and liquid crystal alignment treatment agent (8), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)" and "evaluation of the printability of the composition and liquid crystal alignment treatment agent" (Evaluation of coating film end) "and" Evaluation of voltage retention rate (VHR) (general cell) ".
於合成例8之合成方法所得之聚醯亞胺粉末(8)(1.60g)中,加入S1(7.52g)及NMP(5.01g),於70℃下攪拌24小時使其溶解。於此溶液中,加入PB(10.0g)及DME(2.51g),於40℃下,攪拌5小時,得組成物(9)。此組成物中,確認未發現混濁或析出物等異常,而為均勻之溶液。又,此組成物(9)亦作為液晶配向處理劑(9)之評估用。 To the polyimide powder (8) (1.60 g) obtained by the synthesis method of Synthesis Example 8, S1 (7.52 g) and NMP (5.01 g) were added and stirred at 70 ° C for 24 hours to dissolve. To this solution, PB (10.0g) and DME (2.51g) were added and stirred at 40 ° C for 5 hours to obtain a composition (9). In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a homogeneous solution. In addition, this composition (9) is also used for evaluation of the liquid crystal alignment treatment agent (9).
使用所得之組成物(9)及液晶配向處理劑(9),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「組成物及液晶配向處理劑印刷性之評估(塗膜端部之評估)」、「電壓保持率(VHR)之評估(一般晶胞)」、 「液晶晶胞之製作及液晶配向性之評估(PSA晶胞)」及「液晶晶胞之製作及液晶配向性之評估(SC-PVA晶胞)」。 Using the obtained composition (9) and liquid crystal alignment treatment agent (9), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)" and "evaluation of the printability of the composition and liquid crystal alignment treatment agent" (Evaluation of coating film end) '', `` Evaluation of voltage retention rate (VHR) (general cell) '', "Fabrication of liquid crystal cells and evaluation of liquid crystal alignment (PSA cell)" and "Fabrication of liquid crystal cells and evaluation of liquid crystal alignment (SC-PVA cell)".
於合成例9之合成方法所得之聚醯亞胺粉末(9)(1.65g)中,加入S1(10.3g)及NEP(7.76g),於70℃下攪拌24小時使其溶解。於此溶液中,加入PB(6.46g)及EC(1.29g),於40℃下,攪拌3小時,得組成物(10)。此組成物中,確認未發現混濁或析出物等異常,而為均勻之溶液。又,此組成物(10)亦作為液晶配向處理劑(10)之評估用。 To the polyimide powder (9) (1.65 g) obtained by the synthesis method of Synthesis Example 9, S1 (10.3 g) and NEP (7.76 g) were added, followed by stirring at 70 ° C for 24 hours to dissolve. To this solution, PB (6.46g) and EC (1.29g) were added and stirred at 40 ° C for 3 hours to obtain a composition (10). In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a homogeneous solution. In addition, this composition (10) is also used for evaluation of the liquid crystal alignment treatment agent (10).
使用所得之組成物(10)及液晶配向處理劑(10),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「組成物及液晶配向處理劑印刷性之評估(塗膜端部之評估)」及「電壓保持率(VHR)之評估(一般晶胞)」。 Using the obtained composition (10) and liquid crystal alignment treatment agent (10), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)" and "evaluation of the printability of the composition and liquid crystal alignment treatment agent" (Evaluation of coating film end) "and" Evaluation of voltage retention rate (VHR) (general cell) ".
於合成例10之合成方法所得之聚醯亞胺粉末(10)(1.60g)中,加入S1(3.76g)及NEP(10.0g),於70℃下攪拌24小時使其溶解。於此溶液中,加入BCS(11.3g),於40℃下,攪拌3小時,得組成物(11)。此組成物中,確認未發現混濁或析出物等異常,而為均勻之溶液。又,此組 成物(11)亦作為液晶配向處理劑(11)之評估用。 To the polyimide powder (10) (1.60 g) obtained by the synthesis method of Synthesis Example 10, S1 (3.76 g) and NEP (10.0 g) were added, followed by stirring at 70 ° C for 24 hours to dissolve. To this solution, BCS (11.3g) was added and stirred at 40 ° C for 3 hours to obtain a composition (11). In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a homogeneous solution. Again, this group The finished product (11) is also used for evaluation of the liquid crystal alignment treatment agent (11).
使用所得之組成物(11)及液晶配向處理劑(11),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「組成物及液晶配向處理劑印刷性之評估(塗膜端部之評估)」及「電壓保持率(VHR)之評估(一般晶胞)」。 Using the obtained composition (11) and liquid crystal alignment treatment agent (11), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)" and "evaluation of the printability of the composition and liquid crystal alignment treatment agent" (Evaluation of coating film end) "and" Evaluation of voltage retention rate (VHR) (general cell) ".
於合成例11之合成方法所得之聚醯亞胺粉末(11)(1.70g)中,加入S1(5.33g)及γ-BL(13.3g),於70℃下攪拌24小時使其溶解。於此溶液中,加入BCS(7.99g),於40℃下,攪拌3小時,得組成物(12)。此組成物中,確認未發現混濁或析出物等異常,而為均勻之溶液。又,此組成物(12)亦作為液晶配向處理劑(12)之評估用。 To the polyimide powder (11) (1.70 g) obtained by the synthesis method of Synthesis Example 11, S1 (5.33 g) and γ-BL (13.3 g) were added, followed by stirring at 70 ° C for 24 hours to dissolve. To this solution, BCS (7.99g) was added and stirred at 40 ° C for 3 hours to obtain a composition (12). In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a homogeneous solution. In addition, this composition (12) is also used for evaluation of a liquid crystal alignment treatment agent (12).
使用所得之組成物(12)及液晶配向處理劑(12),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「組成物及液晶配向處理劑印刷性之評估(塗膜端部之評估)」及「電壓保持率(VHR)之評估(一般晶胞)」。 Using the obtained composition (12) and liquid crystal alignment treatment agent (12), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)" and "evaluation of the printability of the composition and liquid crystal alignment treatment agent" (Evaluation of coating film end) "and" Evaluation of voltage retention rate (VHR) (general cell) ".
於合成例12之合成方法所得之聚醯亞胺粉末(12)(1.65g)中,加入S1(7.76g)及NMP(5.17g),於70℃下攪拌24小時使其溶解。於此溶液中,加入BCS(5.17g)及PB (7.76g),於40℃下,攪拌3小時,得組成物(13)。此組成物中,確認未發現混濁或析出物等異常,而為均勻之溶液。又,此組成物(13)亦作為液晶配向處理劑(13)之評估用。 To the polyimide powder (12) (1.65 g) obtained by the synthesis method of Synthesis Example 12, S1 (7.76 g) and NMP (5.17 g) were added, followed by stirring at 70 ° C for 24 hours to dissolve. In this solution, add BCS (5.17g) and PB (7.76g), and stirred at 40 ° C for 3 hours to obtain a composition (13). In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a homogeneous solution. In addition, this composition (13) is also used for evaluation of the liquid crystal alignment treatment agent (13).
使用所得之組成物(13)及液晶配向處理劑(13),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「組成物及液晶配向處理劑印刷性之評估(塗膜端部之評估)」及「電壓保持率(VHR)之評估(一般晶胞)」。 Using the obtained composition (13) and liquid crystal alignment treatment agent (13), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)" and "evaluation of the printability of the composition and liquid crystal alignment treatment agent" (Evaluation of coating film end) "and" Evaluation of voltage retention rate (VHR) (general cell) ".
於合成例13之合成方法所得之聚醯亞胺粉末(13)(1.60g)中,加入S1(5.01g)及NEP(7.52g),於70℃下攪拌24小時使其溶解。於此溶液中,加入PB(12.5g),於40℃下,攪拌3小時,得組成物(14)。此組成物中,確認未發現混濁或析出物等異常,而為均勻之溶液。又,此組成物(14)亦作為液晶配向處理劑(14)之評估用。 To the polyimide powder (13) (1.60 g) obtained by the synthesis method of Synthesis Example 13, S1 (5.01 g) and NEP (7.52 g) were added, followed by stirring at 70 ° C for 24 hours to dissolve. To this solution, PB (12.5g) was added and stirred at 40 ° C for 3 hours to obtain a composition (14). In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a homogeneous solution. In addition, this composition (14) is also used for evaluation of the liquid crystal alignment treatment agent (14).
使用所得之組成物(14)及液晶配向處理劑(14),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「組成物及液晶配向處理劑印刷性之評估(塗膜端部之評估)」、「電壓保持率(VHR)之評估(一般晶胞)」、「液晶晶胞之製作及液晶配向性之評估(PSA晶胞)」及「液晶晶胞之製作及液晶配向性之評估(SC-PVA晶胞)」。 Using the obtained composition (14) and liquid crystal alignment treatment agent (14), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)" and "evaluation of the printability of the composition and liquid crystal alignment treatment agent" (Evaluation of coating film end), "Evaluation of voltage retention rate (VHR) (general cell)", "Fabrication of liquid crystal cell and evaluation of liquid crystal alignment (PSA cell)" and "Evaluation of liquid crystal cell Production and evaluation of liquid crystal alignment (SC-PVA cell) ".
於合成例13之合成方法所得之聚醯亞胺粉末(13)(1.70g)中,加入S1(4.69g)及γ-BL(18.8g),於70℃下攪拌24小時使其溶解。於此溶液中,加入BCS(9.37g)及PB(14.1g),於40℃下,攪拌3小時,得組成物(15)。此組成物中,確認未發現混濁或析出物等異常,而為均勻之溶液。又,此組成物(15)亦作為液晶配向處理劑(15)之評估用。 To the polyimide powder (13) (1.70 g) obtained by the synthesis method of Synthesis Example 13, S1 (4.69 g) and γ-BL (18.8 g) were added, followed by stirring at 70 ° C for 24 hours to dissolve. To this solution, BCS (9.37g) and PB (14.1g) were added and stirred at 40 ° C for 3 hours to obtain a composition (15). In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a homogeneous solution. In addition, this composition (15) is also used for evaluation of the liquid crystal alignment treatment agent (15).
使用所得之組成物(15)及液晶配向處理劑(15),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「電壓保持率(VHR)之評估(一般晶胞)」及「液晶配向處理劑噴墨塗佈性之評估」。 Using the obtained composition (15) and liquid crystal alignment treatment agent (15), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand hole)" and "voltage retention rate (VHR) evaluation (general crystal Cell) "and" Evaluation of Inkjet Coating Properties of Liquid Crystal Alignment Treatment Agent ".
於合成例14之合成方法所得之聚醯亞胺粉末(14)(1.60g)中,加入S1(12.5g)及NEP(2.51g),於70℃下攪拌24小時使其溶解。於此溶液中,加入K1(0.08g)及BCS(10.0g),於40℃下,攪拌5小時,得組成物(16)。此組成物中,確認未發現混濁或析出物等異常,而為均勻之溶液。又,此組成物(16)亦作為液晶配向處理劑(16)之評估用。 To the polyimide powder (14) (1.60 g) obtained by the synthesis method of Synthesis Example 14, S1 (12.5 g) and NEP (2.51 g) were added, followed by stirring at 70 ° C for 24 hours to dissolve. To this solution, K1 (0.08g) and BCS (10.0g) were added and stirred at 40 ° C for 5 hours to obtain a composition (16). In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a homogeneous solution. In addition, this composition (16) is also used for evaluation of the liquid crystal alignment treatment agent (16).
使用所得之組成物(16)及液晶配向處理劑(16),進行「組成物及液晶配向處理劑印刷性之評估(沙孔 之評估)」、「組成物及液晶配向處理劑印刷性之評估(塗膜端部之評估)」及「電壓保持率(VHR)之評估(一般晶胞)」。 Using the obtained composition (16) and liquid crystal alignment treatment agent (16), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (Sha Kong "Evaluation", "Evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of the coating film end)" and "Evaluation of the voltage retention rate (VHR) (general cell)".
於合成例15之合成方法所得之聚醯亞胺粉末(15)(1.60g)中,加入S1(15.0g)及γ-BL(2.51g),於70℃下攪拌24小時使其溶解。於此溶液中,加入K1(0.08g)、BCS(2.51g)及PB(5.01g),於40℃下,攪拌5小時,得組成物(17)。此組成物中,確認未發現混濁或析出物等異常,而為均勻之溶液。又,此組成物(17)亦作為液晶配向處理劑(17)之評估用。 To the polyimide powder (15) (1.60 g) obtained by the synthesis method of Synthesis Example 15, S1 (15.0 g) and γ-BL (2.51 g) were added and stirred at 70 ° C for 24 hours to dissolve. To this solution, K1 (0.08g), BCS (2.51g) and PB (5.01g) were added, and the mixture was stirred at 40 ° C for 5 hours to obtain a composition (17). In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a homogeneous solution. In addition, this composition (17) is also used for evaluation of the liquid crystal alignment treatment agent (17).
使用所得之組成物(17)及液晶配向處理劑(17),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「組成物及液晶配向處理劑印刷性之評估(塗膜端部之評估)」及「電壓保持率(VHR)之評估(一般晶胞)」。 Using the obtained composition (17) and liquid crystal alignment treatment agent (17), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)" and "evaluation of the printability of the composition and liquid crystal alignment treatment agent" (Evaluation of coating film end) "and" Evaluation of voltage retention rate (VHR) (general cell) ".
於合成例16之合成方法所得之聚醯亞胺粉末(16)(1.70g)中,加入S1(2.66g)及NEP(10.7g),於70℃下攪拌24小時使其溶解。於此溶液中,加入BCS(5.33g)及PB(7.99g),於40℃下,攪拌3小時,得組成物(18)。此組成物中,確認未發現混濁或析出物等異常,而為均勻之溶 液。又,此組成物(18)亦作為液晶配向處理劑(18)之評估用。 To the polyimide powder (16) (1.70 g) obtained by the synthesis method of Synthesis Example 16, S1 (2.66 g) and NEP (10.7 g) were added, followed by stirring at 70 ° C for 24 hours to dissolve. To this solution, BCS (5.33g) and PB (7.99g) were added and stirred at 40 ° C for 3 hours to obtain a composition (18). In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a uniform solution liquid. In addition, this composition (18) is also used for evaluation of the liquid crystal alignment treatment agent (18).
使用所得之組成物(18)及液晶配向處理劑(18),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「組成物及液晶配向處理劑印刷性之評估(塗膜端部之評估)」及「電壓保持率(VHR)之評估(一般晶胞)」。 Using the obtained composition (18) and liquid crystal alignment treatment agent (18), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)" and "evaluation of the printability of the composition and liquid crystal alignment treatment agent" (Evaluation of coating film end) "and" Evaluation of voltage retention rate (VHR) (general cell) ".
於合成例17之合成方法所得之聚醯亞胺粉末(17)(1.60g)中,加入S1(8.77g)及NMP(5.01g),於70℃下攪拌24小時使其溶解。於此溶液中,加入BCS(8.77g)及EC(2.51g),於40℃下,攪拌3小時,得組成物(19)。此組成物中,確認未發現混濁或析出物等異常,而為均勻之溶液。又,此組成物(19)亦作為液晶配向處理劑(19)之評估用。 To the polyimide powder (17) (1.60 g) obtained by the synthesis method of Synthesis Example 17, S1 (8.77 g) and NMP (5.01 g) were added and stirred at 70 ° C for 24 hours to dissolve. To this solution, BCS (8.77g) and EC (2.51g) were added, and stirred at 40 ° C for 3 hours to obtain a composition (19). In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a homogeneous solution. In addition, this composition (19) is also used for evaluation of the liquid crystal alignment treatment agent (19).
使用所得之組成物(19)及液晶配向處理劑(19),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「組成物及液晶配向處理劑印刷性之評估(塗膜端部之評估)」及「電壓保持率(VHR)之評估(一般晶胞)」。 Using the obtained composition (19) and liquid crystal alignment treatment agent (19), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)" and "evaluation of the printability of the composition and liquid crystal alignment treatment agent" (Evaluation of coating film end) "and" Evaluation of voltage retention rate (VHR) (general cell) ".
於合成例18之合成方法所得之聚醯亞胺粉末(18) (1.60g)中,加入S1(10.0g)及NEP(3.76g),於70℃下攪拌24小時使其溶解。於此溶液中,加入BCS(3.76g)及PB(7.52g),於40℃下,攪拌3小時,得組成物(20)。此組成物中,確認未發現混濁或析出物等異常,而為均勻之溶液。又,此組成物(20)亦作為液晶配向處理劑(20)之評估用。 Polyimide powder obtained by the synthesis method of Synthesis Example 18 (18) To (1.60g), S1 (10.0g) and NEP (3.76g) were added and stirred at 70 ° C for 24 hours to dissolve. To this solution, BCS (3.76g) and PB (7.52g) were added and stirred at 40 ° C for 3 hours to obtain a composition (20). In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a homogeneous solution. In addition, this composition (20) is also used for evaluation of the liquid crystal alignment treatment agent (20).
使用所得之組成物(20)及液晶配向處理劑(20),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「組成物及液晶配向處理劑印刷性之評估(塗膜端部之評估)」及「電壓保持率(VHR)之評估(一般晶胞)」。 Using the obtained composition (20) and liquid crystal alignment treatment agent (20), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)" and "evaluation of the printability of the composition and liquid crystal alignment treatment agent" (Evaluation of coating film end) "and" Evaluation of voltage retention rate (VHR) (general cell) ".
於合成例19之合成方法所得之樹脂固體成份濃度25質量%之聚醯胺酸溶液(19)(10.0g)中,加入NMP(16.0g)及BCS(15.7g),於25℃下攪拌4小時,得組成物(21)。此組成物中,確認未發現混濁或析出物等異常,而為均勻之溶液。又,此組成物(21)亦作為液晶配向處理劑(21)之評估用。 To the polyamic acid solution (19) (10.0g) with a resin solid content concentration of 25% by mass obtained by the synthesis method of Synthesis Example 19, NMP (16.0g) and BCS (15.7g) were added and stirred at 25 ° C 4 In hours, the composition (21) is obtained. In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a homogeneous solution. In addition, this composition (21) is also used for evaluation of a liquid crystal alignment treatment agent (21).
使用所得之組成物(21)及液晶配向處理劑(21),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「組成物及液晶配向處理劑印刷性之評估(塗膜端部之評估)」及「電壓保持率(VHR)之評估(一般晶胞)」。 Using the obtained composition (21) and liquid crystal alignment treatment agent (21), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)" and "evaluation of the printability of the composition and liquid crystal alignment treatment agent" (Evaluation of coating film end) "and" Evaluation of voltage retention rate (VHR) (general cell) ".
於合成例3之合成方法所得之聚醯亞胺粉末(3)(1.70g)中,加入NMP(14.7g),於70℃下攪拌24小時使其溶解。於此溶液中,加入BCS(12.0g),於40℃下,攪拌3小時,得組成物(22)。此組成物中,確認未發現混濁或析出物等異常,而為均勻之溶液。又,此組成物(22)亦作為液晶配向處理劑(22)之評估用。 To the polyimide powder (3) (1.70 g) obtained by the synthesis method of Synthesis Example 3, NMP (14.7 g) was added and stirred at 70 ° C for 24 hours to dissolve. To this solution, BCS (12.0g) was added and stirred at 40 ° C for 3 hours to obtain a composition (22). In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a homogeneous solution. In addition, this composition (22) is also used for evaluation of the liquid crystal alignment treatment agent (22).
使用所得之組成物(22)及液晶配向處理劑(22),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「組成物及液晶配向處理劑印刷性之評估(塗膜端部之評估)」及「電壓保持率(VHR)之評估(一般晶胞)」。 Using the obtained composition (22) and liquid crystal alignment treatment agent (22), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)" and "evaluation of the printability of the composition and liquid crystal alignment treatment agent" (Evaluation of coating film end) "and" Evaluation of voltage retention rate (VHR) (general cell) ".
於合成例20之合成方法所得之樹脂固體成份濃度25質量%之聚醯胺酸溶液(20)(10.5g)中,加入NMP(14,7g)及BCS(18.5g),於25℃下攪拌4小時,得組成物(23)。此組成物中,確認未發現混濁或析出物等異常,而為均勻之溶液。又,此組成物(23)亦作為液晶配向處理劑(23)之評估用。 To the polyamic acid solution (20) (10.5g) with a resin solid content concentration of 25% by mass obtained by the synthesis method of Synthesis Example 20, NMP (14,7g) and BCS (18.5g) were added and stirred at 25 ° C After 4 hours, the composition (23) was obtained. In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a homogeneous solution. In addition, this composition (23) is also used for evaluation of the liquid crystal alignment treatment agent (23).
使用所得之組成物(23)及液晶配向處理劑(23),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「組成物及液晶配向處理劑印刷性之評估(塗 膜端部之評估)」及「電壓保持率(VHR)之評估(一般晶胞)」。 Using the obtained composition (23) and liquid crystal alignment treatment agent (23), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)" and "evaluation of the printability of the composition and liquid crystal alignment treatment agent" (Tu "Evaluation of membrane end)" and "Evaluation of voltage retention rate (VHR) (general cell)".
於合成例6之合成方法所得之聚醯亞胺粉末(6)(1.65g)中,加入NMP(14.2g),於70℃下攪拌24小時使其溶解。於此溶液中,加入BCS(11.6g),於40℃下,攪拌3小時,得組成物(24)。此組成物中,確認未發現混濁或析出物等異常,而為均勻之溶液。又,此組成物(24)亦作為液晶配向處理劑(24)之評估用。 To the polyimide powder (6) (1.65 g) obtained by the synthesis method of Synthesis Example 6, NMP (14.2 g) was added and stirred at 70 ° C for 24 hours to dissolve. To this solution, BCS (11.6g) was added and stirred at 40 ° C for 3 hours to obtain a composition (24). In this composition, it was confirmed that there was no abnormality such as turbidity or precipitates, but a homogeneous solution. In addition, this composition (24) is also used for evaluation of the liquid crystal alignment treatment agent (24).
使用所得之組成物(24)及液晶配向處理劑(24),進行「組成物及液晶配向處理劑印刷性之評估(沙孔之評估)」、「組成物及液晶配向處理劑印刷性之評估(塗膜端部之評估)」及「電壓保持率(VHR)之評估(一般晶胞)」。 Using the obtained composition (24) and liquid crystal alignment treatment agent (24), "evaluation of the printability of the composition and liquid crystal alignment treatment agent (evaluation of sand holes)" and "evaluation of the printability of the composition and liquid crystal alignment treatment agent" (Evaluation of coating film end) "and" Evaluation of voltage retention rate (VHR) (general cell) ".
由上述結果得知,本發明之實施例的組成物所得之聚醯亞胺膜,與比較例之組成物所得之聚醯亞胺膜相比較時,顯示出未發生沙孔而具有均勻的塗膜性,此外,聚醯亞胺膜之端部具有高度之直線性,且其端部之膨大狀態亦為較小。具體而言,例如,使用本發明之(A)成份的特定溶劑之組成物,與不使用該成份之組成物相比較,即,實施例2與比較例1之比較、實施例3與比較例2之比較、實施例5與比較例3之比較及實施例6與比較例4之比較。該些比較例中,與對應之實施例相比較時,得知於聚醯亞胺膜上的沙孔數為更多,此外,聚醯亞胺膜之塗膜端部的塗膜性亦為不佳等結果。又,該些實施例之組成物,亦作為液晶配向處理劑進行評估,使用該些組成物的實施例之結果,亦作為液晶配向處理劑之結果。 From the above results, it can be seen that the polyimide film obtained from the composition of the examples of the present invention shows a uniform coating without occurrence of sand holes when compared with the polyimide film obtained from the composition of the comparative example. In addition, the end of the polyimide film has a high degree of linearity, and the expanded state of the end is also small. Specifically, for example, a composition using a specific solvent of the (A) component of the present invention is compared with a composition not using the component, that is, the comparison between Example 2 and Comparative Example 1, Example 3 and Comparative Example Comparison of 2, comparison between Example 5 and Comparative Example 3, and comparison between Example 6 and Comparative Example 4. In these comparative examples, when compared with the corresponding examples, it is known that the number of sand holes in the polyimide film is more, and the coating film property of the coating film end of the polyimide film is also Poor results. In addition, the compositions of these examples were also evaluated as liquid crystal alignment treatment agents, and the results of the examples using these compositions were also used as results of liquid crystal alignment treatment agents.
又,使用本發明之組成物的液晶配向處理劑所得之液晶配向膜,與比較例之液晶配向處理劑所得之液晶配向膜相比較時,得知即使製作液晶配向膜之際的燒結為低溫狀態時,液晶顯示元件中之電壓保持率(亦稱為VHR)亦為更優良之結果。具體而言,例如,使用本發明 之(A)成份之特定溶劑的液晶配向處理劑,與不使用該成份之液晶配向處理劑之比較,即,實施例2與比較例1之比較、實施例3與比較例2之比較、實施例5與比較例3之比較及實施例6與比較例4之比較。該些比較例中,與對應之實施例相比較時,得知其VHR之值為更低值。特別是,不僅製作液晶晶胞後即刻之數值,於高溫槽保管後之數值亦為更低值,即,確認伴隨高溫其VHR之降低顯得更為劇烈之結果。 In addition, when the liquid crystal alignment film obtained by using the liquid crystal alignment treatment agent of the composition of the present invention is compared with the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the comparative example, it is known that even when the liquid crystal alignment film is produced, the sintering is at a low temperature state At this time, the voltage retention ratio (also called VHR) in the liquid crystal display element is also a better result. Specifically, for example, using the present invention (A) The liquid crystal alignment treatment agent of the specific solvent of the component is compared with the liquid crystal alignment treatment agent not using the component, that is, the comparison between Example 2 and Comparative Example 1, the comparison between Example 3 and Comparative Example 2, and the implementation Comparison between Example 5 and Comparative Example 3 and between Example 6 and Comparative Example 4. Among these comparative examples, when compared with the corresponding examples, it is found that the VHR value is a lower value. In particular, not only the value immediately after the production of the liquid crystal cell, but also the value after storage in the high-temperature bath is a lower value, that is, it is confirmed that the decrease in VHR with the high temperature appears to be more drastic.
本發明之組成物,成聚醯亞胺膜之際,可製得一種抑制伴隨潑彈所造成之沙孔的產生,且端部之塗膜性亦為優良之聚醯亞胺膜。此時,即使進行低溫之燒結,也可以製作聚醯亞胺膜。 When the composition of the present invention forms a polyimide film, a polyimide film that suppresses the generation of sand holes caused by splashing and has excellent coating properties at the end can be prepared. At this time, even if low-temperature sintering is performed, a polyimide film can be produced.
又,將本發明之組成物作為液晶配向處理劑使用時,可製得一種抑制伴隨潑彈所造成之沙孔的產生,且端部之塗膜性亦為優良的液晶配向膜。此外,即使製作液晶配向膜之際的燒結為低溫狀態時,於液晶顯示元件中亦可形成具有優良電氣特性,特別是電壓保持率(亦稱為VHR)為優良之液晶配向膜。因此,具有本發明之液晶配向處理劑所得之液晶配向膜的液晶顯示元件,為具有優良信賴性者,而可適用於大畫面且高精細度之液晶電視或中小型之汽車導航系統或智慧手機等,且對於TN元件、STN元件、TFT液晶元件,特別是VA 模式、PSA模式及SC-PVA模式等之垂直配向型的液晶顯示元件為有用者。 In addition, when the composition of the present invention is used as a liquid crystal alignment treatment agent, a liquid crystal alignment film that suppresses the generation of sand holes caused by splashing and has excellent coating film properties at the ends can be obtained. In addition, even when the sintering at the time of manufacturing the liquid crystal alignment film is in a low temperature state, a liquid crystal alignment film having excellent electrical characteristics, particularly excellent voltage retention (also referred to as VHR) can be formed in the liquid crystal display element. Therefore, the liquid crystal display device having the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present invention is one with excellent reliability and can be applied to a large-screen and high-definition LCD TV or a small and medium-sized car navigation system or smartphone Etc., and for TN elements, STN elements, TFT liquid crystal elements, especially VA Vertical alignment type liquid crystal display elements such as mode, PSA mode and SC-PVA mode are useful.
Claims (23)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013213117 | 2013-10-10 | ||
JP2013-213117 | 2013-10-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201529659A TW201529659A (en) | 2015-08-01 |
TWI649362B true TWI649362B (en) | 2019-02-01 |
Family
ID=52813207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW103135373A TWI649362B (en) | 2013-10-10 | 2014-10-13 | Composition, liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP6668754B2 (en) |
KR (1) | KR102259997B1 (en) |
CN (1) | CN105814141B (en) |
TW (1) | TWI649362B (en) |
WO (1) | WO2015053394A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6593021B2 (en) * | 2015-08-07 | 2019-10-23 | Jsr株式会社 | Liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element |
WO2017170943A1 (en) * | 2016-03-31 | 2017-10-05 | 日産化学工業株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
JP6786861B2 (en) * | 2016-04-26 | 2020-11-18 | 宇部興産株式会社 | Polyimide precursor, polyimide, polyimide film, polyimide laminate, polyimide / hard coat laminate |
CN109643038B (en) * | 2016-08-24 | 2022-01-25 | 日产化学株式会社 | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element |
KR102225386B1 (en) * | 2017-02-28 | 2021-03-08 | 제이에스알 가부시끼가이샤 | Liquid crystal aligning agent, liquid crystal aligning film and its manufacturing method, liquid crystal element, and polymer |
CN110945416B (en) * | 2017-07-27 | 2022-08-26 | 日产化学株式会社 | Resin composition, resin film, and liquid crystal display element |
JP7074142B2 (en) * | 2017-11-20 | 2022-05-24 | Jsr株式会社 | Manufacturing method of liquid crystal element |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201443157A (en) * | 2013-05-09 | 2014-11-16 | Jsr Corp | Liquid crystal aligning agent and method for producing liquid crystal aligning agent, liquid crystal aligning film, liquid crystal display element, method for producing liquid crystal aligning film, retardation film and method for producing retardation |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0237324A (en) | 1988-07-27 | 1990-02-07 | Sanyo Electric Co Ltd | Production of polyimide oriented film |
JP4154736B2 (en) * | 1996-06-21 | 2008-09-24 | チッソ株式会社 | varnish |
JP5899605B2 (en) | 2010-01-12 | 2016-04-06 | Jnc株式会社 | Thermosetting composition |
JP5911123B2 (en) * | 2011-09-01 | 2016-04-27 | とし子 岩井 | Sanitary sheet set for wiping off the deposits of instruments that have come into contact with food, and method for wiping and reducing deposits on instruments that have touched food |
JP5852411B2 (en) * | 2011-10-31 | 2016-02-03 | アスモ株式会社 | Rotor and motor |
JP5999107B2 (en) | 2012-01-18 | 2016-09-28 | 日産化学工業株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
KR102159410B1 (en) * | 2013-03-14 | 2020-09-23 | 제이엔씨 주식회사 | Liquid crystal aligning agents and liquid crystal display devices |
-
2014
- 2014-10-10 WO PCT/JP2014/077219 patent/WO2015053394A1/en active Application Filing
- 2014-10-10 CN CN201480067004.XA patent/CN105814141B/en active Active
- 2014-10-10 KR KR1020167011818A patent/KR102259997B1/en active Active
- 2014-10-10 JP JP2015541652A patent/JP6668754B2/en active Active
- 2014-10-13 TW TW103135373A patent/TWI649362B/en active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201443157A (en) * | 2013-05-09 | 2014-11-16 | Jsr Corp | Liquid crystal aligning agent and method for producing liquid crystal aligning agent, liquid crystal aligning film, liquid crystal display element, method for producing liquid crystal aligning film, retardation film and method for producing retardation |
Also Published As
Publication number | Publication date |
---|---|
KR102259997B1 (en) | 2021-06-02 |
JPWO2015053394A1 (en) | 2017-03-09 |
CN105814141B (en) | 2018-12-11 |
TW201529659A (en) | 2015-08-01 |
KR20160070777A (en) | 2016-06-20 |
CN105814141A (en) | 2016-07-27 |
WO2015053394A1 (en) | 2015-04-16 |
JP6668754B2 (en) | 2020-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI620794B (en) | Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element | |
TWI649362B (en) | Composition, liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element | |
KR102234876B1 (en) | Liquid-crystal orientation treatment agent, liquid-crystal orientation film, and liquid-crystal display element | |
TWI673548B (en) | Liquid crystal alignment treatment agent and liquid crystal display element using same | |
KR102218510B1 (en) | Treatment agent for liquid crystal orientation, liquid crystal orientation film, and liquid crystal display device | |
JP6083382B2 (en) | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element | |
TWI513753B (en) | A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device | |
TWI649411B (en) | Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element | |
KR102026039B1 (en) | Composition liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element | |
JP6617878B2 (en) | Liquid crystal alignment treatment agent and liquid crystal display element using the same | |
KR102135493B1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
TWI638008B (en) | Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element | |
JPWO2020080477A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element using it | |
JP6575770B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
WO2016076412A1 (en) | Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element |